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Abstract 
Duchenne muscular dystrophy (DMD) is an inherited, lethal disorder characterised 
by progressive muscle degeneration and associated bone abnormalities. It has 
previously demonstrated that P2RX7, a purinergic receptor, contributed to the 
pathogenesis of DMD, and found that P2RX7 ablation alleviated the severity of the 
disease. In this work a dystrophic mdx mouse crossed with the global P2RX7 
receptor has been used to generate a knockout mouse model (mdx/P2X7-/-), and 
compared its morphometric, mechanical and tissue properties against those of mdx, 
a mouse model without the dystrophin protein, as well as a wild type (WT) and a 
P2RX7 knockout (P2X7-/-).  Micro-computed tomography (µCT), three-point bending 
testing, scanning electron microscopy (SEM) and nanoindentation were utilised in 
the study. The bones were analysed at approximately 4 weeks of age to examine the 
impact of P2RX7 ablation on the bone properties during the acute disease phase, 
before muscle wasting is fully developed.  
The results show that P2RX7 purinoceptor ablation has produced improvement or 
significant improvement in some of the morphological, mechanical and tissue 
properties of the dystrophic bones examined. Specifically, although the ablation 
produced smaller bones with significantly lower total cross-section area (Tt.Ar) and 
Second Moment of Area (SMA), significantly higher cortical bone area (Ct.Ar), 
cortical bone area ratio (Ct.Ar/Tt.Ar) and trabecular bone volume fraction (BV/TV) 
are found in the mdx/P2X7-/- mice than in any other types. Further, the mdx/P2X7-/- 
bones have relatively higher average flexural strength, work-to-fracture and 
significantly higher strain to failure compared with those of mdx, suggesting greater 
resistance to fracture. Indentation modulus, elasticity and creep are also significantly 
improved in the knockout cortical bones over those of mdx. These findings seem to 
suggest that specific pharmacological blockade of P2RX7 may improve dystrophic 
bones, with a potential for therapeutic application in the treatment of the disease.  
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Glossary 
 
Gene A gene is a functional unit, usually encoding a protein or 
RNA, whose inheritance can be followed experimentally. 
Mutation  A mutation is a particular class of variant allele that 
usually confers a phenotypically identifiable difference to 
a reference "wild type" phenotype. 
Recessive A recessive phenotype is one that is only detected when 
both alleles have a particular variant or mutation 
Genotype Genotype is the description of the genetic composition of 
the animals, usually in terms of particular alleles at 
particular loci. 
Phenotype Phenotype is the result of interaction between genotype 
and the environment and can be determined by any 
assay. 
Z-score It can be derived by any value in such a set of data by 
dividing the value of its difference from the mean by 
standard deviation (SD) value. 
Cardiomyopathy The heart muscle becomes enlarged, thick, or rigid. In 
rare cases, the muscle tissue in the heart is replaced with 
scar tissue 
Sarcolemma Also called the myolemma, is the cell membrane of a 
striated muscle fiber cell. 
Myolemma The thin, transparent, extensible membrane covering 
every striated muscle fiber. 
Promoter A region of DNA that initiates transcription of a particular 
gene. Promoters are located near the transcription start 
sites of genes, on the same strand and upstream on the 
DNA. 
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DAP Dystrophin-associated protein is a protein that helps to 
form the connection between intracellular dystrophin and 
the extracellular basal lamina. 
GABA Gamma-aminobutyric acid (GABA) is a major inhibitory 
neurotransmitter in the central nervous system.  
Paracrine signaling A form of cell-to-cell communication in which a cell 
produces a signal to induce changes in nearby cells, 
altering the behaviour or differentiation of those cells. 
SAMR1   Age-matched normal mouse or control 
SAMP6   Senescence-accelerated mouse or senile osteoporosis 
PND 35   Postnatal days 35 
PND 70   Postnatal days 70 
Ahr−/− Aryl hydrocarbon receptor (AHR) knockout. It is a ligand-
activated transcriptional regulator, is ubiquitously 
expressed in most organs and can be activated by a 
structurally diverse range of chemicals of which the best 
characterised ones include a variety of environmental 
contaminants. 
Ahr+/+    Wild-type or control 
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin is a polychlorinated 
dibenzo-p-dioxin (sometimes shortened, though 
inaccurately, to simply "dioxin") with the chemical formula 
C12H4Cl4O2. TCDD is a colourless solid with no 
distinguishable odour at room temperature. It is usually 
formed as a side product in organic synthesis and 
burning of organic materials. 
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Chapter 1 
Introduction  
Duchenne muscular dystrophy (DMD) is the most common type of muscular 
dystrophy. It is a debilitating disease causing progressive muscle degeneration 
leading to severe disability and death of young men. DMD is also associated with 
cognitive impairment. Loss of dystrophin in DMD disrupts structural scaffolds for 
dystrophin-associated proteins as well as specific signaling processes, causing 
cognitive and behavioural impairment and bone structure abnormalities (Blake et al., 
2002), both independent of functional muscle impairment.  Both patients (Rufo et al., 
2011) and mdx (DMD model) mice  (Nakagaki et al., 2011) were found to have lower 
bone mass, which is strongly associated with the degree of motor function and 
muscle strength. The decline in bone mineral density is usually attributed to the 
progressive muscle fiber degeneration, although there may be other factors inherent 
to the disease which also contribute to bone tissue impairment (Akhter et al., 2004; 
Beaupied et al., 2007; Nakagaki et al., 2011).   
The ability of bone to adapt to mechanical loads is usually linked to muscle activity, 
and bone loss in muscle paralysis is indicative of the importance of mechanical 
stimulation for bone regulation. In the late stages of DMD progression, the impact of 
muscle loss on the dystrophic bone structure is evident. However, early bone 
abnormalities found prior to substantial muscle loss indicate that there may be other 
factors inherent to DMD, which also contribute to the loss of bone mass (Anderson et 
al., 1993; Bianchi and Morandi, 2008; Nakagaki and Camilli, 2012). Studies by 
Anderson et al. (1993), Rufo et al. (2011) and Novotny et al. (2011) showed up to 
50% loss in strength and stiffness in mdx mouse model of DMD compared to those 
of the control, resulting in the development of micro-damage (Saito and Marumo, 
2010) and bone fracture (Bianchi and Morandi, 2008). 
As a result of low bone mass, DMD patients have significant increased risk of 
fracture (McDonald et al., 2002; Pouwels et al., 2013; Vestergaard et al., 2001) and 
commonly sustain low-energy fractures. Falling was the most common mechanism 
of fracture affecting mostly in the lower limb (McDonald et al., 2002). Early bone 
abnormality studies on mice bone have revealed severely reduced bone mass 
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causing bone structural changes. The structural changes in bone are sensed by 
bone cells which adjust bone tissue mass and architecture in response to the 
mechanical load applied (Anderson et al., 1993).    
Bone tissue consists of organic and inorganic materials, such as minerals including 
calcium, phosphate and collagen. These elements make the bone tissue strong, and 
one of the most rigid structures in the body (Dalla and Bankoff, 2012). For example, 
collagen gives the bone tissue properties such as flexibility and the ability to support 
tensile loads, while minerals support compressive loads. It is essentially a complex 
viscoelastic composite with hierarchically organised structure (Figure 1-1). It has 
regular, yet optimised, arrangement and orientation of the components, making bone 
as a heterogeneous and anisotropic material (Rho et al., 1998). 
 
Figure 1-1 Hierarchical structural organisation of bone. 
(a) cortical and cancellous bone; (b) osteons with Haversian systems; (c) lamellae; 
(d) collagen fiber assemblies of collagen fibrils; (e) bone mineral crystals, collagen 
molecules, and non-collagenous proteins (Rho et al., 1998).  
 
Frost (Frost, 1987) was the first to articulate the importance of functional bone strain 
as a controlling stimulus for bone architecture, a relationship that has come to be 
known as the mechanostat, which is a model describing bone growth and bone loss. 
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It is a refinement of Wolff's law described by Julius Wolff (1836–1902). He suggested 
that survival of the skeleton (but also of other tissues, such as fibrous tissue, hyaline 
cartilage, fibrocartilage, cementum, or dentin) requires the functional coordination of 
modeling and remodeling. Modeling adapts bone to overloads, by enhancing 
additions of new bones and by changing bone architecture, and remodeling adapts 
bone to underloads by removing bone next to marrow and conserving normally used 
bone. Bone growth and bone loss is stimulated by the local mechanical elastic 
deformation of bone. Generally strains lower than 800μStrain would lead to 
resorption; a strain between 800μStrain and 1500μStrain would lead to bone 
adaptation, whilst over 1500μStrain leads to overload and fracture occurs at 
approximately 15000μStrain. There is a mechanism that monitors bone metabolism 
(longitudinal growth, bone modeling, and remodeling activities) in relation to 
mechanical usage (Tyrovola, 2015). 
Several scenarios have been envisaged on the mechanisms behind the DMD bone 
abnormality (Abou-Khalil et al., 2013; Bianchi et al., 2003; Rufo et al., 2011). DMD 
causes absence of dystrophin, which disrupts structural scaffolds involving 
dystrophin-associated proteins and loss of anchoring for specific signaling proteins 
(Blake et al., 2002). Therefore, the absence of dystrophin could be directly 
responsible for bone structure alterations. However, there is no data on dystrophin 
being expressed in osteoblasts or osteoclasts. On the other hand, dystrophic muscle 
degeneration is associated with chronic sterile inflammation. Abou-Khalil et al. 
(2013) demonstrated that chronic inflammation contributes to dystrophic bone 
damage. In DMD patients, prolonged corticosteroid treatment can further exacerbate 
this abnormality (Bianchi et al., 2003; Söderpalm et al., 2007).   
Genetic knockout mice have been widely studied to demonstrate the improvement or 
deterioration of diseases (Nakagaki et al., 2011). This approach has great 
significance in alternative therapeutic advances targeted towards clinical application 
in humans. Knockout mice have one or more genes disrupted to develop an animal 
model for a certain disease. These genetically disrupted mice can then be 
investigated to understand the physiology of their function, which can be applied to 
others. The characteristics of the animal models can be demonstrated through 
symptoms that depend on which genes or receptors are altered. 
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DMD gene mutations are associated with P2RX7 purinoceptor up-regulation, which 
leads to the death of human DMD lymphoblasts (Ferrari et al., 1994) and muscles in 
the mdx mouse model of DMD (Yeung et al., 2006; Young et al., 2012, 2013). 
P2RX7 activation in mdx muscles triggers a specific mechanism of autophagic cell 
death (Young et al., 2015). Recent work showed that this receptor is a good target 
for pharmacological treatment of DMD, as its genetic ablation (knockout) reduced 
both muscle loss and inflammation (Sinadinos et al., 2015). P2RX7 is expressed in 
both osteoblasts and osteoclasts, but it appears to have different roles in bone 
physiology and in disease states. Unfortunately, what these roles are is still unclear 
as different P2RX7 knockouts produced conflicting results on whether it affects bone 
formation or bone resorption or both. In this work, the influence of P2RX7 inhibition 
on the morphological and the mechanical behaviour of the bones were examined. 
Given that the bone abnormalities in mdx mice have been linked to chronic 
inflammation (Abou-Khalil et al., 2013), the reduced inflammation found in 
mdx/P2X7-/- muscles (Sinadinos et al., 2015) may be responsible for the reduced 
bone loss in these mice.  If P2RX7 is abnormally active in dystrophic bones, its 
absence might improve the bone properties.  On the other hand, activation of P2RX7 
receptor has been linked primarily to osteoclast functions (Agrawal and Gartland, 
2015; Agrawal et al., 2003; Gartland, 2012), hence its ablation could have a negative 
impact on the bone.  It is hypothesise that P2RX7 ablation would not exacerbate the 
dystrophic bone phenotype.  To test the hypothesis, a previously established double 
mutant (mdx/P2X7-/-, Sinadinos et al. 2015) has been used, examined the 
morphometric, mechanical and tissue properties of long bones of mdx/P2X7-/- mice 
against those of mdx as well as wild type (WT) and P2RX7 knockout (P2X7-/-) mice. 
Young et al. (2012)  reported that there was abnormally high activity of P2RX7 in the 
dystrophic muscle. Based on the alleviation of symptoms in mdx mice with the 
P2RX7 receptor disrupted (Sinadinos et al., 2015), it was concluded that the P2RX7 
disruption improved the dystrophic mice bone and muscle in six-month-old mice. The 
positive impact of depletion of P2RX7 on bone tissue could be investigated using 
non-destructive µCT, which has significant advantages in terms of imaging the tissue 
at high resolution.    
Biomedical imaging technology is of vital importance in the field medical diagnosis. 
Its contribution brings new knowledge leading to improved life for future generations. 
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There is no doubt that biomedical imaging has facilitated new treatments to disease. 
This is due to its unique ability to provide anatomical and physiological information. 
In humans, imaging modalities such as conventional x-ray, computed tomography 
(CT), magnetic resonance imaging (MRI) and ultrasound are well-established tools in 
modern medicine. They have made great contributions towards detecting and 
characterizing pathologies in humans, such as cancer. The same applies to animal 
research studies. The development of µCT has created a system that allows 
researchers to see the microstructure of animals without destroying tissues. This is 
of great significance in modern medicine, as it enables study of disease at the 
molecular level (Paulus et al., 2000; Ritman, 2006, 2002; Schambach et al., 2010).  
Previous literature applying µCT and histomorphometry on mdx and wild-type mice 
has found evidence that bone tissues are affected in mdx mice similar to low Z-
scores observed in patients (Nakagaki and Camilli, 2012; Rufo et al., 2011). Z-score 
is a measure of bone mineral apparent density (BMAD) using DXA machine. It is the 
number of standard deviation by comparing a measurement to a reference sample of 
age- and gender-matched of healthy population. However, both the segmentation 
and the image analysis methods used to image mice bones are in need of updating 
(Rufo et al., 2011). The techniques used in this work therefore aim to extend 
previous work by combining µCT with image processing tools such as ImageJ/BoneJ 
plugins to quantify the skeletal phenotype of two knockout mice, as well as wild-type 
and dystrophic mice. An extended study using a three-point bending technique to 
determine the mechanical properties of the bone has also been conducted across 
the genotypes. A study of fracture mechanisms using the Scanning Electron 
Microscopy (SEM) has been used later to examine the micro-fracture paths and 
fracture modes. This is followed by a nanoindentation experiment to further compare 
the material properties of the mice bone at a microscopic level. This is the first time 
such technique has been used for the assessment of bone across the genotypes. 
 Description of Gaps in Research Literature 
The effect of P2RX7 disruption on bone morphology is unclear. There is no research 
data on the effects of the ablation of the receptor on bone morphology and properties 
in mice at an early age (four-week), or the impact of this receptor on mdx bones. 
Using the imaging protocol to create high-resolution µCT images, the bone 
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morphologies of knockout, mdx and wild-type mice can be quantified and compared. 
Furthermore, the biomechanical properties obtained from the mechanical testing can 
provide useful insight into the mechanical behaviour of the bones. Although several 
studies have reported on the biomechanical, biochemical and morphometry 
properties of mdx mice and control mice, there is no report on the tissue properties 
of the bones across the genotypes.  
Research Questions 
The fundamental question that motivates this doctoral research is: What role does 
the P2RX7 receptor play in the DMD disease process? To answer this question, the 
aim and objectives are given below. 
Statement of Aims 
Overall Aim 
The aim of this work is to develop an understanding of morphological and 
mechanical behaviour of mouse bone across the genotypes, by imaging hard tissues 
using micro-computed tomography, mechanical testing and nanoindentation to 
evaluate the structural, material and tissue properties of the bones.  
Objectives 
1: To compare the morphometric properties of different genotypes using micro CT 
imaging 
Utilising a state-of-the-art µCT scanner, imaging protocols were used to image mice 
tibias of four different genotypes.  
Recent evidence suggests that, at three weeks of age, mdx mice show bone 
abnormalities that are unlikely to be caused by muscle irregularities (Nakagaki et al., 
2011). For this reason, bones of wild-type, mdx and P2RX7 knockout and double 
knockout of four-week-old mice were used to establish whether blocking this 
receptor would have a direct effect on the bone structure.  
Following µCT imaging and subsequent 3D reconstruction of the four genotypes, 
including P2RX7 knockout mice, the images underwent processing using semi-
automated segmentation implemented in ImageJ (USA). The morphological 
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parameters implemented in BoneJ (Doube et al., 2010) involved were bone 
volume/total volume (BV/TV), trabecular thickness (Tb.Th), trabecular spacing 
(Tb.Sp) and connectivity density (Conn.D) at the proximal metaphyseal tibia, and 
total cross-sectional area (Tt.Ar), cortical bone area (Ct.Ar), and cortical area fraction 
(Ct.Ar/Tt.Ar) at the midtibia. These parameters define the bone structure and 
distribution for each genotype. Assessing whether disruption or blockade of the 
P2RX7 receptor can improve both muscles and bones in dystrophic mice is of great 
significance for the treatment of DMD, as all alternative therapeutic approaches used 
so far (including gene therapy) only target muscles.  
2. To evaluate the biomechanical properties of bone across the genotypes. 
Understanding how the bone responds to mechanical stress requires a description of 
the mechanical behaviour of bones. Thus, three-point-bending mechanical testing 
was carried out to assess the structural and material properties of the bones across 
the genotypes to assess the effects of the absence of dystrophin and P2RX7 
receptors.  The results were analysed together with the morphometric properties (1).  
3. To evaluate the tissue properties of the bones across the genotypes 
Nanoindentation was carried out to assess the bone tissue properties across the 
genotypes, and the results were analysed together with the morphometric properties 
(1) and structural and material properties (2).  
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Chapter 2 
Literature Review 
2.1 Bone Structure and Composition 
Bone of present-day mammals and birds is a stiff skeletal material made principally 
of the fibrous protein collagen, impregnated with a mineral closely resembling 
calcium phosphate. Bone also contains water, which is very important mechanically.  
Bone is the only structure that is essentially collagen mineralised with calcium 
phosphate and containing cell bodies (Currey, 2002). 
2.1.1 Bone Tissue 
Bone tissues are organised in a hierarchical level as shown in Table 2-1 and Figure 
2-1 (Rho et al., 1998).  
Table 2- 1 Bone Hierarchical Structure.  
Level Structure 
Macrostructure  Cortical bone and trabecular bone 
Microstructure (10-500 µm) 
Haversian systems, osteons, single 
trabeculae 
Sub-microstructure (1-10 µm) Lamellae 
Nanostructure (from a few hundred 
nanometers to 1 µm) 
Fibrillar collagen, embedded minerals 
Sub-nanostructure (below a few 
hundred nanometers) 
molecular structure of constituent 
elements, such as mineral, collagen, 
non-collagenous organic proteins 
 
At the macrostructure level, bone consists of cortical bone and trabecular bone. The 
trabecular bone is actively remodelled compared with the cortical bone. Every year, 
25% of trabecular bone whilst 2–3% of cortical bone undergoes remodelling 
(Swaminathan, 2001). In remodelling the bone involved is usually a small individual 
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packet called a basic multicellular unit (BMU), and typically the amount of bone 
remaining after the process is little changed; new bone has more or less replaced old 
bone. Therefore, the trabecular bone is considered younger than the cortical bone 
(Currey, 2002).    
At the microstructure level, the bone is composed of mineralised collagen fibres 
stacked parallel to form layers, called lamellae. All mature bone is mostly lamellar.  It 
also exists in a separate form: Haversian systems (used by British and other 
European) or secondary osteons (used by Americans) (Currey, 2002).  
 
Figure 2-1 Bone structure. 
(A) A gross anatomy of a mouse skeleton. (B) A mouse tibia bone showing the 
cortical part at diaphysis and trabecular part at the metaphysis towards the 
periphery. (C) A histological image of a transverse section of mouse cortical bone 
showing the circumferential lamellae.  Cortical bone remodeling is rare in mice, and 
most of the cortex comprises circumferential lamellae laid down on the outer 
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(periosteal) surface as the bone grows. While the remnants of the less well-
organised bone formed during endochondral ossification are seen on the inner 
(endosteal) surface (Adapted from Human and Mouse Atlas, 2012).   
 
2.1.1.1 Cortical bone 
Cortical bone, in both human and mouse species, forms a majority of the long bone 
diaphysis such as tibia and femur, and it surrounds a medullary cavity filled with 
yellow bone marrow that is mostly made of fat cells (Hadjidakis and Androulakis, 
2006; Treuting and Dintzis, 2012). Cortical bone has higher volume fraction of 
mineralised material (90-95%) and lower surface area than trabecular bone. This is 
due to a slower turnover rate compare to that of trabecular bone. In human and 
mammalian bones, the cortical bone porosity is usually less than 5% (Clarke, 2008). 
In mice, the cortical bone comprises a mixture of woven bone formed by 
endochondral ossification and circumferential lamellar bone laid down on the 
outside. In very young mice, the diaphyseal cortex contains a high proportion of 
woven bone. As the mouse ages, the woven bone is lost, and only circumferential 
lamellae remain. Mouse diaphyseal cortical bone rarely undergoes Haversian 
remodelling seen in human bone, thus does not usually contain osteons (Figure 2-1). 
Although there are no Haversian Systems (osteons), marrow-filled intracortical 
porosities develop with age. In contrast to mice, human cortical bone is composed of 
osteons circumferential lamellae on the outer and inner surfaces and interstitial 
lamellas between osteons (Figure 2-2).  
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Figure 2-2 (A) In a mouse model, the cortex comprises a mixture of woven bone 
formed by endochondral ossification and circumferential lamellar bone laid down on 
the outside. As the mouse ages, the woven bone is lost, and only circumferential 
lamellae remain. Although Haversian systems (osteons) and marrow-filled 
intracortical porosities do not develop with age. (B) In humans, Haversian systems 
(osteons) are the product of remodeling of bone and comprise a central vascular 
channel surrounded concentrically by bone lamellae. Continuous remodeling leads 
to overlapping, partial osteons (Adapted from Human and Mouse Atlas, 2012).  
 
2.1.1.2 Trabecular bone 
Trabecular bone is also known as spongy or cancellous bone. It has a porous 
structure where the spaces are filled with bone marrow and blood vessels. In mice, 
the primary spongiosa, comprised of bony trabeculae with cartilage cores and 
relatively little marrow space, lies in the first 250 µm or so below the cartilage growth 
plate (Figure 2-3) (Treuting and Dintzis, 2012). It is believed that trabecular bone 
plays an important role in supplying nutrients to the bone and has a relatively high 
metabolic activity (Hadjidakis and Androulakis, 2006). In very young mice, trabecular 
bone is woven in structure. Trabecular bone more actively remodels itself than does 
the cortical bone. As a result, trabecular bone is younger than the more mature 
cortical bone. Similar to human, trabecular bone of mice also remodels. Trabecular 
bone turnover in mice is approximately 0.7% per day as measured in the distal 
femur. Each episode of remodeling takes about 2 weeks to complete. In human, 
bone turnover is about 0.1% per day and each remodeling takes about 6-9 months to 
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complete. Age-related changes in bone mass in mice are dominated by age-related 
factors, not sex steroid deficiency as in both human and rodents. Knowledge of the 
causes of the disease in mice should therefore be applicable to human when the 
inherent limitations are recognised (Jilka, 2013). 
 
Figure 2-3 Histological images of immature trabecular bone.  
(A) In 6-week old mice, cartilage cores are present in trabeculae (TB) of the primary 
spongiosa (PS). The marrow cavity (MC) predominantly filled by hemopoietic tissue. 
(B) In human fetal bone, the trabeculae have cartilage cores that are remnants of the 
cartilage anlagen or growth plate (Adapted from Human and Mouse Atlas, 2012).  
 
2.1.2 Bone Matrix 
Bone matrix consists of water, the organic materials (collagen and non-collagenous 
proteins) and inorganic materials (mineral crystals) (Currey, 2002). The major 
organic constituent of bone is type I collagen, with trace amount of types III and V 
and FACIT collagens (Clarke, 2008). Type I collagen represents approximately 90% 
of the organic composition of the whole bone tissue. The inorganic materials known 
as crystals of hydroxyapatite (HA) [3Ca3(PO4)2·(OH)2] are found within the collagen 
fibres in the bone matrix, they tend to be oriented in the same direction as the 
collagen fibres  (Hadjidakis and Androulakis, 2006).  
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2.1.3 Bone Cells 
Bone is permeated by and lined by various kinds of specialised cells. There are four 
commonly known types of bone cells (Figure 2-4). The bone lining cells, osteoblasts, 
and osteoclasts cover the bone tissue surface while osteocytes are imprisoned in the 
hard bone tissue and connect with neighbouring osteocytes (Currey, 2002; 
Hadjidakis and Androulakis, 2006).  
 
Figure 2-4 Four types of cells are found within bone tissue.  
Osteogenic cells are undifferentiated and develop into osteoblasts. When 
osteoblasts get trapped within the calcified matrix, their structure and function 
changes, and they become osteocytes. Osteoclasts develop from monocytes and 
macrophages and differ in appearance from other bone cells (http://cnx.org).  
 
2.1.4 Osteoblasts and Osteocytes 
Osteoblasts derive from bone lining cells and are responsible for the formation of 
bone. They initially lay down the collagenous matrix, osteoid, in which mineral is later 
deposited, and they probably also have a role in its mineralisation (Currey, 2002). 
Osteoblasts do not function individually but are found in clusters along the bone 
surface, lining on the layer of bone matrix that they produce. They originate from 
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multipotent mesenchymal stem cells, which have the capacity to differentiate into 
osteoblasts, adipocytes, chondrocytes, myoblasts, or fibroblasts (Hadjidakis and 
Androulakis, 2006). As the new bone is formed, a small number of osteoblasts are 
trapped within the newly formed matrix and become osteocytes. The osteocytes are 
connected to each other and to the bone lining cells through a dense network of 
channels called canaliculli. They are responsible for regulating the bone remodelling 
by maintaining the oxygen and mineral levels in the bone through homeostasis 
process. In cancellous bone the density of the osteocytes varies from about 90,000 
mm-3 in rats to about 30,000 mm-3 in cows. In general, the larger the animal, the 
lower the density of osteocytes (Currey, 2002).  
Osteocytes are responsible for detecting and responding to mechanical loading and 
initiating the bone adaptation process. Osteocytes support osteoclast formation and 
activation when direct cell to cell contact with osteoclast precursors is allowed (You 
et al., 2008; Zhao et al., 2002). In addition, You et al. (2008) identified soluble signals 
as a mechanism osteocytes might use to regulate osteoclast formation due to 
mechanical loading. 
2.1.5 Osteoclasts 
Another type of bone tissue maintaining cells is osteoclasts. Osteoclasts are 
multinucleated cells derived from the monocytes which originate from bone marrow. 
Unlike osteoblasts, they are responsible for the resorption and replacement of old 
and damaged bone matrix. Osteoclasts are important in liberating minerals and other 
molecules stored in the bone matrix. They secrete an acid phosphatase to a specific 
site of the bone and unfix calcium in the mineralised bone to break it down. In time-
lapse photography they give the appearance of being extremely aggressive, 
clamping themselves to the bone’s surface and leaving a space underneath a ruffled 
border that is very mobile and beneath which the bone can be dissolving. Debris, 
both organic and mineral, are packed into little vesicles and pass through the cell 
body of the osteoclast and are dumped into the space above. When osteoclasts 
have done their job they disappear and presumably die (Currey, 2002).   
The presence or absence of mechanical stimulation have been reported by previous 
studies to affect the bone homeostasis, in association with osteoporosis  
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(Manolagas, 2000). A study in mice has shown that bone resorption is amplified in 
the absence of mechanical loading. The osteocytes might serve to attract and guide 
active osteoclasts to replace regions of damaged and disused bones (You et al., 
2008).   
2.1.6 Bone Remodeling 
Bone remodelling is a complex process to replace old with new bone tissues, and 
the interaction between the different cells is regulated by biochemical and 
mechanical factors (Hadjidakis and Androulakis, 2006). Bone cells include 
osteoblasts and osteoclasts responsible for formation of bone and break down the 
bone tissue to allow new bone formation, respectively. The functions of the bone 
cells are critical in providing bone tissue maintenance, repair and remodelling.  
Figure 2-5 shows a basic human bone remodeling process at 3-weeks and 3-
months, involving the bone cells and hormone regulator (i.e. parathyroid hormone 
(PTH), Calcitonin and Vitamin D). This process is important in both human and mice 
skeletal systems in order to maintain the homeostasis of the calcium and the integrity 
of bone structure. Histologically, the basic bone remodeling processes are similar. 
However, mouse cortical bone rarely undergoes Haversian remodeling as seen in 
human bone, and the mouse cortex mostly comprises circumferential lamellae 
instead of the osteonal structures common in human (Treuting and Dintzis, 2012). 
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Figure 2-5 An illustration of cells involved in bone remodeling cycle.  
The remodeling cycle consists of three phases: (1) resorption, at which point the 
osteoclasts digest old bone; (2) reversal, when mononuclear cells appear on the 
bone surface; and (3) formation, when osteoblasts form new bone in place of what 
has been resorbed (www.sierrasil.com). 
 
It is also essential to subsequently remodel woven bone into mature lamellar bone. 
At the nano-structural level, the bone lining cells regulate the movement of ions 
between the plasma and the bone, and they can be found on all surfaces of the 
bones. Osteoblasts are responsible for developing new bone tissues. Osteoblasts 
are thought to be derived from cells associated with blood vessels. Once active, they 
start to produce the organic component of bone which is osteoid. Osteoid is 
predominantly made from collagen. Minerals start to crystallise around the collagen 
scaffold to form Hydroxyapatite (HA) which contains calcium phosphate. 
 
2.1.7 Bone Mechanotransduction 
Several studies have investigated the mechanisms of impact of mechanical loading 
on bone cells. The transduction of the mechanical signals into the bone cells is 
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termed bone mechanotransduction. The process is important for the maintenance of 
skeletal homeostasis in human adults. At cell level, the applied mechanical forces 
are sensed by individual cells or certain sensor cells, and the sensation is active at 
the cellular level. At tissue level, this will generate biochemical signals in order to 
transduce the mechanical signals and modulate bone formation and resorption 
(Sikavitsas et al., 2001).  
It is believed that the mechanical properties of bone depend on a multi-level bone 
structure (Weiner and Wagner 1998; Rho et al., 1998). There is a correlation 
between the bone structures and their mechanical functions. Different levels of bone 
structure may provide information on various pathological diseases such as aging, 
osteoporosis, osteoarthritis and other degenerative diseases (Rho et al., 1998). In 
their review, Rho et al. (1998) highlighted several research challenges that may 
advance our knowledge of bone structure as a structure and as a material.  
The adaptation of bone to mechanical stimulation is important to initiate 
osteogenesis process. When a body is subjected to external loading, the muscles 
will be stimulated to adapt to the loading conditions and their activities increased. 
This will in turn stimulate the bone cells and initiate the bone formation. By contrast, 
when mechanical stimulation is lacking, the bone will respond by reducing its density 
that may lead to bone resorption and fracture. A study by Oppl et al. (2014) on 
human subjects suffering from immobilization or disuse of the musculoskeletal 
system found profound reduction in whole body bone density.  In the animal study, 
the importance of mechanical adaptation of bone structures in mice was shown in a 
report by Fritton et al. (2005). They showed an increase of 9% to 14% bone mineral 
content in proximal metaphysis of mouse tibia at 2 and 6 weeks of age, respectively, 
due to increased controlled cyclic axial loading. Findings of Lynch et al. (2010) 
supported the report of Fritton et al. (2005), where enhanced trabecular bone mass 
and density regardless of sex were found when dynamic compressive loads were 
applied. These findings open up further research opportunities in the use of 
mechanical loading to enhance bone mass and to combat low bone mass related 
diseases, such as osteoporosis.  
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2.2 Duchenne Muscular Dystrophy (DMD) 
Duchenne Muscular Dystrophy (DMD) is the most common and severe form of 
muscular dystrophy affecting 1 in 5000 boys (McGreevy et al., 2015; Pant et al., 
2015). It causes progressive muscle degeneration and wasting leading to severe 
disability and eventually death in young males.  
This most frequent disease in children starts in striated muscles. Progressively lost, 
dystrophic muscle is replaced with connective tissue and fat (Bianchi and Morandi, 
2008; Wagner, 2008) (Figure 2-6). Consequently, the patient would experience 
muscle weakness including difficulties in standing, climbing stairs and walking. In 
some cases, disease will affect cardiac muscles leading to cardiomyopathy. 
DMD is also associated with cognitive impairment and bone abnormalities. The latter 
two symptoms were initially considered to be the consequences of muscle weakness 
i.e. the lack of educational opportunities and asymmetrical strength distribution 
affecting the intellectual development and bone formation and function, respectively.  
DMD is caused by mutations in the DMD gene encoding dystrophin (Ito et al., 2006). 
It is the largest gene in the human genome (Nowak and Davies, 2004). DMD 
patients lack dystrophin which is extremely important for human muscle function. 
Primary muscle weakness eventually leads to death due to the secondary effect of 
the disease such as respiratory failure related to functional loss of respiratory 
muscles and diaphragm or due to the cardiac failure. A definite diagnosis for DMD is 
the absence of dystrophin protein in muscle biopsy (Deconinck and Dan, 2007). 
According to Deconinck & Dan (2007), the pathological features of dystrophic muscle 
fibres were often observed in clusters where muscle necrosis was always found. 
Patients at an early age suffer from progressive loss of ambulation and skeletal 
deformities leading to severe disability developing long before death. There is no 
cure for the disease (Bianchi and Morandi, 2008; Blake et al., 2002) and the current 
treatment focuses on alleviating the symptoms and prolonging the patient’s life. 
However, current research trials are actively looking at the potential of gene 
(Wagner, 2008; Wang, 2010) and myoblasts or stem cells therapy (Nowak and 
Davies, 2004).  
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Figure 2-6 Comparison of (a) healthy and (b) mdx muscle tissues. 
(a) Healthy muscle shows a normal sarcolemmal immunostaining pattern (b) mdx 
muscle tissues show the complete absence of sarcolemmal staining in muscle fibers 
which is a characteristic of DMD (Adapted from Davies and Nowak, 2006).  
 
2.2.1 Clinical Progression of DMD 
The clinical symptoms of DMD manifest at 3-5 years of age. DMD eventually leads to 
wheel-chair dependence at the age of 10 to 12 years. Symptoms associated with 
DMD are typically muscle degeneration that causes thin and weak thigh, tip-toeing, 
weak stomach muscles that cause the stomach to protrude, shoulders and arms held 
backward, swayback, weak buttock muscles, and thick calves due to fat tissue 
accumulations. Also, the patient will experience poor balance and awkward walking 
with difficulties in rising from a lie down position (Figure 2-7).  
Patients with DMD have frequently been reported to have cognitive impairment. This 
occurs as a result of signaling abnormality and the most likely cause of these 
cognitive behavioural phenotypes is independent of the functional muscle 
impairment (Blake et al., 2002). A recent study on 3 to 16 year old children has 
shown a cumulative loss of dystrophin isoforms (Rasic et al., 2014). This has been 
identified to cause a greater risk in the reduction of intellectual ability among DMD 
males. This impaired cognitive performance in DMD patients is non-progressive, 
indicating its developmental origin. The precise pathological mechanisms underlying 
this abnormality are still poorly understood.  
20 
 
 
Figure 2-7 An illustration of Gowers’ sign in a patient with Duchenne muscular 
dystrophy. 
The figure shows a sequence of manoeuvres required to rise from the supine 
position (http://clinicalgate.com). 
 
In addition, DMD patients are known to suffer a decline in bone mineral density. The 
old theory implied that patients are immobile and therefore less muscle activity 
attributed to the progressive muscle fibre degeneration and wasting causes the bone 
(Fritton et al., 2005; Lynch et al., 2010; Oppl et al., 2014). Bone adaptation to 
mechanical loads is known to be linked mainly to muscle activity, where the forces 
due to muscle contraction result in osteogenic simulation. Therefore, muscle wasting 
and immobility cause the bone loss, highlighting the importance of mechanical 
stimulation for bone tissue regulation. This fits with the impact of muscle loss on the 
dystrophic bone structure being more profound during later stages of the disease. 
However, more recent studies found that bone abnormalities occur prior to muscle 
loss e.g. already present in 4-week old dystrophic mouse bones (Nakagaki et al., 
2011; Rufo et al., 2011). This could indicate that other, primary factors inherent to 
the disease are responsible (see below).  
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Considering the clinical features of DMD, fracture prevalence in this group has been 
studied by McDonald et al. (2002). About 40% of 378 males were found to have 
fractures, most commonly at the age of 8 to 11 years old and about 47% has lost 
mobility permanently because of such fractures. The study also estimated that 20-
25% of boys (Bachrach, 2005) will experience long bone fractures. The key 
contributing factor is the reduced bone density (Blake et al., 2002; Nowak and 
Davies, 2004) 
The main medication given to the child having DMD are glucocorticosteroids  
(deflazacort and prednisone) (Ay et al., 2009; Bianchi and Morandi, 2008; Bonifati et 
al., 2000; Wagner, 2008). These drugs prolong the ambulation period by a few 
months (Bianchi and Morandi, 2008; Bianchi et al., 2003). Earlier studies based on 
analysis after 2 year trial period, suggested that the earlier the drug is given to the 
child, the slower the progression of the disease (Bonifati et al., 2000). However, 
more recent studies indicate severe side effects associated with this treatment. 
Particularly relevant to this thesis, Bianchi & Morandi (2008) suggested that the 
status of bone of the patient should be obtained prior to steroid therapy being 
initiated because the side effects were found to particularly affect the bone, with 
bone density deteriorating rapidly, exacerbating the bone phenotype and contributing 
to the higher frequency of fractures in DMD patients (Wagner, 2008).  
2.2.2 Structure and Functions of the Dystrophin gene and its products 
Dystrophin is located at the intracellular side of muscle sarcolemma and is a key 
element of  a membrane-spanning protein complex that connects the cytoskeleton to 
the basal lamina (McGreevy et al., 2015). Dystrophin is the largest known gene 
(Figure 2-8). It can be found predominantly in skeletal and cardiac muscles. The 
precise functions of dystrophin are still unclear although its absence in DMD 
resulting in the severe and multi-organ  pathology shows its importance (Blake et al., 
2002). The identification of mutations in the dystrophin gene as the cause of DMD 
led the way for the positional cloning of many other genes responsible for single 
gene disorders. Figure 2-8 shows the organisation of these promoters and the 
resulting proteins. Dystrophin can be organized into four separate regions based on 
sequence homologies and protein-binding capabilities. These are the actin-binding 
domain at the NH2 terminus, the central rod domain, the cysteine-rich domain, and 
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the COOH-terminal domain. The expression of the full-length dystrophin transcript is 
controlled by three independently regulated promoters. The brain (B), muscle (M) 
and Purkinje (P) promoters reflect the major sites of expression of this particular 
dystrophin. The B promoter drives expression primarily in cortical neurons and the 
hippocampus of the brain while the P promoter is expressed in the cerebellar 
Purkinje cells and also skeletal muscle. The M promoter results in high levels of 
expression in skeletal muscles and cardiomyocytes, and also at low levels in some 
glial cells in the brain. These three promoters are situated within a large genomic 
interval of 400 kb (Blake et al., 2002). 
 
Figure 2-8 The DMD gene and proteins.  
The DMD gene encompasses 2.5 Mb in the Xp21 locus and encodes 7 different 
protein isoforms. The full-length dystrophin transcripts are expressed in brain (B), 
muscle (M), and cerebellar Purkinje cells (P) and encode the 427-kDa proteins. The 
shorter isoforms are Dp260, Dp140, Dp116, and Dp71 kDa and show predominant 
expression in retina (R), brain (B3), and Schwann cells (S), respectively with the 
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smallest isoform (G) having generalised expression. The utrophin is an autosomal 
homologue of dystrophin with a similar structure but a different pattern of expression 
(Adapted from Blake et al. 2002). 
Figure 2-9 shows the dystrophin anchors a complex of dystrophin-associated 
proteins including dystroglycans, sarcoglycans, and various combinations of α/β-
dystrobrevins and syntrophins. It is responsible for interacting with the muscle cell 
cytoskeleton and connecting it with the proteins in the extracellular matrix (ECM) and 
other molecules to support the muscle cell membrane (sarcolemma) structure 
(summarised in Ervasti (2007)). The absence of muscle dystrophin causes disruption 
and reduction in dystrophin-associated proteins leading to costamere 
disorganization, sarcolemmal fragility causing excessive levels of calcium ions to 
enter the muscle cells causing muscle necrosis. Muscle death results in progressive 
muscle weakness and eventually is followed by fibrosis and fat replacement of the 
muscle tissue (Jiang et al., 2005; Klingler et al., 2012). 
 
Figure 2-9 Structure of dystrophin-associated protein (DAP) complex in normal 
mouse skeletal muscle. 
Dystrophin has a critical role in the maintenance of stability by creating a link 
between the contractile machinery in the cell and the extracellular matrix via the 
dystroglycan complex (Kapsa et al., 2003). 
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Regarding the cognitive impairment associated with DMD, Taylor et al. (2010) and 
Rasic et al. (2014) provided some evidence that mutations affecting Dp140 and 
Dp71/Dp40 expressed in the brain have been more frequently associated with more 
severe cognitive impairment. In general, based on standard intellectual assessment 
they found that the risk is increased as a result of the cumulative loss of central 
nervous system expressed dystrophin isoforms. Multiple lines of evidence point to an 
important role of dystrophin at central synapses and to its absence impacting on 
synaptic transmission (Knuesel et al., 2000; Moukhles and Carbonetto, 2001). More 
recent data show that the absence of dystrophin alters the spatio-temporal pattern of 
GABAergic synaptic transmission within the specific brain regions (Krasowska et al., 
2014). 
Another important non-muscle aspect of the pathology of particular significance for 
this thesis is low bone mineral density associated with DMD, which has been 
reported in human (Bianchi and Morandi, 2008; Bianchi et al., 2003; Rufo et al., 
2011; Söderpalm et al., 2007) and dystrophic mouse bones (Nakagaki et al., 2011; 
Novotny et al., 2011; Rufo et al., 2011). In the human, the authors published 
information on bone markers in DMD patients where increased bone turnover, 
mainly in the form of bone resorption was confirmed. As a consequence, it can be 
expected that bone formation is elevated. This was in accordance with their finding 
of a decreased level of osteocalcin. In mice, these authors demonstrated that the 
DMD model mouse (mdx) presents with bone abnormalities at 3 weeks of age, which 
is too early for the bone disease process to be influenced by muscle wasting. 
Interestingly, analysis of biochemical and biomechanical properties showed the mdx 
femur having significantly lower bone tissue quality when compared with the healthy 
femur. They found that mdx femur showed the characteristic presentation of 
osteopenia at a time when muscle fiber degeneration was still not significant. They 
suggested that there are intrinsic factors that might be interact with the reduced 
mechanical stimuli in children with DMD and compromise the bone quality.  
In the late stages of DMD progression, the impact of muscle loss on the dystrophic 
bone structure is evident. However, early bone abnormalities found prior to 
substantial muscle loss indicate that there may be other factors inherent to DMD, 
which also contribute to the loss of bone mass, bone mineral density, cellular, 
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molecular and mineral composition (Anderson et al., 1993; Bianchi and Morandi, 
2008; Nakagaki et al., 2011). For example, studies by Anderson et al. (1993), Rufo 
et al. (2011) and Novotny et al. (2011) showed up to 50% loss in strength and 
stiffness in the mdx mouse model of DMD compared to those of the control, resulting 
in the development of micro-damage (Saito and Marumo, 2010) and bone fracture 
(Bianchi and Morandi, 2008).  
Several scenarios have been envisaged on the mechanisms behind the DMD bone 
abnormality (Abou-Khalil et al., 2013; Bianchi et al., 2003; Rufo et al., 2011). DMD 
causes absence of dystrophin, which disrupts structural scaffolds involving 
dystrophin-associated proteins and loss of anchoring for specific signalling proteins 
(Blake et al., 2002). Therefore, the absence of dystrophin could be directly 
responsible for bone structure alterations. However, there is no data on dystrophin 
being expressed in osteoblasts or osteoclasts. On the other hand, dystrophic muscle 
degeneration is associated with chronic sterile inflammation, and Abou-Khalil et al. 
(2013) demonstrated that chronic inflammation contributes to the dystrophic bone 
damage. In DMD patients, prolonged corticosteroid treatment can further exacerbate 
this abnormality (Bianchi et al., 2003; Söderpalm et al., 2007).  
2.3 Animal models of DMD 
Experiments in animal models have allowed the roles of specific genes in-vivo to be 
studied and provided useful information on the disease mechanisms (Allamand and 
Campbell, 2000) and on the development of potential treatment strategies for DMD 
(Kornegay et al., 2012; McGreevy et al., 2015).  
Particularly effective have been gene knockouts or the introduction of a pathogenic 
(mutant) genes in mice. For DMD, there are a number of animal models that are 
widely used in research. These include  fish (Bassett and Currie, 2010; Kawahara et 
al., 2014), mouse (Nakagaki and Camilli, 2012; Nakagaki et al., 2011; Rufo et al., 
2011) and dogs (Kornegay et al., 2012). On average, the protein-coding regions of 
the mouse and human genomes are 85% identical; some genes are 99% identical 
while others are only 60% identical. Most recently, Selsby and co-workers (2015) 
have studied the potential of the porcine animal model for DMD. They identified and 
completed the initial characterization of a natural porcine model of dystrophin 
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insufficiency. Muscles from these animals display characteristic focal necrosis 
concomitant with decreased abundance and localization of dystrophin-glycoprotein 
complex components. These pigs recapitulate many of the cardinal features of 
muscular dystrophy, have elevated serum creatine kinase activity, and preliminarily 
appear to display altered locomotion. They also suffer from sudden death preceded 
by EKG abnormalities. Pig dystrophinopathy models could allow refinement of 
dosing strategies in human-sized animals in preparation for clinical trials. 
2.3.1 Dystrophin-deficient mouse model (mdx) 
Dystrophin-deficient mouse (mdx) was developed in 1984 (Bulfield et al., 1984) and 
is still the most widely used animal model for DMD. It is so because the mdx has a 
rapid disease onset (i.e. around 3-4 weeks of age), short maturation period and are 
less expensive than other models. The mdx mouse is therefore well-established as a 
pre-clinical model for DMD (Montgomery et al., 2005). Although there are a few 
distinctions with the human pathological process, the X-linked recessive mutation in 
the dystrophin gene of the mdx mouse resembles that seen in boys with DMD 
(Lovering et al., 2005). It is also a valuable tool in the development of therapeutic 
strategies (Allamand and Campbell, 2000). Up until the age of 1-week, muscles 
appear normal and start to degenerate and regenerate in cycles of around 3 to 4-
weeks of age (Turk et al., 2005). From 4 month the degeneration process in mdx leg 
muscles becomes less severe and regeneration starts to dominate. However, the 
pathology progresses, albeit at a much lower rate while it is present continuously in 
the diaphragm. For average life span, female wild-type mice lived 27.0 months and 
male wild-type mice lived 26.5 months. In contrast, the average life span for female 
mdx mice was 22.5 months and for male mdx mice 21.5 months (Chamberlain et al., 
2007; Grounds et al., 2008). 
mdx presents with the typical increased levels of muscle creatinine kinase (MCK) 
and pyruvate kinase in the serum, accompanied by histological indicators of skeletal 
muscle degeneration and regeneration. The mouse muscle cannot withstand 
mechanical forces due to compromised function of the dystrophin associated protein 
complex (DAPC) (Whitmore and Morgan, 2014). Whitmore and colleagues (2014) 
suggested that the different parts of the complex play different roles in the regulation 
of muscle function. Despite the same complex being functionally compromised there 
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are different degrees of severity, affecting different tissues, depending on which part 
of the complex is inactivated.   
The mdx mouse model has been used to study DMD pathogenesis (Montgomery et 
al., 2005; Nakagaki et al., 2011) and to develop its treatment (Allamand and 
Campbell, 2000; Gussoni et al., 1999; Wang, 2010). At an early stage, mdx mouse 
pathology was found to parallel the severity of human DMD (Nowak and Davies, 
2004; Wagner, 2008). Although the mdx mouse does not show progressive muscle 
fibrosis in leg muscles, as seen in human DMD (Anderson et al., 1993), recent 
studies revealed that it has a pro-fibrotic phenotype (Sinadinos et al., 2015). 
Moreover, the main advantage of mdx and the reason these mice have been used in 
most of DMD studies, is the ability of manipulating the mouse genome for functional 
experiments. Nakagaki et al. (2012) found that there is a change in muscle activities 
of mdx mice, which lead to loss of muscle function at 21 days of age, i.e.during the 
pre-necrotic stage. At the age of 4 weeks, Anderson et al. (1993) and Nakagaki et al. 
(2011) reported the muscle degeneration to be more severe and also accompanied 
by intense muscle inflammation.  
2.3.2 P2RX7 Receptor Knockout Model 
In the present study, the role of the P2RX7 purinergic receptor in the pathogenesis of 
DMD will be investigated. Purinergic receptors respond to extracellular ATP and lots 
of ATP is released from damaged muscles (inflammatory condition). P2RX7 is one 
member of the large family of P2 receptors and it is different from the others in many 
ways. As an example, its activation is well known to induce cellular apoptosis 
(Agrawal and Gartland, 2015).  In response to prolonged, high ATP stimulation, 
P2RX7 can exhibit wider permeation to molecules that may be associated with cell 
death by apoptosis or necrosis. P2RX7 has been shown to induce autophagy in 
various cell types and its high level of activation is cytotoxic to cells whilst the low 
level P2RX7 stimulation can provide metabolic advantage which is the ability to 
adapt to conditions of limited nutrient supply (Amoroso et al., 2012; Young et al., 
2015). Importantly, P2RX7 receptor is also associated with the modulation of bone 
formation and function. ATP is released from osteoblasts upon mechanical and 
nucleotide stimulation and mediates paracrine signalling to neighbouring cells via 
P2RX7 activation. P2RX7 expression in osteoblasts is a differentiation-dependent 
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expression and the receptor is mainly expressed in mature bone forming 
osteoblasts. In osteoclasts, ATP release is associated with P2RX7 activation, but the 
exact mechanism has not yet been determined (Kvist et al., 2014).  
DMD gene mutations are associated with P2RX7 purinoceptor up-regulation, which 
leads to the death of both human DMD (Ferrari et al., 1994) and mdx cells (Yeung et 
al., 2006; Young et al., 2012). P2RX7 activation in mdx muscles triggers a specific 
mechanism of autophagic cell death (Young et al., 2015). Recent work showed that 
this receptor is a good target for pharmacological treatment of DMD, as its genetic 
ablation (knockout) reduced both muscle loss and inflammation (Sinadinos et al., 
2015). P2RX7 is expressed in both osteoblasts and osteoclasts, but it appears to 
have different roles in bone physiology and in disease states. If P2RX7 is abnormally 
active in dystrophic bones, its absence might improve the bone properties.  On the 
other hand, activation of P2RX7 receptor has been linked primarily to osteoclast 
functions (Agrawal and Gartland, 2015; Agrawal et al., 2003; Gartland, 2012) hence 
its ablation could have a negative impact on the bone.   
Specific animal models of DMD (mdx) have been created in which the P2RX7 
receptor has been genetically disrupted (mdx/P2X7-/-, double knockout). Using the 
mdx (Bulfield et al., 1984) and the P2RX7 receptor knockout mice (Solle et al., 
2001). The genetically disrupted P2RX7 receptor mouse generated by Solle et al.( 
2001) has been explored by Ke et al. (2003) to assess the receptor involvement in 
bone development and remodelling. They found that the P2RX7 receptor is a good 
target in management of skeletal disorders. The receptor was found in both 
osteoblasts and osteoclasts of wild-type (WT) but not in the knockout mice. This 
model has shown a direct function of P2RX7 in bone formation: The study found the 
reduction of total and cortical bone content as well as of the periosteal circumference 
occurring in the femur while there was a reduction in periosteal bone formation and 
excessive increment in trabecular bone resorption in tibia of the P2RX7 knockout 
mice.  
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2.4 Evaluation of Bone Microstructure using Micro-Computed 
Tomography (µCT) 
2.4.1 Basic Concepts 
Micro-Computed Tomography (µCT) has the same basic principles as CT for 
medical diagnosis currently available in most hospitals. The main difference between 
them is the higher resolution obtained from µCT, which can reach between 50 
microns (Davis and Wong, 1996; Paulus et al., 2000) and 50 nm (Bruker µCT) 
(Stock, 2009). µCT is considered more cost-effective than Magnetic Resonance 
Microscopy (MRM) and it is preferable to others in terms of high resolution and 
signal-to-noise ratio (SNR) in imaging implants and mineralized tissues (Krug, 
Burghardt , Majumdar, 2011). Most µCT systems have high resolution flat panel and 
small focal spot size that allow high resolution imaging of small animals. In µCT the 
same image reconstruction techniques as in clinical-scale CT are applied. CT 
systems using fan-beam geometries apply fan-beam reconstructions based on 
filtered back-projection algorithms originated from the early days of clinical CTs. The 
recently introduced flat panel based µCT employs variants of the Feldkamp-David-
Kress (FDK) algorithm for cone-beam reconstruction. Both reconstruction techniques 
need to be adapted to the specific small animal scanner geometry (Bartling et al., 
2007). Currently, there is an increasing interest in animal research studies using 
µCT, as these animal models may lead to clinical applications (Chappard et al., 
2005; Holdsworth and Thornton, 2002; Paulus et al., 2000).  
The past decade has seen the rapid development of µCT in small animal imaging 
(Paulus et al., 2000; Schambach et al., 2010). μCT has now become the gold 
standard for the evaluation of bone morphology and other small animals (Martı´n-
Badosa et al., 2003). μCT has been used to evaluate morphology measurements in 
animal (Bonnet et al., 2009; Waarsing et al., 2004) and human tissues (Müller et al., 
1998; Thomsen et al., 2005). This increasing demand in utilising µCT for research 
purposes has demonstrated that the scanner capability of providing high spatial 
resolution in high contrast structures (Jiang et al., 2000). In addition, its ability to 
image the internal structure without destroying the original specimens is valued and 
allows further investigation such as histomorphometric analysis (Bischoff et al., 
2011). The acquired three-dimensional (3D) data sets have also been used as inputs 
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for finite element (FE) analysis which can be used to estimate the bone mechanical 
properties virtually (Brassey et al., 2012; Oftadeh et al., 2015; Rietbergen et al., 
1996; Silva et al., 2005).  
The principles of CT implies taking x-ray projection images of an object from many 
angles around the object, and mathematically converting this set images into a stack 
of cross-sectional image slices, which represents a 3D image. These projection 
images are taken incrementally over a total rotation of either 180° or 360°. While the 
individual projection x-ray images are 2D images, the rotation of the imaged sample 
relative to the x-ray source and camera allows the precise 3D location of the 
scanned objects to be calculated (provided the objects are within the camera field of 
view at all angles of rotation) (Figure 2-10) (Bruker microCT, n.d.). 
 
Figure 2-10 An illustration of a µCT scanner geometry.  
A cone beam x-ray projection to enable volume scanning of the object. The object is 
located between the x-ray source and the detector, and rotates on the holder during 
scanning.  
 
High spatial resolution is an important feature in µCT imaging. Spatial resolution 
describes how far two features of the object need to be separated to be 
distinguishable in the measured image (Rueckel et al., 2014). µCT provides higher 
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spatial resolution than that of current clinical CT. µCT can provide a resolution of 
below 100 µm for small animal imaging, (Bartling et al., 2007; Stock, 2009). The 
imaging resolution is determined largely by the size and number of detector 
elements, the size of the X-ray focal spot, and the source-object-detector (SOD) 
distances (Bartling et al., 2007; Verdelis et al., 2011).  
For example, a short SOD would place the animal closer to the x-ray source than the 
detector, thereby be magnified by the factor of M= (ODD/SOD), improving the spatial 
resolution. However, the Field of View (FOV) will be compromised. With the advent 
of large flat-panel detector, higher magnification factors will be possible.  This is 
because active detector area will increase significantly. Short SOD, however, 
requires micro-focus x-ray tubes since larger focal spot size will cause significant 
image blurring (penumbral blurring) (Bartling et al., 2007) (Figure 2-11). Focal spot 
size is an important factor to determine image resolution and quality of the x-ray 
image. Focal spot is the actual area on the target where the electrons transfer their 
energy to the target atoms where the X-rays are generated. Typical focal spot size 
for micro-focus CT is 3 µm.   
 
Figure 2-11 Focal spot size. 
Large focal spot size (left) increase geometric blurring which is called penumbra 
whilst small focal spot size (right) improves in-plane resolution, where the ability to 
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detect details is improved enabling geometric or projection magnification without 
penumbra. 
 
Before the advent of µCT, histology often used where the object is cut into thin slices 
and examined under a light microscope, a time-consuming, labour-intensive process. 
The conventional x-ray system produces 2D shadow images of the internal 
structures; however, the depth information is overlapped or superimposed. 
Therefore, µCT provides an alternative technique to produce image of the object 
non-invasively and less time consuming.  
Scanner Geometry 
There are four types of scanner geometry system, as discussed in Stock (2009): (1) 
pencil, (2) fan, (3) parallel, and (4) cone beam geometries. µCT employs the cone 
beam geometry. The geometry consists of a micro-focus x-ray tube source that is 
suitable for volumetric scanning. When x-rays diverge and travel from the tube 
source, they pass through the object and are detected by a high resolution detector. 
Specifically in this geometry, each of the detector rows receives the information from 
more than one slice of the object, except for the middle row. This effect becomes 
greater when the x-rays pass through a rotational axis object. In addition, short 
scanner geometries, where the source-to-object distance (SOD) is smaller than 
object-to-detector distance (ODD), will bring the object close to the source and high 
spatial resolution will be produced.  According to Bartling et al (2007) and Stock 
(2009), a micro-focus x-ray tube with a small focal spot size will reduce significant 
image blurring (penumbral blurring) which degrades resolution.  
X-ray Source 
There are three criteria for a micro-focus x-ray source:  (1) Small focal spot size; (2) 
a high photon flux, ɸ and (3) a suitable range of x-ray energy. The small focal spot 
size produces high spatial resolution which eliminates the negative influence of 
image blurring. The emitted x-ray photon flux, ɸ, is roughly proportional to the 
product of the x-ray anode current (I) and the square of the tube voltage (V) and the 
tube power is P = V·I, the available x-ray flux is limited by the size of the focal spot, 
which can only absorb a certain amount of heat (anode heating). The maximum 
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power that an x-ray tube can emit thus also depends on the heat capacity of the 
anode material and the tube technique used. Tubes with rotating anode support 
much higher output than tubes with stationary anodes since heat is evenly 
distributed along the focal spot trajectory. 
High x-ray flux is desirable for small animal CT imaging to achieve high temporal 
resolution and short scan times: if the photon flux is high enough, sufficient x-ray 
photons reach the detector and can be collected in short times for each projection. A 
sufficient amount of x-ray photons is required to limit image noise and allow good 
low-contrast spatial resolution (Bartling et al., 2007). 
2.4.2 Image Acquisition 
In the µCT system, the animal is positioned on a rotating stage and sandwiched 
between source and detector. The animal rotates on a single axis over 360° during 
scanning, allowing the attenuated x-rays to be detected on a 2D planar array. A 
series of 2D slices are reconstructed to create 3D reconstruction by means of filtered 
back projection. This projection has become a standard algorithm to filter the blurred 
reconstruction across regions (Stock, 2009).   
In x-ray acquisition, the image contains information about the intensity reduction 
inside the 3D object. This is because the X-ray absorption is corresponding to 
exponential law. In order to achieve the best low-contrast spatial resolution in small 
animal CT imaging, a range of tube voltages should be considered to select the 
appropriate x-ray energies. For higher x-ray energies the energy-dependent 
absorption coefficient µ(E) is small and low-contrast spatial resolution is limited due 
to the small number of x-ray photons absorbed in the animal.  If x-ray energy is low 
and thus µ(E) large, most photons are absorbed in the animal and the contrast 
resolution is limited by the small amount of x-ray photons reaching the detector 
(Bartling et al., 2007). 
There are several artefacts as a result of x-ray attenuation, such as geometrical 
blurring, streak-like artefact due to reconstruction and beam hardening. The most 
common artefact relevant to bone density measurement is beam hardening, its 
occurrence can be more than 36.2% (Meganck et al., 2009). Beam hardening is 
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caused by a preferential absorption of low energy photons. It can be corrected either 
during image acquisition or image reconstruction (software or added filter).  
2.4.3 Image Processing 
The next step after image acquisition is processing the stack of images including 
filtration and segmentation. The function of each type of filter in the field of bone 
imaging has to be reported as suggested in Bouxsein et al. (2010). During image 
reconstruction, noise reduction is carried out as part of the procedure to maintain 
sharp contrast between bone and marrow. The most commonly used filters are 
Gaussian filter and median filter. A Gaussian filter is easy to use and fast for large 
dataset. Both filters can provide good results, although minimum filtering is required 
to avoid degrading the image data. One has to bear in mind that reducing the noise 
will simultaneously reduce the image details or signal-to-noise (SNR) ratio. Different 
filter materials will have different ability to reduce beam hardening artefacts by 
affecting the x-ray spectrum. X-ray beam filtration is known to affect the signal to 
noise ratio and the contrast to noise ratio, therefore, careful selection of a filter is 
important, as given in Meganck et al. (2009) and Bouxsein et al. (2010).  
Segmentation is one of the crucial parts in the evaluation of morphological 
parameters of the bone. The segmentation process is defined as separation of bone 
and non-bone based on the grey scale level for subsequent quantitative analysis. 
Accurate segmentation is to ensure that errors due to artefacts are minimised in the 
determination of morphometric parameters (Bouxsein et al. 2010). There are several 
techniques for segmentation, the common and simplest technique is to use threshold 
technique. Previous studies have proposed techniques on threshold selection 
relative to image histogram (Weszka and Rosenfeld, 1978). They established two 
criteria on threshold evaluation: discrepancy and error measures as well as 
busyness measures. A discrepancy measure was based on the difference between 
the original and the smoothed pictures whilst a busyness or roughness measure was 
computed on the smoothed picture. Both methods produced good results on 
segmented images. An important issue in segmentation relates to the contouring 
method employed to define the area in each slice to be included for segmentation 
and subsequent morphology quantifications (Bouxsein et al. 2010). The easiest 
method is to create a constant circular or rectangular area. However, this method 
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does not allow separation of cortical and trabecular bone as well as the background. 
More precise contouring for specific cortical and trabecular bone regions therefore is 
required, and this may be achieved manually on a slice-by-slice basis or using 
automated algorithms (Buie et al., 2007). Alternatively, semi-automated 
segmentation (Janc et al., 2013) and global thresholding (Kohler et al., 2005) 
methods may be used to generate more reliable bone morphometric data. There are 
several approaches in delineating the trabecular region, such as a uniform ROI, an 
irregular anatomic contour adjacent to the endocortical surface, or an irregular 
anatomic contour a few pixels away from the endocortical boundary (Figure 2-12). 
 
 
Figure 2-12 Contouring methods used to delineate the trabecular bone from 
the cortical bone.  Three approaches: (A) A regular, uniformly shaped region of 
interest; (B) an irregular, anatomic region of interest adjacent to the endocortical 
boundary, drawn using an automated algorithm (Buie et al., 2007) and (C) an 
irregular, anatomic region of interest drawn manually a few voxels away from the 
endocortical surface (Bouxsein et al., 2010). 
 
A built-in thresholder can use the stack histogram (frequency distribution plots) and 
apply several different auto threshold algorithms. The automatic threshold calculates 
a threshold without any human judgment involved. Therefore it may offer an 
advantage of reducing human bias in the segmentation step. The preference of a 
method or threshold algorithm greatly depends on the problem to be solved.  
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2.4.4 Image Analysis 
Reliable freeware has been used to analyse bone parameters. ImageJ is a public 
domain image processing program that has flexible plugins and functions for bone 
morphological measurement. The plugin is called BoneJ. The parameters for image 
analysis such as volume fraction and bone thickness and other parameters are 
recommended in the guidelines of Bouxsein et al (2010). BoneJ has provided the 
most powerful image processing program in the public domain to analyse bones 
(Doube et al., 2010).  
2.4.5 Image Segmentation 
Following µCT scanning and data acquisition, the µCT data sets undergo 
segmentation, an important step in image analysis (Bouxsein et al., 2010). 
Segmentation is used to identify which pixels in the image belong to one or several 
regions of interests (Mateos-Perez and Pascau, 2013). A recent study has 
implemented a modified segmentation method by Buie et al. (2007) using Matlab 
(Cervinka et al., 2015). Buie et al (2007) proposed a dual threshold technique to 
segment the bone regions by utilizing the C+ Visualization Toolkit. Firstly, the 
periosteal surface is produced by thresholding the reference image, followed by 
applying morphological closing operations and connective filtering. Next, the 
reference image is thresholded again and combined with the non-bone region mask 
to get marrow cavities where subsequent steps eliminate the trabeculae. The output 
of the two steps is combined where masks of trabecular, cortical and non-bone 
region are created. However, Cervinka et al (2015) pointed out that this method fails 
to remove larger cortical pores. There are alternative methods developed as in-
house software algorithms (Janc et al., 2013; Liu et al., 2009). 
To be accurate in segmenting the bone, it is important to compare the processed 
images with the reference image. This ensures that the processed images are a 
good representation of the actual structures. Previous studies segmented the cortical 
and trabecular bones using the threshold method determined from the attenuation 
histogram of the volume of interest (VOI) (Microview Software v.2.2, GE Healthcare). 
By using visual inspection, they correlated the threshold value with the grey scale 
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image of the cortical bone and with the masked bone volume of the trabecular bone 
(Monir et al., 2010). 
IsoData algorithm is a default automatic thresholding algorithm in ImageJ. The 
algorithm used is based on operator judgement whether the ROI is well segmented. 
The algorithm works by dividing the image into object and background by taking an 
initial threshold, then the averages of the pixels at or below the threshold and pixels 
above are computed. The averages of those two values are computed, the threshold 
is incremented and the process is repeated until the threshold is larger than the 
composite average. Threshold= (average background + average objects)/2.                                                                                          
In this work, a slice-by-slice hand contouring technique was applied to separate 
trabecular bone over cortical bone and subsequently segmented using default 
IsoData algorithm. This technique is the gold standard and has been used to validate 
other proposed methods, for example, the dual-threshold method (Buie et al., 2007). 
Automated software can be used to separate the trabecular bone from cortical bone, 
however, some bone sites, such as close to the growth plate or in vertebrae, the 
cortical bone is thin, perforated and poorly defined, so that automated methods are 
limited in application. Manual VOI delineation has the advantage of providing quality 
control for the scanned datasets, and letting the analyst actually look at the imaged 
bone structures and gain a visual impression of the experimental outcome (Analysis 
of bone by micro-CT General information, n.d.).  The semi-automated slice-by-slice 
hand contouring and default IsoData algorithm technique described in Section 3.4.3 
was used in this study to separate the trabecular and cortical bone from the 
background.            
2.4.6 ImageJ and BoneJ 
Image processing software commonly comes with the scanning hardware. The 
software can be costly and its functionality inflexible (Doube et al., 2010).  
Furthermore, the method or algorithm of the software is not detailed in most of the 
literature (Baiker et al., 2012; Verdelis et al., 2011). ImageJ was developed as an 
open source plugin. It can be operated using computer hardware remote from the 
scanning machine, regardless of the specifications except for Java program. It has 
been extensively used for image processing and analysis of various image formats. 
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BoneJ is one of the ImageJ plugins specifically developed for bone measurements. It 
has features and standard measurements for bone image analysis. The algorithms in 
the plugin were validated by analysing image data from 3D µCT, CT and synchrotron 
µCT. Doube et al. (2010) described the philosophy and validation of BoneJ, and 
illustrated its applicational scenarios. Algorithms in BoneJ were validated by running 
them on test data and comparing computed results to expected results. Test data 
included synthetic images, images of real objects and mathematically defined clouds 
of points (Fit Sphere and Fit Ellipsoid), all with known geometry. 
Most recent studies have shown the validity of BoneJ plugin in the determination of 
the common trabecular bone parameters such as Bone Volume Fraction (BV/TV), 
Trabecular Thickness (Tb.Th), and Trabecular Space (Tb.Sp) (Collins et al., 2015; 
Doube et al., 2011; Hsu et al., 2016; Macintosh et al., 2013; Salmon et al., 2015). 
BoneJ is also capable of analysing human muscle as seen in Frank-Wilson et al 
(2015). The applications of the software are further utilised to examine the 
differences in different species of animals (Doube et al., 2011). Furthermore, BoneJ 
is useful to display bone thickness as a heat map which is easy to understand. For 
example, the osteoarthritic trabeculae are thicker and better connected than the 
osteoporotic elements (Abel et al. 2013).  
In addition to the capability of BoneJ in quantifying the morphological properties of 
the bone, it is also able to quantify geometric properties, for example, second 
moment of area (I) (Collins et al., 2015). BoneJ has been used to calculate the 
diaphyseal cross-section geometry properties of humeral, femoral and tibial bones 
(Macintosh et al., 2013). Further, BoneJ has been used to calculate the 3D moment 
of inertia of feline limb bones  (Doube et al., 2009).  
2.5 Quantitative morphological properties of bone. 
Bone morphological properties have been studied by a numerous researchers to 
investigate pathophysiological diseases and the effects of treatments, particularly in 
mouse bones. Critical morphological parameters have been identified quantitatively 
to assess bone microarchitecture changes across studies, as described in Section 
2.5.1 and 2.5.2 (Bouxsein et al., 2010). The changes due to bone diseases and 
treatments can be evaluated quantitatively rather than qualitatively because bone 
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remodel at a rate of 10% a year for human adult whilst it is rare for mouse. Because 
bone microarchitecture has a major role in determining bone quality and strength, 
µCT has been utilised as a non-invasive method for evaluation of 3D bone geometry, 
volumetric bone density, microarchitecture and properties of the bone matrix (Brandi, 
2009). Bouxsein et al. (2010) has produced practical guidelines to evaluate bone 
microarchitecture in rodents using µCT. The guidelines include the approaches to 
image acquisition, image evaluation, and reporting the findings. Bouxsein et al. 
(2010) asserted that four parameters as the minimal set of variables that should be 
reported when describing trabecular bone morphology (i.e., BV/TV, Tb.Th, Tb.Sp, 
and Tb.N) and cortical bone morphology (i.e., Tt.Ar, Ct.Ar, Ct.Th, and Cr.Ar/Tt.Ar).  
Using µCT, the bone morphology of different mouse strains can be quantified for 
different parts of the mouse skeletal system (Alexander et al., 2001; Hsu et al., 2016; 
Kohler et al., 2005; Turner et al., 2001; Zhang et al., 2015). Microstructural 
properties, such as trabecular bone volume fraction (BV/TV) and bone thickness, are 
the common parameters in evaluating bone microstructure. They have been shown 
to change under the influence of genetic factors (Boutroy et al., 2005; Turner et al., 
2001).  
The well recognised clinical consequences of DMD bone phenotypes are bone 
mineral density deficiency (Bianchi et al., 2003; Morgenroth et al., 2012; Rufo et al., 
2011; Söderpalm et al., 2007) and increased bone fracture incidence (McDonald et 
al., 2002; Pouwels et al., 2013; Vestergaard et al., 2001).  Hence, a comprehensive 
approach to investigate the material and structural properties of bone is required to 
better understand the bone phenotype in DMD.   
2.5.1 Trabecular bone morphometry 
Bone Volume Fraction 
Bone volume fraction (BV/TV) is the ratio of mineralised bone volume to total of bone 
with marrow space volume (Equation 2-1)   
Volume fraction=    2-1 
Volume fraction is one of the most widely reported to determine the amount of 
mineralised tissue. In a study to determine the treatment efficacy, bone volume 
volume spaceMarrow  volume Bone
 volume Bone

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fraction represents the net response of the osteoblasts for bone formation and 
osteoclasts for resorption. Bone volume fraction does not provide information on the 
bone microstructure; therefore mean trabecular thickness and mean trabecular 
spacing were introduced (Boskey, 2001). Various indicators can be used to describe 
trabecular and cortical bone microarchitecture. Other related parameters are listed in 
Bouxsein et al. (2010). A summary of morphometric parameters for cortical and 
trabecular bones of healthy and mdx mice reported in the literature is given in Table 
2.2.  
Trabecular thickness (Tb.Th) and Spacing (Tb.Sp). 
The BoneJ algorithm calculates the thickness of the trabecular bone struts in the 
region of interest. It calculates the diameter of the maximum sphere that fits within 
the structure at every point in the ROI (Figure 2-13). A method by Hildebrand and 
Rüegsegger (1997) was implemented by BoneJ. This method used the volume-
based local thickness to accommodate the anisotropic properties of the bone. This 
method has overcome the limitations of surface-based methods which overestimate 
arbitrary and irregular structures. Moreover, the plugin also provides a thickness map 
with colour gradients for morphological assessments (Abel et al., 2013; Doube et al., 
2010).  
 
Figure 2-13 An example of local thickness.  
Local thickness, Ƭ(p), of a structure, Ω, determined by fitting maximal spheres to the 
structure (Hildebrand and Rüegsegger, 1997). 
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2.5.2 Cortical bone morphometry 
Bouxsein et al. (2010) asserted that at least four parameters (Tt.Ar, Ct.Ar, 
Ct.Ar/Tt.Ar, Ct.Th) must be used in describing cortical bone morphology. Therefore, 
these indicators were used in this study for cortical bone assessment. These 
parameters allow comparison across studies when different sized volumes of interest 
are scanned.  
Total cross-sectional area (Tt.Ar) and cortical bone area (Ct.Ar) 
According to Bouxsein et al. (2010), to compute average cross-sectional area 
measurements, the volume of interest (ie, a cylinder) is divided by the number of 
slices and voxel height or slice thickness. For total cross-sectional area, Tt.Ar =Tt.V 
/(no. of slices × voxel height) and cortical bone area , Ct.Ar = Ct.V/ (no. of slices × 
slice thickness). The unit is mm2. These measurements were used to obtain 
accurate internal and external diameter measures for calculating the second moment 
of area (SMA) at the point of failure for bone structural evaluation. Tt.Ar 
characterises the resistance to axial compression and tension. Ct.Ar is a separate 
measurement for each tranverse slice section (AnalyzeDirect, 2014). In the present 
study, the ‘Slice geometry’ plugin in BoneJ was used. It calculates the cortical bone 
parameters for each transverse slice section and the cross-sectional geometric 
properties of shapes (Figure 2-14). The parameters extracted from the plugin are 
cross-sectional area (or cortical area), centroid, mean density, second moment of 
area, section modulus and local thickness (2D and 3D). The input image should be 
in 8-bit or 16-bit stack and the measurement can be limited to rectangular ROI.  
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Figure 2-14 3D annotation displays the stack, principal axes and centroids. 
Cortical bone parameters were calculated based on the directions defined. Slice 
geometry is used to calculate the cross-sectional geometric properties of shapes for 
all slices in a stack of images.  
 
Cortical bone area fraction (Ct.Ar/Tt.Ar) and cortical bone thickness (Ct.Th) 
Ct.Ar/Tt.Ar is the ratio of cortical bone area to total cross-sectional area within a 
given volume of interest. Ct.Th is the average thickness of the cortex in a stack of 
images. The ‘Thickness’ plugin in BoneJ as mentioned above, defines the thickness 
at a point as the diameter of the greatest sphere that fits within the structure and 
which contains the point. The plugin calculates the mean and standard deviation of 
the volume of interest.  Table 2-2 shows a comparison of morphometric parameters 
for cortical and trabecular bones of healthy and mdx mice from the previous studies. 
The authors reported different bone parameters to compare the bone phenotypes 
and they were using limited number of samples. Although there are differences in 
mice age, weight and bone parts, the authors showed similar pattern of significantly 
higher cortical and trabecular bone properties in WT compared to those of mdx mice.   
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Table 2-2 A comparison of morphometric parameters for cortical and trabecular 
bones of healthy and mdx mice from the literature.  
Referenc
e 
Type 
of 
bone 
Cortical Trabecular 
Tt.Ar 
(mm2) 
Cr.Th 
(mm) 
Cr.Ar 
(mm2) 
BV/TV 
Tb.Th 
(mm) 
Tb.Sp 
(mm) 
Nakagaki 
et al. 
(2011) 
3-
weeks 
mice 
femur 
WT: 
0.812±0.11 
mdx: 
0.615±0.09 
WT: 
0.065±
0.004 
mdx: 
0.037±
0.005 
WT: 
0.204±
0.02 
mdx: 
0.114±
0.01 
N.R 
WT: 
0.029± 
0.001 
mdx: 
0.018± 
0.001 
N.R 
Novotny 
et al. 
(2011) 
7-
weeks 
mice 
tibia 
N.R 
WT: 
0.202±
0.004 
mdx: 
0.210±
0.007 
WT: 
0.69±0
.03 
mdx: 
0.114±
0.01 
WT: 0.092± 
0.013 
mdx: 0.059± 
0.005 
WT: 
0.041± 
0.002 
mdx: 
0.038± 
0.002 
WT: 
0.192
± 
0.006 
mdx: 
0.237
± 
0.008 
Rufo et 
al. (2011) 
24-
weeks 
mice 
tibia 
WT: 
0.62±0.04 
mdx: 
0.55±0.02 
WT: 
244.0±
13.0 
mdx: 
230.0±
11.0 
WT: 
0.40±0
.01 
mdx: 
0.35±0
.02 
WT: 9.2±0.9 
mdx: 
5.7±1.1 
WT: 
0.036± 
0.0023 
mdx: 
0.037± 
0.0026 
WT: 
0.236
± 
0.007
3 
mdx: 
0.289
± 
0.028
5 
*N.R= Not reported 
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Structural Model Index (SMI) 
A primary bone parameter in the description of the microstructure of trabecular bone 
is SMI. SMI may be used to determine the geometry of the trabeculae is of a plate or 
a rod shape in 3D trabecular bone images (Figure 2-15). “Rods” are regions of 
trabecular bone characterized by being elongated and cylindrical, whereas “plates” 
are extensive, flatter regions (Salmon et al., 2015). SMI is included in BoneJ and it is 
based on the mathematical model by Tor Hildebrand & Ruegsegger (1997). The 
method calculates the change in bone surface area. The limiting SMI values to 
indicate plateness and rodness are 0 and 3, respectively. In human, trabecular 
plates have a higher tissue mineral density compare to that of trabecular rods. 
Interestingly, Wang et al. (2015) found that this suggests a lower bone turnover as a 
result of lower surface to volume ratio in trabecular plates.  To study trabecular 
architecture and mechanics, connectivity and anisotropy should also be studied 
(Odgaard, 1997). 
 
Figure 2-15 3D µCT of trabecular bone. 
The structural elements of trabecular bone showing a plate-like (right) and a rod-like 
bone structure (left). The relative proportion of rods to plates in trabecular bone is 
thought to be important for bone’s mechanical competence, with plates considered to 
be mechanically superior to rods (Adapted from www.metafilter.com).  
SMI has been used as a standard measurement parameter for trabecular bones. 
However, a recent report questioned this approach to determine the rodness and 
plateness of trabecular bone (Salmon et al., 2015). It argued that SMI assumes that 
the entire surface is convex while the intricate connections within the trabecular 
continuum suggest that a high proportion of the surface could be concave. Moreover, 
they tested SMI and compared the results with the fraction of the surface that is 
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concave (CF) and mean ellipsoid factor (EF). The proportion of the surface area that 
is concave (the “concave fraction,” CF) can be calculated as the proportion of the 
total surface area (S) covered by triangles that decrease in area during mesh dilation 
(U). Briefly, for each point of the structure’s medial axis, a small ellipsoid is seeded 
and iteratively dilated, rotated, and translated slightly until no further increase in 
volume is achieved. Then, the largest ellipsoid containing each point in the structure 
is determined, and the EF calculated for that point. Mean EF values summarizing all 
the foreground pixels in each image were calculated and used for comparisons 
(Salmon et al., 2015).  They found EF method is able to discern better the trabecular 
geometries of mammalian and avian bones (Doube, 2015).  
Connectivity Density (Conn.D) 
According to Russ & Dehoff (2001), connectivity is a property that applies primarily to 
network structures such as blood vessels or neurons in tissues used to describe the 
number of redundant connections between locations. It was also defined as the 
maximum number of trabeculae that can be cut without separating the structure. By 
the definition of Conn.D, plate perforation and rod connection contribute to an 
increase in Conn.D and plate perforation filling and rod disconnection contribute to 
decreased Conn.D (Odgaard, 1997). Connectivity can be determined by various 
methods as discussed in Odgaard (1997). A practical method is the topological 
approach where trabecular bone is considered as a node-and-branch network. 
BoneJ Connectivity density uses the Euler characteristic or Euler number of 3D data 
(Figure 2-16). In ImageJ, this value is very sensitive to the number of particles in the 
image and noise. Connectivity density (Conn.D) can be calculated by dividing the 
connectivity estimated by the volume of the sample. It is recommended to present 
the connectivity in a density form (Bouxsein et al., 2010).  
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Figure 2-16 Two consecutive serial sections of trabecular bone. 
Topological changes between the two sections are indicated by the circles. By noting 
and counting these occurrences, the Euler number density may be calculated 
(Odgaard, 1997).  
2.6 Evaluation of Bone Mechanical Competency using Three-Point 
Bending Testing. 
The ability of bone to resist fracture is important for the study of the mechanical 
competence of the bone. Many types of mechanical tests have been proposed for 
testing of mouse bones (Akhter et al., 2004). Bone has a well-defined organisational 
hierarchy, mechanical tests scale the natural length scale from mineral and protein 
levels to whole bone tests. Beaupied et al. (2007) critically reviewed biomechanical 
tests available for measuring bone fragility. There are torsional testing, traction and 
compression as well as bending testing. Reviews on specimen preparation prior 
testing are also included. A practical guideline by Jepsen et al. (2015) has provided 
recommendations for evaluating phenotypic changes in mouse bones.  
Three-point bending is one of the most common arrangements for testing of whole 
bones. Due to its simplicity, the mechanical properties of mouse bones have been 
determined using this setup.  The changes in the structural and material properties 
might be due to exercise (Frajacomo et al., 2013; Wallace et al., 2007; Wergedal et 
al., 2006), variation among inbred mouse strains (Wergedal et al., 2006), accelerated 
senescence (Silva et al., 2002) and ovariectomy (Maïmoun et al., 2012). Akhter et al. 
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(2004) reported a comprehensive analysis of transgenic mice using three-point 
bending tests.  
Mechanical testing of bone may contribute to the understanding of how bone 
responds to mechanical stimuli in selected genotypes, such as the absence of 
dystrophin and P2RX7 receptor. Such an investigation has been conducted by 
Nakagaki et al. (2011) on mdx and control (wild-type, WT) 21-day old mice bones. 
Using three-point bending test, Nakagaki et al. (2011) found that mdx mice have 
reduced fracture resistance compared to WT mice bones. The results corroborate 
the findings of Novotny et al. (2011), with a similar trend observed for 7-weeks and 
24-months old mice. They found that mdx mice have reduced 50-80% in tibial 
strength and stiffness compared to that of the WT mice. The cross-sectional moment 
of inertia (CSMI) and the cortical cross-sectional area of the mdx midtibia was 25% 
and 6-17% lower than those of the WT mice. This shows that mdx bones are smaller 
than WT.  
Silva et al. (2002) compared morphological, mechanical and densitometric properties 
of long bones from SAMP6 (senile osteoporosis) mice to those of SAMR1 (control 
strain). They found increased bone size, decreased bone strength and increased 
mineralisation in SAMP6 mice. The results were analogous to changes in aging adult 
bones. Further, Silva et al (2004) reported mouse bone structural and material 
properties using four-point bending and nanoindentation approaches. These 
approaches allow determination of bone tissue properties to identify changes as the 
result of pathogenesis process. 
A report on muscle-bone interactions by Montgomery et al (2005) showed that mdx 
mice have significantly larger hindlimb muscles than controls due to extensive 
fibrosis. Larger hindlimb muscles may have contributed to greater BMD and fracture 
strength in mdx mice than controls even when accompanied by a dystrophic 
phenotype.  The data showed a relationship between the hindlimb muscle mass and 
the femoral BMD.  
A number of guidelines (Jepsen et al., 2015; Turner and Burr, 1993) and 
experimental work have been published on whole bone bending testing (Akhter et 
al., 2004; Donnelly et al., 2010). Whole bone three-point bending test is useful for 
measuring the mechanical properties of small animal bones and it is easy to 
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implement. In this test, the whole-bone is loaded in bending until failure at a constant 
loading rate. Table 2-4 shows a summary of the reported three-point bending tests.  
To date, there have been no reports of bone properties from P2RX7 receptor 
knockout mouse bones. A recent work shows that this receptor is a good target for 
the pharmacological treatment of DMD, as its blockade ameliorated muscle and non-
muscle symptoms as well as inflammation (Sinadinos et al., 2015). However, 
ablation or blockade of P2RX7 could affect bone formation and function directly due 
to its regulatory role in bone cells, where this receptor activation has been linked, 
primarily, to osteoclast functions (Agrawal and Gartland, 2015; Agrawal et al., 2003; 
Gartland, 2012). If P2RX7 is abnormally active in dystrophic bones in a manner 
similar to the over-activation in muscles, its disruption might improve the bone 
structure. On the other hand, its ablation leading to deficient bone formation and 
excessive resorption could have a negative impact. It is therefore of great interest to 
examine the impact of P2RX7 receptor ablation on the dystrophic bone structure, as 
this might be a new treatment avenue for this lethal disease.   
  
2.6.1 Biomechanical properties of bone 
The fracture prevalence in DMD patients is increased as the disease progresses. A 
report by McDonald et al. (2002) has revealed that the peak age for the occurrence 
of fractures in DMD is in 8-11 years old (40.2%) and the most predominance fracture 
site is in the lower limb. 47% of fractures occurred more commonly in the 
independently mobile group than other mobility group (total of 102 number of 
fractures). They suggested the contributing factors are reduced bone density, 
diminished power and motor agility and increased susceptibility to injury during play. 
Moreover, the effects of any treatment on bone structural properties may be reflected 
on changes in material and/or tissue properties (Ferretti et al., 2001; Van der Meulen 
et al., 2001).  Therefore, it is of great interest to assess bone strength and fracture 
risk in bone related diseases to evaluate the bone quality. For trabecular bone, 
however, the biomechanical properties traditionally obtained using compressive 
testing may cause error up to 40% and may not be able to detect changes in the 
mechanical properties (Odgaard, 1997). According to Odgaard (1997), there are two 
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important problems with all studies of mechanical properties of trabecular bone. 
First, the mechanical properties have almost never been described completely. The 
mechanical properties vary with loading orientation, that is, trabecular bone is 
mechanically anisotropic. Second, reported mechanical constants are rarely 
accurate. Mechanical tests are influenced by inherent errors and problems, which 
include specimen geometry, friction of endplate, structural end phenomena, storage, 
continuum assumption, viscoelasticity and temperature effects. Consequently, the 
mechanical test of trabecular bone may not be able to detect changes in the 
mechanical properties of the bone.  
The mechanical properties of bone tissue may play a critical role in bone strength, in 
addition to bone mineral density. For clinical investigations, laboratory tests of whole 
bone strength are often used as a surrogate measure for in vivo fracture prediction. 
These will provide comprehensive knowledge on the specific gene functions and 
disease mechanisms (Blank, 2001; Chen et al., 2015; Finnilä et al., 2010; Herlin et 
al., 2013; Volkman et al., 2004). Alterations in these mechanical properties would be 
expected to play a significant factor in bone fracture risk, even though it has not been 
clear what mechanical properties are most important (Currey, 2004). A number of 
parameters can be obtained to understand comprehensively the bone fracture 
mechanism (Table 2-3). The most recent work (Jepsen et al., 2015) has provided a 
practical and systematic guideline focused on the testing of long diaphysis and 
cortical bones.  
Table 2-3 Basic biomechanical terminologies (Jepsen et al. (2015).  
Structural properties Material properties 
Stiffness (N/mm) Elastic Modulus (or tissue level stiffness) 
(N/mm2) 
Maximum load (or whole bone strength) 
(N) 
Ultimate stress (tissue-level strength) 
(N/mm2) 
Postyield displacement (mm) Postyield strain (mm/mm) 
Work-to-fracture (N·mm) Toughness (N/mm2) 
 
An investigation of the relationship between the material properties and the geometry 
and mechanical behaviour of whole bone is challenging and complicated.  This is 
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because bone is a composite hierarchical material (Poundarik and Vashishth, 2015). 
To understand the mechanical behaviour of whole bones during physiological 
loading would facilitate the understanding of the effects of various pathological 
processes and drug treatments (Poundarik and Vashishth, 2015; Sharir et al., 2008).  
The biomechanical parameters shown in Table 2-3 may be used to characterise the 
bone integrity. The structural or whole-bone properties are measured using intact 
bones which are size-dependent whereas material or tissue level properties assess 
the material and are size-independent (Jepsen et al, 2015). The load-displacement 
curve has been used to determine the structural and material properties (Figure. 2-
17). From the slope of the linear part of the curve, stiffness (or flexural modulus) can 
be determined. Maximum load, postyield displacement and work-to-fracture can be 
derived from the same curve. The maximum load represents the general integrity of 
the bone structure. Postyield displacement and work-to-fracture represent ductility 
and fracture resistance, respectively.    
 
Figure 2-17 A typical load-displacement curve.  
The stiffness, S (slope of the curve); maximum load, work-to-fracture (area under the 
curve) and postyield displacement (PYD) (indicative of ductility). Red Cross 
represents final fracture (Adapted from Jepsen et al. 2015). 
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Stress and strain curve is obtained when load converts into stress and deformation 
converts into strain. The slope of the curve within the elastic region is defined as the 
elastic or Young’s modulus. The Young’s modulus obtained from the slope of the 
elastic portion of the stress-strain curve is a measure of the intrinsic stiffness of the 
material (Turner, 2006). 
The strength of the bone is defined by the load sustained before the failure (Dalla 
and Bankoff, 2012). It is not directly proportional to risk of fracture for which work-to-
fracture should be used. Bone strength is a first parameter to assess bone 
competency following a treatment. Bone mineral density (BMD) is considered as a 
gold standard to evaluate the bone strength (Amman and Rizzoli, 2003), although 
BMD cannot predict bone fracture risk accurately (Graeff et al., 2007). Bone mineral 
provides strength and stiffness to the tissue while collagen provides viscoelastic 
properties and resistance to fracture. The mineral to collagen ratio does affect the 
bone strength and brittleness (Wang et al., 2002).   
A multi-scale analysis was reported in which they found differences in the 
mineralisation level between Phospho1-/- (lack of phosphatase) and oim-/- 
(osteogenesis imperfecta model) mouse bones (Rodriguez-Florez et al. 2014). 
However, the tissue elastic modulus was reduced in both bones. They concluded 
that mineralization is not the only determinant of tissue elastic moduli and that they 
are not necessarily correlated. They also suggested other determinants such as the 
deviation in size, composition and organisation of bone mineral affecting bone micro-
mechanics.  
Table 2-4 A summary of three-point bending tests from the literature. 
Reference Type of bone 
 
Disease 
 
Displacement 
Rate (mm/s) 
 
Span 
(mm) 
Ammann et al. 
(1997) 
24-week-old 
mice tibia 
Estrogen 
deficiency 
0.033 8 
Turner et al. 
(2000) 
16-week-old 
mice femur & 
lumbar 
Low bone mass 0.500 5 
Akhter et al. 17-week-old LRP5 mutant 0.0500 5 
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(2004) mice femur 
Montgomery et al. 
(2005) 
16-week old 
mice femur 
DMD 0.100 5 
Finnila et al. 
(2010) 
35 & 70 post 
natal days rat 
Dioxin  
0.155  13 
(Donnelly et al., 
2010) 
6-week-old 
male rat 
Vitamin D and 
calcium 
deficiency 
0.050 7.5 
Nakagaki et al. 
(2011) 
4-week-old 
mice femur 
DMD 0.050 5 
Novotny et al. 
(2011) 
7-week-old 
mice tibia 
DMD 0.033 10 
Herlin et al. (2013) 
8-12-week-old 
mice tibia 
TCDD-induced 
toxicity 
0.155 6.5 
Melville et al. 
(2014) 
4-18-week-old 
mice femur 
Estrogen 
Receptor-Alpha 
deficiency 
0.100 6 
*N.R= Not reported 
Table 2-5 The mechanical properties of mdx and control mice reported in the 
literature. 
Reference 
Type of 
bone 
Max. Load 
(N) 
Stiffness 
(N/mm) 
Yield Load  
(N) 
Energy to 
Fracture 
(N·mm) 
Montgomery 
et al. (2005) 
16-weeks 
old mice 
femur 
WT: 
20.9±2.2 
mdx: 
23.1±1.9 
WT: 45.8± 
9.6 
mdx: 
55.1±15.6 
N.R 
WT: 4.8±0.72 
mdx: 5.1±1.6 
Novotny et 
al. (2011) 
7-weeks 
mice tibia 
N.R N.R N.R 
WT: 
3.15±0.24 
mdx: 
2.32±0.28 
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Nakagaki et 
al. (2011) 
3-weeks 
old mice 
femur 
WT: 
4.60±1.05 
mdx: 
2.25±0.41 
WT: 
10.76±1.62 
mdx:  
5.82±2.69 
WT: 
2.98±0.51 
mdx: 
1.76±0.37 
N.R 
*N.R= Not reported 
2.7 Evaluation of Bone Fracture Surface Morphology using 
Scanning Electron Microscope (SEM) 
Scanning electron microscope (SEM) is a powerful technique for investigating bone 
architectural integrity and bone quality. It is effective in investigating the bone 
morphology and fracture surfaces (Zhang et al. 2015; Banse et al. 2005). SEM can 
be used to compare morphologically the fracture surfaces of the genotypes that have 
undergone mechanical testing to investigate the failure mechanisms. It uses 
electrons produced by heating of a tungsten filament or a field emission gun. The 
electron beam is accelerated through a high voltage field and makes its way through 
electromagnetic lenses which focus and direct the beam towards the sample. Once it 
hits the sample, other electrons (backscatter or secondary) are ejected from the 
sample. Detectors collect the secondary or backscattered electrons, and convert to 
signals sent to a viewing screen. Coating is necessary for nonconductive materials 
like bone before scanning (Li et al., 2013). Creating a conductive layer of metal on 
the sample inhibits charging, reduces thermal damage and improves the secondary 
electron signal required for topographic examination in the SEM.   
To date, no studies have been reported on SEM studies post mechanical testing of 
mouse bones of different genotypes. The established histomorphometry techniques, 
where the bone was sliced into thin sections  is destructive compare to SEM, 
although it may provide higher resolution (Carbonare et al., 2005).   
Back-scattered Electron (BSE) and SEM were carried out together with 
Thermogravimetry Analysis (TGA) to assess the mineral content in the 7 week young 
mouse bones (Rodriguez-Florez et al., 2014). Chen et al. (2006) investigated mouse 
bones of 4 to 32 week old of SAMP6 (senescence-accelerated mouse or senile 
osteoporosis) and SAMR1 (age-matched normal mouse or control); while Rubin et 
al. (2004) investigated C57BL/6J (low bone mass) and C3H/HeJ (high bone mass) 
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types. Both studies utilised SEM and TEM. At periosteum level at 1 month of age, 
Chen et al (2006) found no difference in Sharpey's fiber diameters and number of 
mast cells using SEM and TEM, respectively. Sharpey's fibers are the fibers rooting 
from the periosteum and seen continuously with anteromedial bundle. Rubin et al 
(2004) found fewer trabecular numbers in the vertebra and femur in C57BL/6J 
compared to those of C3H/HeJ, but morphologically at the meso-structural level, 
they appeared similar.  
 
2.8 Evaluation of Bone Material Properties using 
Nanoindentation. 
Nanoindentation has been used to investigate the intrinsic bone material properties 
by measuring the hardness and elastic modulus at the nanoscale in human bone 
(Fan et al., 2002; Hoffler, 2005; Zioupos and Currey, 1998; Zioupos, 2005; Zioupos 
et al., 2008), dentin (Habelitz et al., 2001; Zioupos and Rogers, 2006) and mouse or 
rat bone (Akhter et al., 2004; Finnilä et al., 2010; Herlin et al., 2013; Jämsä et al., 
2002; Rodriguez-Florez et al., 2013). In addition, the use of nanoindentation has 
been extended to assess also storage and loss modulus (viscoelastic properties) in 
dynamic nanoindentation when dynamic oscillation is included, as reviewed by 
Cohen & Kalfon-Cohen (2013). The nanoindentation technique is useful in 
investigating the nanomechanical properties of bone microstructure of different 
phases due to changes caused by specific bone disease (Jämsä et al., 2002; 
Maïmoun et al., 2012). However, there has been no literature reported on the 
nanomechanical properties of mdx and P2RX7 receptor knockout mouse bones.  
Storage modulus (E’) is an indication of bone tissue’s ability to store deformation 
energy in elastic manner. Higher E’ denotes higher strength and mechanical rigidity 
characteristic as oppose to lower E’. Loss modulus (E’’) is a measure of energy 
dissipation. Though material is less stiff or hard, more energy may be dissipated as 
heat, increasing E’’. Much less energy is stored if the molecules can move with the 
force leading to a rapid decline in E’. The relative changes in E’ and E’’, for example, 
E' is larger than E" indicates that the material has some capacity to store energy and 
should be able to return, to some extent, to its initial configuration before a 
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mechanical force is applied. The material behaves as an elastic solid, although some 
of the mechanical energy is dissipated. When the applied force is higher, the 
microstructure collapses and the mechanical energy given to the material is 
dissipated. This means that the material flows; E" becomes larger than E'. Reduced 
modulus, Er is related to the stiffness of the bone. A higher modulus represents a 
stiffer material. For diamond indenter, the Er is dominated by the sample properties.  
Previous studies using nanoindentation have been carried out in small animal bones 
such as mouse bones. For example Silva et al. (2004) has extended their work from 
Silva et al. (2002) on assessing the material properties of mouse bones of SAMP6 
(senescence-accelerated mouse or senile osteoporosis) and SAMR1 (age-matched 
normal mouse or control) at 4 and 12 months of age using the nanoindentation 
technique.  They found distinct changes for elastic modulus and hardness in SAMP6 
mouse bones. It is known that the elastic modulus of cortical bone depends on its 
degree of mineralisation. Modulus correlates with calcium content in cortical bone 
across a range of animal species, and ash fraction or other measures of 
mineralisation explain 25-30% of the variation in the elastic modulus of human 
cortical bone. The same conclusion was also made for cortical and tibia bones of rat 
exposed to dioxin (Finnila et al., 2010).  
The nanoindentation parameters from both standard and dynamic protocols have 
been used to quantitatively measure the hardness of the trabecular and cortical bone 
of new born rats. In their study, the findings showed a disturbed maturation process 
of the pup tibia at the bone matrix level as a result of the exposure to 
Tetrachlorodibenzo-p-dioxin (TCDD) (Finnila et al., 2010). The limitation of this 
method is variations within a single sample may be as high as 40% to 60%, due to 
sample surface roughness (Hengsberger et al., 2002), for example. To reduce the 
variation, precise and selective positioning of the indent in the heterogeneous bone 
microstructure is needed.  
A most recent study utilised the nanoindentation technique to examine mouse 
cortical and trabecular bones to study the multi-scale hierarchy organizational bone 
for a better understanding of the age related changes in bone properties. The study 
reported a detailed multi-scale analysis of long bones in male Wistar rats with ages 
of 1, 3, 5, 7, 9, 11, 14, 15, 16, and 17 months. Femoral trabecular and cortical bone 
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properties (i.e., microarchitecture, mechanical properties, and mineral contents) were 
measured by multi-level tests. This study partly provided a theoretical basis for an 
understanding the age-related macro-mechanical properties, microarchitecture and 
material properties, and the degradation of male skeleton properties caused by 
aging. Age-related bone properties at multi-levels (i.e., microarchitecture parameters 
of femur, failure load and elastic modulus of femoral cortical bone, and size and 
roughness of bone mineral grains) will provide a fundamental basis for clinical 
research on age-related bone properties (Zhang et al. 2015). 
 
The nanoindentation approach has an attractive feature of testing precisely local 
mechanical properties of a single bone structural unit. For this reason, 
nanoindentation may help in understanding the bone quality and bone alteration at 
the nanoscale of the mdx/P2X7-/- and DMD model of mouse bones.  Furthermore, 
nanoindentation test can assess local time-dependent viscoelastic mechanical 
properties. No research has been reported so far to use the nanoindentation to 
investigate the mdx and WT as well as associated animal model bone matrix 
properties at nanoscale.  
Nanoindentation has been used to investigate tissue quality by measuring both 
hardness and elasticity with high resolution. The viscoelastic properties of the 
material can be determined from small areas at high spatial resolution (30 nm) 
(Ammann and Rizzoli, 2003; Lewis and Nyman, 2008). Depth-sensing indentation 
systems thus, appear well suited for investigating bone properties at matrix level. 
Bone matrix level contains inorganic salts primarily hydroxyapatite and some calcium 
carbonate and collagen fibers.   
One of the challenges to obtain reliable data in bones is their anisotropy, 
inhomogeneity and irregularity.  Fan et al. (2002) were the first to quantitatively 
evaluate the anisotropy of cortical bone using the nanoindentation technique. 
Anisotropic properties are due to the three-dimensional arrangement of collagen 
fibrils, a main reason for the reported high variation in the results (Finnilä et al., 2010; 
Herlin et al., 2013).  
Ritchie et al. (2008) and Isaksson (2010) reported a variation in results between 9 
and 40%, respectively. The latter employed different nanoindentation methods to 
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compare the time-dependent viscoelastic properties of cortical and trabecular bones. 
They found that a high frequency semi-dynamic test (Coefficient of Variation 9-10%) 
showed higher precision. There are potential sources of error in the determination of 
stress intensities from the edge-cracked thick-walled cylinder in bending stress-
intensity solutions due to (i) the experimental precision with which the bone geometry 
and mechanical parameters can be measured and (ii) the deviations of the cross 
sections of rat and mouse bone from the circular cylinder with uniform wall thickness 
(Ritchie et al., 2008). 
Turner et al. (1999) reported the elastic modulus of cortical and trabecular bones of 
human femur using nanoindentation. The calculation of Young’s modulus using 
nanoindentation assumes that the material is elastically isotropic. The results 
suggest that this assumption does not limit nanoindentation as a technique for 
measurement of Young’s modulus in anisotropic bone. The review by Ruppel et al. 
(2008) focused on the changes in bone structure due to osteoporosis and associated 
diseases. They also discussed the importance of matrix organisation and how the 
constituents differ from each other i.e. trabecular, cortical, lamellae, mineral crystal 
and collagen fibers; and nanoindentation was able to discriminate the microstructural 
details of bone. 
A review by Lewis and Nyman (2008) comprehensively discussed the principles of 
the nanoindentation technique and presented information on areas for future studies. 
Bone tissues and teeth as mineralised hard tissues were discussed, hence a good 
reference for studying the material properties of the tissues. The principle of 
nanoindentation lies in measuring the load and the deformation of an object using a 
very small tip probe as it is advanced into the surface of the object producing an 
imprint (Shepherd et al., 2011). Diamond is most commonly used and it has a tip 
radius less than 25 nm to ensure good imaging resolution and nanometer-scale 
indents at the level of osteons and lamellae. The data from load-displacement curves 
are used to estimate the elastic modulus using the Oliver and Pharr method (Oliver 
and Pharr, 2004). This is done from the unloading phase data as the near maximum 
load derivative of a power law fitted polynomial (Zioupos and Rogers, 2006). The 
most commonly used protocol is quasistatic or standard, comprising a loading, a 
hold and a unloading phase. When dynamic oscillation is included, viscoelastic 
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behaviour can also be assessed. The viscoelastic behaviour of bone at the 
macroscopic scale is primarily due to microstructural features, interfaces, or fluid 
flow, rather than viscous behaviour of the bone tissue. As viscoelasticity affects the 
fatigue behaviour of materials, the microscale properties may provide a measure of 
bone quality associated with initial damage formation (Shepherd et al., 2011). 
 
2.8.1 Advanced (Standard) Nanoindentation 
The fundamental nanoindentation equations were developed by Oliver and Pharr 
(1992), who developed an analytical model and a measurement protocol to 
quantitatively calculate elastic modulus and hardness. The modulus was defined as 
the ratio between stress and strain ( ), and can be directly computed from the 
nanoindentation load-displacement curve under a small load. The Oliver & Pharr 
method (Oliver and Pharr, 2004) has been developed into an acceptable standard 
analytical technique for mechanical property deconvolution. This technique has been 
widely used where the indentation technique is adapted specifically for the 
characterisation of small-scale mechanical behaviour. It relies on a time-independent 
response in the experimental time frame, developed without the need to image the 
hardness impression. An assumption in this method is that the slope of the unloading 
response is purely elastic. A review by Lewis and Nyman (2008) has the most 
complete synthesis to date of characterisation of mineralised hard tissues.  
In addition, Zioupos and Rogers (2006) explained in detail the various parameters of 
the nanoindentation method in investigating the structure of human dentine and 
enamel. A number of nanoindentation protocols can be used to produce various 
impression characteristics. The most commonly used is quasi-static or standard 
protocol, which consists of a loading, a hold and an unloading. The indentation 
modulus is calculated from the load-deformation curve during unloading-retracting 
phase as per Oliver and Pharr method (1992). Zioupos and colleague showed that 
nanoindentation can be used to study biomaterial in general and for the local 
characterisation where it is used to probe properties within small volumes.    
As mentioned above a nanoindentation loading protocol consists of a loading phase, 
a hold phase, and an unloading phase, as shown in Figure 2-18(a). The fundamental 
 /
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experimental parameters of nanoindentation are illustrated in Figure 2-18(b). In 
dynamic mode as shown Figure 2-18(b), a further implementation may result from 
analysis of the amount of energy absorbed (ψp) and recovered upon indentation (ψe). 
This may provide some quantification of the plastic response of the material.   
 
Figure 2-18 Advanced and sinus load-time curves. 
(a) Load-time traces for two examples of advanced/standard and dynamic/sinus 
nanoindentation loading protocols at a maximum load of 10 mN. The standard 
protocol includes a hold phase to study penetration creep strain. (b)  Load-depth 
traces of the protocols showing where the elastic modulus values are produced in 
the unloading phase of the indentations and two further implementations we derived 
here to quantify plasticity (by measuring the plastic and elastic work fractions ψp, ψe 
under the sinus trace) and the development of creep penetration strain in the hold 
phase of the standard protocols (Zioupos and Rogers, 2006).  
 
Considering the hierarchical structure of bone, the viscoelastic properties from 
nanoindentation may not reflect the macroscopic behaviour of bone, regardless of 
the loading protocol used. The deformation mechanisms during indentation differ 
from those in macroscopic testing. When a Berkovich indentation tip is used, there is 
damage formation below the tip where permanent deformation occurs (Shepherd et 
al., 2011). 
Table 2-6 shows the application of advanced nanoindentation technique on small 
animal bones. The nanoindentation instruments make it possible to examine the 
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material properties at the bone matrix level considering the hierarchical structure of 
bone.  
 
Table 2-6 Bone matrix properties obtained using the nanoindentation technique on 
small animal bone from the literature.  
Reference 
Type 
of 
bone 
Hardness (GPa) 
Elastic Modulus 
(MPa) 
Creep, Cit (%) 
Silva et al. 
(2004) 
4mo & 
12 mo 
mice 
tibia 
4mo 
SAMR1:980±90  
SAMP6:1110±103 
12mo 
SAMR1:1110±90 
SAMP6:1260±80 
4mo 
SAMR1:27.8±1.8  
SAMP6:29.9±2.1 
12mo 
SAMR1:30.8±1.8  
SAMP6:33.1±1.3 
N.R 
Finnila et 
al. (2010) 
Post 
natal 
days 
(PND) 
35 & 
70 rat 
PND 35 
Control:804.2±55.5 
Treated:838.0±76.8 
PND70 
Control:978.8±102.
9 
Treated:923.1±91.9 
PND 35 
Control:19.0±1.7 
Treated:19.4±1.5 
PND70 
Control:19.3±2.3 
Treated:20.0±3.0 
Acreep (overall 
creep strain 
amplitude) 
PND 35 
Control:0.019±0.
002 
Treated:0.019±0.
003 
PND70 
Control:0.016±0.
004 
Treated:0.017±0.
004 
Herlin et 
al. (2013) 
8-12 
weeks 
old 
mice 
Ahr+/+(Cortical) 
Control: 677±33 
TCDD: 710±46 
Ahr-/-(Cortical) 
Control: 732.41±2.0 
Ahr+/+(Cortical) 
Control: 24.1±2.0 
TCDD: 24.7±3.3 
Ahr-/-(Cortical) 
Control: 25.5±1.4 
Ahr+/+(Cortical) 
Control: 9.1±0.7 
TCDD: 9.0±0.7 
Ahr-/-(Cortical) 
Control: 8.6±0.3 
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TCDD: 710±35 
Ahr+/+(Trabecular) 
Control: 635±38 
TCDD: 712±46 
Ahr-/-( Trabecular) 
Control: 663±67 
TCDD: 622±86 
TCDD: 25.2±1.5 
Ahr+/+(Trabecular) 
Control: 19.3±1.9 
TCDD: 21.8±1.0 
Ahr-/-(Trabecular) 
Control: 19.8±2.0 
TCDD: 19.4±2.9 
TCDD: 8.8±0.4 
Ahr+/+(Trabecula
r) 
Control: 9.2±0.5 
TCDD: 8.3±0.6 
Ahr-/-
(Trabecular) 
Control: 9.1±1.4 
TCDD: 9.6±1.2 
*N.R= Not reported 
 
2.8.2 Sinus (Dynamic) Nanoindentation 
Dynamic nanoindentation provides an evaluation of time-dependent properties of a 
material. Herlin et al (2013) and Finnila et al. (2010) reported results using both 
quasi-static and dynamic protocols on rodents’ bones. Sun et al. (2014) also used 
both protocols on other biomaterials (nacre, cattle horn and beetle cuticle).  
Time-dependent viscoelastic properties of animal bones have been studied by 
Isaksson et al. (2010). They examined the time-dependent behaviour of bovine 
cortical and trabecular bones including creep, the effect of loading rate, dissipated 
energy, and semi-dynamic testing. They suggested a high frequency semi-dynamic 
test, and the protocol was used to demonstrate that the bone has the ability to adapt 
to mechanical loading by storing and damping the energy exerted (Cohen et al, 
2013). Table 2-7 shows the primary dynamic protocol measurements reported in the 
literature; while Table 2-8 shows the additional parameters representative of the 
viscoelasticity of the bone.  
Table 2-7 Primary bone matrix properties obtained from the nanoindentation 
technique on small animal bones using the dynamic protocol. * (p<0.05) 
Reference 
Type 
of 
bone 
Hardness (GPa) 
Elastic Modulus 
(MPa) 
Plasticity 
Finnila et Post PND 35 PND 35 PND 35 
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al. (2010) natal 
days 
(PND) 
35 & 
70 rat 
Control:951.4±94.0 
Treated:940.3±100.
5 
PND70 
Control:1196.6±16
6.5* 
Treated:1074.8±14
5.9 
Control:19.6±1.6 
Treated:19.6±1.6 
PND70 
Control:20.0±1.8 
Treated:20.3±3.2 
Control:0.75±0.03 
Treated:0.76±0.03 
PND70 
Control:0.71±0.03
* 
Treated:0.74±0.04 
Herlin et 
al. (2013) 
8-12 
weeks 
old 
mice 
Ahr+/+(Cortical) 
Control: 845±51* 
TCDD: 921±52 
Ahr-/-(Cortical) 
Control: 864±52 
TCDD: 844±53 
Ahr+/+(Trabecular) 
Control: 804±52 
TCDD: 863±56 
Ahr-/-( Trabecular) 
Control: 795±73 
TCDD: 789±94 
Ahr+/+(Cortical) 
Control: 23.0±0.8 
TCDD: 23.9±1.1 
Ahr-/-(Cortical) 
Control: 23.6±1.2 
TCDD: 22.5±1.4 
Ahr+/+(Trabecular) 
Control: 17.4±1.4* 
TCDD: 19.5±1.1 
Ahr-/-(Trabecular) 
Control: 17.8±1.4 
TCDD: 17.9±2.2 
Ahr+/+(Cortical) 
Control: 25.9±0.5 
TCDD: 26.7±1.8 
Ahr-/-(Cortical) 
Control: 25.1±0.4* 
TCDD: 26.0±1.3 
Ahr+/+(Trabecular) 
Control: 31.8±1.5 
TCDD: 30.6±0.8 
Ahr-/-(Trabecular) 
Control: 30.8±0.8 
TCDD: 30.5±1.2 
 
Table 2-8 Additional bone matrix properties obtained from the nanoindentation 
technique on small animal bones using the dynamic protocol. * (p<0.05) 
Reference 
Type of 
bone 
Phase Diff. (º) E.Store (GPa) E.Loss (GPa) 
Finnila et 
al. (2010) 
Post 
natal 
days 
(PND) 35 
& 70 rat 
PND 35 
Control:107±1.3 
Treated:11.4±1.7 
PND70 
Control:9.9±1.7 
Treated:11.1±1.9 
PND 35 
Control:22.9±1.7 
Treated:22.6±1.7 
PND70 
Control:25.8±3.0* 
Treated:25.1±3.4 
PND 35 
Control:4.5±0.7 
Treated:4.7±1.0 
PND70 
Control:4.7±0.9 
Treated:5.1±1.3 
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Chapter 3 
Experimental Methods 
This research was ethically reviewed and approved by the University of Portsmouth. 
The microCT imaging and mechanical testing were conducted in the Mechanical 
Behaviour of Materials (MBM) laboratory, School of Engineering; animal preparation 
and SEM at the School of Pharmacy and Biomedical Sciences laboratory, University of 
Portsmouth (Approval gained from the Institutional Ethical Review Board and the Home 
Office UK ref 70/7479) while the nano-indentation experiments were conducted in the 
Biomechanics Labs, Cranfield Forensic Institute, Cranfield University, Shrivenham, 
Defence Academy of the UK.  
3.1 Experimental Design 
A summary of four primary experiments and two secondary experiments is represented 
in Figure 3-1.  
The animals were selected based on previous studies and detailed in Sinadinos et al. 
(2015).  The soft tissue was dissected to obtain tibia bones from each mouse (n=6 per 
genotype). To assess the specific role of P2RX7 receptor in DMD pathogenesis, P2RX7 
ablation in mdx mice (mdx/P2X7-/-) was adopted. The impact of ablation was determined 
at 4-weeks of age. This age group was chosen because at 4 weeks, it has been found 
that muscle inflammation is not prominent and they are considered to be in a more 
reparative or fibrotic phase (Giordano et al., 2015).  At this age, the disease is fully 
manifested but the muscle loss and its effects on bone properties are thought not yet 
significant.   
The present study utilised state-of-the-art micro-focus CT to create high resolution 
images of mouse bones to investigate whether the disrupted gene will have a direct 
effect on the bone structure. A previous study has shown that at approximately 3-weeks 
of age development of bone abnormalities can be observed. Notably, at this age, 
64 
 
degeneration of the bone cannot be affected by a previous muscular alteration as a 
result of modifications in gait and posture and by muscle weakness (Nakagaki et al., 
2011).  
Figure 3-1 shows the experimental flowchart for imaging, biomechanical and tissue 
properties analyses. µCT scanning was used for 3D microstructure analysis, bone 
image analysis for morphometric properties evaluation, three-point bending test for 
bone strength assessment, SEM for fracture morphology evaluation, two 
nanoindentation protocols for tissue properties analysis and TGA technique for bone 
composition analysis.  
Nano- and micro- indentation testing, microtensile and microcompressive testing, and 
bending tests on whole bone specimens, offer the possibility to mechanically probe 
small animal bone and investigate the effects of aging, therapeutic treatments, disease, 
and genetic variation. In addition to traditional strength tests on small animal bones, 
fracture mechanics tests were also used to test tissue properties for fracture (Ritchie et 
al., 2008; Vashishth, 2008). 
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Figure 3-1 The experimental approaches used in this study. 
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3.2 The animal models 
The animal models were prepared at the School of Pharmacy and Biomedical Sciences 
laboratory, University of Portsmouth. Animal models were central to the research as 
there is no in vitro system allowing testing a disease involving interdependent processes 
of muscle damage and inflammation. The mdx mouse is currently considered the most 
appropriate pre-clinical model to test treatment efficacy for DMD (http://www.treat-
nmd.eu/research/preclinical/dmd-sops/). All animal experiments were performed in 
accordance with the approvals of the Institutional Ethical Review Board and the Home 
Office UK (70/7479).  
Age matched male mice (wild-type, mdx, P2X7-/-, mdx/P2X7-/-) of mean age 31 days 
were used in the experiments. Some mice were collected at 28 days of age, some at 29 
days, and some at 31 days (Table 3- 1).  
Table 3- 1 Types of mice used in this study.  
 
 
 
 
 
 
 
 
 
 
N=number of sample tested. 
 
Genotype Genetic background Age Gender N 
WT 
C57BL10, wild-type, 
healthy 
28 days Male 6 
mdx 
DMD or dystrophic 
mice (Bulfield et al., 
1984)  
29 days and 
31 days 
Male 6 
P2X7-/- 
P2RX7 receptor 
knockout mice (Solle 
et al., 2001) 
29 days and 
31 days 
Male 6 
mdx/P2X7-/- 
mdx and P2RX7 
receptor knockout 
(double mutant) 
mice (Young et al., 
2015) 
28 days Male 6 
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The mdx/P2X7-/- were generated by crossing P2RX7 receptor knockout male mice 
(Solle et al., 2001)(Solle et al., 2001) with mdx C57Bl/10ScSn-Dmdmdx/J female mice 
(Harlan Lab, UK), and genotypes were confirmed by genomic DNA PCR (Sinadinos et 
al., 2015). Animals were maintained in a 12 hours light/dark cycle and fed normal diet 
and water ad libitum. A total of 24 male mouse bones were used in the study. These 
included wild-type (C57BL10, n=6), dystrophic (mdx, n=6) (Bulfield et al., 1984), P2X7-/- 
(n=6) (Solle et al., 2001) and mdx/P2X7-/- (n=6) (Young et al., 2015), as summarised in 
Table 3- 1.  
3.3 Sample Preparation 
The tibia was prepared by carefully dissecting the muscle tissues and also other leg 
parts under a microscope. The tibias were placed in 10% buffered formalin overnight 
prior to saline storage in a fridge at 4°C for scanning and mechanical analysis. The 
tibias were kept in the saline solution until they were ready for scanning and mechanical 
testing. Left tibias for each of the genotypes were used for µCT scanning after about 2 
weeks in the saline solution, followed by three-point bending testing, SEM examination 
and nanoindentation in up to 50 weeks. 
After dissection the left tibia from each experimental genotype group were subjected to 
gross tibias geometry measurement before further radiological and biomechanical 
analysis. They were measured three times using a micrometric digital calliper and the 
average was calculated. The length and diameter measurements were taken from the 
centre of the condyles (proximal tibia) to the medial malleolus (distal tibia) (Di Masso et 
al., 2004), as shown in Figure 3-2.  
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Figure 3-2 An illustration of the tibia length measured.  
Tibial gross length and diameter measurements were taken from the centre of the 
condyles (proximal tibia) to the medial malleolus (distal tibia). 
3.4 Micro-computed tomography (µCT) 
The tibias underwent µCT scanning prior to mechanical test using a CT X-Ray 
Inspection System (XT H 225, X-Tek Systems Ltd, UK, Figure 3-3) to acquire a series of 
images of the region of interest of the tibias. The µCT scanner is composed of a sealed 
micro focus X-ray tube with optional rotating target, real-time x-ray visualisation, fast CT 
reconstruction, CT measuring volume up to 250 mm and 600 mm height, 5-axis fully 
programmable part manipulator, customizable macros automate measurement workflow 
and small footprint and castors and roller for easy handling. The maximum weight of 
object that is capable of fitting into this device is 15 kg. The µCT system is capable of 
generating x-ray source at maximum 225 kV with small spot size of 3 µm to work with 
various range of sample sizes. A target was rotating during the x-ray scanning to ensure 
the heat was dissipated effectively and the object can be scanned in a short time to 
produce high resolution images. Using a rotating target, the electron beam falls on a 
moving instead of a fixed surface, which yields much more effective cooling. This offers 
the opportunity to measure objects faster, or denser objects with high accuracy. 
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Figure 3-3 The µCT machine XT H 225 system used in this study (Adapted from 
www.nikonmetrology.com). 
 
The tibia was positioned vertically and secured in a µCT holder to avoid any small 
movements during scanning (Figure 3-4). The tibia was positioned at the center of the 
holder between the detector and the x-ray source (Figure 3-5). The µCT image volume 
included the proximal and the distal tibia, though only proximal metaphyseal and 
midtibia were used in this analysis.  
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Figure 3-4 The position of the mouse tibia.  
The mouse tibia secured in the holder to prevent movement during scanning therefore 
reducing motion artefacts.  
 
 
µCT scanning parameters included: Bone reconstruction kernel, axial scanning plane, 
50 - 55 kVp tube voltage, 95 - 300 μA tube current, voxel size = 6 - 8 μm, rotational step 
= 0.19°/360°. Full data acquisition of the tibia took about 90 minutes and the dataset 
was stored in a separate computer in the same network. The whole process of acquiring 
images, reconstruction and analysis requires a large dataset to be moved between the 
file servers and the different workstations used.  After the scanning finished, the 
projection images were loaded into the reconstruction program CTPRO (Metris X-Tek, 
UK). A reconstruction option includes beam hardening correction. The optimal settings 
need to be assessed empirically for mouse bone sample. Another option is smoothing, 
however, it was not activated to prevent impair detection of fine detail in the image. Ring 
artefact reduction is another correction option to reduce the motion artefact resulting 
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from the rotating sample. Figure 3-6 shows the regions of interest (ROI) selected for 
image evaluation. A destination folder was then chosen for the reconstructed images 
and the reconstruction started. These 3D image stacks were analysed using standard 
image analysis package available provided by the manufacturers of the µCT systems.   
Subsequently, the file extension .vgi (Volume Graphics Info file) was visualised using 
VG Studio Max 2.0 software (Volume Graphics, Heidelberg, Germany). The multiplanar 
reconstruction (MPR) method in the software was used to view the slice images. A 
volume of interest (VOI) was identified to contain a reasonable amount of trabecular and 
cortical bones.  
 
 
Figure 3-5 The arrangement of the tibia inside the µCT chamber.  
The tibia was positioned close to the x-ray window sandwiched by the x-ray tube and 
the detector. 
 
ImageJ was used to carefully select the proximal tibial metaphysis ROI 0.50 mm below 
the growth plate to avoid the primary spongiosa. The image stack for this region was 1.0 
mm with 0.01 mm slice thickness.  The ROI in midtibia consists of 0.54 mm thick of 
bone volume from 4.32 mm below the growth plate. 
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Figure 3-6 Regions of interest (ROI) studied in this work. 
(a) proximal tibia metaphyseal; (b) midtibia. 
 
3.4.1 Image Analysis 
ImageJ 
ImageJ (ImageJ v.1.46r, National Institutes of Health, USA) was used for the image 
analysis.  At proximal metaphyseal tibia level, the whole bone ROI consists of bone 
marrow, trabecular bone and cortical bone; while at midtibia level, the ROI consists of 
bone marrow and cortical bone. 
The quantification of cortical and trabecular bone morphometrics requires an accurate 
image processing method. The images were linearly rescaled to 0 and 255 to get 8-bit 
images and to avoid memory issues. The images were crop down to the minimum 
rectangle that contains the bone of interest. This limited the calculations of pixels inside 
the region of interest, and avoided processing the large image areas outside the sample 
to reduce the dataset size. Further, increasing the RAM to 6000 MB increased the 
ImageJ memory.  
To quantify the cortical and the trabecular bone separately, image segmentation was 
carried out prior to bone parameter analysis. There are various image segmentation 
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methods (Buie et al., 2007; Janc et al., 2013). In this study, two methods were 
implemented to separate bone over the background; and the cortical bone over the 
trabecular bone. The methods are described in Section 3.4.3.  
BoneJ 
BoneJ (Version 1.3.8) was used throughout the bone image analysis process. BoneJ is 
made for bitmap data, and it uses a 7×7 median filter to reduce noise. The image was 
thresholded into binary images for further analysis using default setting in ImageJ. This 
setting was a variation of the IsoData Algorithm also known as iterative intermeans 
(Ridler and Calvard, 1978). Bone morphometry parameters were obtained from the 
BoneJ analysis. The parameter measurements used in this study are shown in Table 3- 
2 and Table 3- 3, as recommended by Bouxsein et al. (2010).  
 
Table 3- 2 Cortical bone morphometry parameters (Refer to Section 3.4.3 for 
measurements). 
Abbreviation Variable Description Standard Unit 
Tt.Ar 
Total cross-sectional 
area 
Total cross-sectional area 
inside the periosteal 
envelope using ‘Slice 
geometry’. 
mm2 
Ct.Ar Cortical bone area 
’Slice geometry’ measure 
the cross-sectional area 
(CSA) of the bone pixels. 
mm2 
Tt.Ar/ Ct.Ar Cortical area fraction  % 
Ct.Th Cortical Thickness Average cortical thickness mm 
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Table 3- 3 Trabecular bone morphometry parameters (Refer to Section 3.4.3 for 
measurements). 
Abbreviation Variable Description Standard Unit 
BV Bone Volume 
Volume of the entire region 
of interest  
mm3 
TV Total Volume 
Volume of the entire region 
of interest(volume inside 
the periosteum) 
mm3 
BV/TV Bone Volume Fraction 
Ratio of the segmented 
bone volume to the total 
volume of the region of 
interest 
% 
Tb.Th Trabecular Thickness 
Mean thickness of 
trabeculae, assessed using 
direct 3D methods 
mm 
Tb.Sp Trabecular Spacing 
Mean distance between 
trabeculae, assessed using 
direct 3D methods. 
mm 
Conn.D Connectivity Density 
A measure of the degree of 
connectivity of trabeculae 
normalised by TV 
1/mm3 
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3.4.2 Image Analysis 
ImageJ was used for bone segmentation while the BoneJ plugin was used for the 
analyses of BV/TV (%), the bone thickness (mm), and the bone spacing (mm). 100 and 
54 contiguous µCT slices were selected at the proximal tibial metapysis and midtibia, 
respectively. VOIs were identified in all genotypes which contain a reasonable amount 
of trabecular or cortical bones.  
The bones (n=24) were analysed and the resulting microarchitectural indices were 
compared across the genotypes. The determination of the threshold level was based on 
visual inspection and automatic thresholding (revised IsoData algorithm) (Bouxsein et 
al., 2010; Stock, 2009) using the reference image (original gray-scale image) (Bouxsein 
et al., 2010). The images were then rescaled to 0 and 255 to get 8-bit images (Bayat et 
al., 2005). The images contain the information of the maximum (255) and the minimum 
(0) values of a pixel. It can store 256 different level of intensity (28 = 256). The more bits 
per pixel an image uses, the more intensity levels can be stored. However, the image 
will need more disk memory space (Mateos-Perez and Pascau, 2013).  
Reducing the bit depth of the images retain the small features of the samples. This will 
reduce the size of the image and make the segmentation step easier with regard to 
lower memory requirements and reduced amount of pixels to process. Another step is 
cropping the images in order to keep the necessary objects within the volume limits. 
This will limit the algorithm to calculate within the pixels of the ROIs. 
After thresholding was performed images were further cleaned by removing small 
fragments. Trabecular bones are highly connected structure, therefore any unconnected 
small objects are unlikely to be bone and can be removed using despeckle operator. 
Volksmann's canals or tubular passages that perforate the surfaces of the cortex must 
be removed using morphological operations, where dilation followed by erosion was 
implemented prior to extraction.  
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3.4.3 Image Analysis using Semi-automatic Segmentation. 
Semi-automatic segmentation procedure was employed in this study. This procedure 
involved manually selecting and drawing the trabecular regions slice by slice. This is 
followed by thresholding and measuring the bone pixels.   
3.4.3.1 Cortical bone 
1. Calculating Total Cross-sectional Area (Tt.Ar) 
The cortical bone images were analysed using ‘Slice Geometry’ plugin. It calculates 
cross-sectional geometric properties of shapes: cross-sectional area, centroid, mean 
density, second moment of area, section modulus, Feret diameter and local thickness 
(2D and 3D) (www.bonej.org/slicegeometry). Measurements can be made prior 
thresholding the images into binary images. To improve the performance of the 
algorithm measurement, a rectangular ROI was drawn around the cross-sectional 
cortical bone to limit the calculation of cross-section geometry to pixels inside ROIs.  
 
 
Figure 3-7 A sequence of analysis using ‘Slice Geometry’ option.  
(a) A rectangle shape was drawn to limit the ROI measured, (b) The process of 
binarisation (thresholding) followed by despeckle & morphological operators, (c) ‘Slice 
Geometry’ options. Note that density-weighted calculations are only applied to centroid 
determination present. 
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The sequence of the analysis is: 
1. Draw a rectangular ROI to include the cross-sectional cortical bone.  
2. Convert stack of images into 8-bits and threshold them into binary input.  
3. Run the ‘Slice Geometry’.  
 
2. Calculating Cortical Bone Area (Ct.Ar) 
 
As recommended in Bouxsein’s guidelines, cortical bone area was calculated by using 
cortical volume (Ct.V) ÷ (number of slices × slice thickness).  However, using BoneJ, 
‘Slice Geometry’ plugin was used to determine the cross-sectional area of the midtibia. 
The plugin calculates the Ct.Ar in transverse plane. Prior to that, the images were 
converted into 8-bits, segmented, cleaned and then ‘Slice Geometry’ was used. The 
plugin scanned the rectangular ROI and count pixels that are above minimum and 
below bone maximum then multiplies by pixel area. The minimum and maximum bone 
values were determined during the thresholding.  
 
3. Calculating Cortical Thickness 
 
‘Thickness’ plugin was used to obtain the mean and standard deviation of the cortical 
thickness. It uses pixel values in the resulting thickness map. The algorithm makes a 
sphere fitting or voxelic spheres which are voxel/pixel size. The image resolution is 
reduced so that each pixel is resolved by fewer, larger pixels. ‘Thickness’ was selected 
to calculate the cortical thickness based on the pixels selected.  
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3.4.3.2 Trabecular bone 
The trabecular bone was selected manually as an irregular anatomic contour adjacent 
to the endocortical surface or an irregular anatomic contour a few pixels away from 
endocortical boundary, as suggested in Bouxsein et al. (2010). This method was used 
for all image slices. The ROIs were then added to the ROI manager. This allows only 
the selected pixels in the ROI contribute to the BV/TV measurement. The same steps 
were applied to the other parameters. The pixel values were managed carefully 
because the ImageJ default known as black is 0 and white is 255, where 255 is 
‘foreground’ and 0 is ‘background’. BoneJ treats 255 as bone and 0 as non-bone.  
The validation of individual threshold values was done by setting up a gold standard 
threshold manually and then tested whether the automatic procedure discovers a value 
that is suitably close.  
To restrict the BV/TV measurement to the relevant ROIs, ROI Manager option was 
selected to instruct the plugin to use the ROIs that were added previously.  
  
Figure 3-8 The Region of Interest (ROI) manager.  
The ROI manager creates a three part label. The first part (image in stacks) is the slice 
number, the second is the y-coordinate of the selection and the third is the x-coordinate 
(Adapted from imagej.nih.gov). 
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The sequence of the analysis is: 
1. Open the stack of images.  
2. The ROIs were drawn manually slice-by-slice using the freehand selections 
adjacent to the endocortical surface, as described in Bouxsein et al. (2010).  
3. The BoneJ plugin was run (Plugins>BoneJ>Fit Sphere), clearing the ROI 
manager of the point ROIs and adding the sphere ROIs (set of circles) to the 
ROI Manager. 
4. Click Add to add the current selection to the list, or press‘t’, the keyboard 
shortcut for the Edit>Selection>Add to Manager command. 
5. The image threshold was adjusted (the pixels of interest are masked in ‘red’) 
6. The plugin was run again (Plugins>BoneJ>Volume Fraction) by selecting the 
measurements to calculate the ROIs (i.e Thickness). The selection was 
restricted to ROIs.  
 
1. Interpolating ROIs 
A common segmentation approach is to draw ROIs on every slice in a stack, which put 
together define a 3D ROI. Interpolate ROIs (Plugins > Stacks > Interpolate ROIs) uses 
the signed integer transform to interpolate between ROIs. The selected trabecular bones 
were interpolated using ‘Interpolate ROIs’. The trabecular region was first drawn as 
close to the endosteum as possible, a few voxels away from endocortical boundary. The 
selected region was then added into the ROI manager. These steps were repeated by 
advancing a few more slices (5-10 slices) depending on the details in the image. The 
steps were repeated until all image stacks were analysed.  
2. Thresholding 
The acquired µCT images consist of a range of phase contrasts corresponding to 
different levels of x-ray absorption (Figure 3-9). For subsequent computational analysis, 
ROI within the field of view can be segmented using a thresholding technique. This 
technique involved the process of replacing the voxel values of features of interest with 
a binary value of 1(solid) and 0 (non-solid). In ImageJ, the voxel values are replaced 
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with 0 (ignore black) and 255 (ignore white) grey levels. The white object will be set on 
black background. The thresholding technique can be implemented in two ways: local 
thresholding and global thresholding. Both plugins are able to automatically process 
binary images. Auto local thresholding can work with 8-bit images whilst auto global 
thresholding can work with both 8- and 16-bit images. The bit depth of an image 
provides information of the minimum and maximum values of a pixel and it directly 
corresponds to the resolution of each pixel. Global thresholding was applied in this 
study.  
 
Figure 3-9 The histogram of a typical 8-bit 3D CT image of tibia.  
The left peak represents background (BG) voxels, the middle peak represents air 
voxels, whereas the right peak represents bone voxels. 
After identifying the features of interest, the images were thresholded using the stack 
histogram in which the histogram of all the slices will be computed. The images were 
thresholded based on the histogram and all the slices are binaries with a single value. 
There are 16 available methods listed in the thresholding option in ImageJ. In this study, 
the default method was chosen to segment the bone and non-bone regions as well as 
cortical and trabecular bone. This method is a variation of the IsoData algorithm (Ridler 
and Calvard, 1978; Doube et al., 2011 ), which works by choosing the optimum 
threshold automatically based on an iterative process.  
Due to the absence of a well-defined valley between the histogram peaks, visual 
inspection was used to facilitate the thresholding and the segmentation (Stock, 2009).  
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3.4.3.2(a) Trabecular Thickness (Tb.Th) and Spacing (Tb.Sp) 
Thickness plugin was used in the study where the plugin defines the thickness at a point 
of the strut, which is the diameter of the greatest sphere that fits within the structure 
which contains the point. Then it is calibrated by multiplying with pixel spacing. BoneJ is 
expected to work with isotropic pixel spacing. For trabecular bone, when the ROIs were 
selected and added in the ROI Manager, the trabecular thickness (Tb.Th) and 
trabecular spacing (Tb.Sp) were assessed. Trabecular spacing is the local thickness of 
the marrow space in between trabeculae. The Tb.Sp at a point in the structure is 
defined by the diameter of the largest sphere that fits within the marrow and that 
contains the point. BoneJ reports a mean Tb.Sp as an arithmetic mean of the pointwise 
Tb.Sp values. It is a similar process for Tb.Th. 
3.4.3.2(b) Structural Model Index (SMI) 
SMI is a standard measurement for the determination of plateness and rodness of 
trabecular structures. SMI was assessed using the binaries voxel images (input). In 
BoneJ, there are two methods to implement: surface mesh dilation (Hildebrand and 
Ruegsegger, 1997) and voxel dilation (Dilate 3D). Surface mesh dilation method is 
preferred whereas voxel dilation is implemented in CTAn (bonej.org/smi). However, 
preliminary analysis shows mostly positive values (convex, SMI+), which could not 
possibly be true. Recent findings from Salmon et al. (2015) showed that SMI does not 
measure the bone plateness and rodness accurately. Hence although the parameter 
was considered in the study, the result has been removed from reporting.    
3.4.3.2(c) Connectivity 
The number of connected structures in a network and its connectivity density (Conn.D) 
was calculated using the connectivity algorithm in BoneJ.  It uses voxel neighbourhoods 
to calculate the Euler characteristic of the volume and adjusts this to give the 
contribution of the volume to the connectivity of the structure it was cut from. 
Essentially, Conn.D is a count of topological holes in the structure (Doube et al., 2010; 
Toriwaki and Yonekura, 2002). Prior to Connectivity calculation, Purify was selected in 
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BoneJ to remove any artefacts in the images with an assumption that there is only one 
particle in the foreground. Results are reported based on the standard report by Parfitt 
et al. (1987) and guidelines by Bouxsein ( 2010).  
       (3-1) 
Conn.D =      (3-2) 
Where  is the connectivity of the image (number of trabeculae) and is the bone 
sample’s contribution to the Euler characteristic of the bone it was connected to. The 
connectivity density (Conn.D) is the connectivity per unit volume (number of trabeculae 
per unit volume).  
Connectivity used a topological approach. Connectivity density (Conn.D) as in Equation 
3-2 is better than Connectivity as the latter makes assumptions about the underlying 
geometry which may or may not be correct. Connectivity measures loops rather than 
branches.  A tree would be seen by Connectivity as having only one 'trabeculae' 
because there are no loops. For trabecular bone, measurement of Connectivity is 
relevant because bone is a single continuum perforated by a continuous marrow space 
and so counting loops gives an indication of its trabecular number. 
Connectivity is influenced by noise, so smoothing or using noise-reduction approaches 
(Gaussian blurring or 3D erode-dilate) the structure before running the analysis is 
necessary to reduce the spurious, small branches or loops.  
3.5 Three-point bending test 
The bending test (Hessle et al., 2013) was done in Mechanical Behaviour and Material 
Laboratory, University of Portsmouth, UK. The aim of the study was to analyse the 
biomechanical properties of bones in the three genotypes compared to the wild-type; in 
particular to examine the impact on bone strength in knockout mice compared with that 
of mdx mice.  
 11
 VolumeStack
1
1 
83 
 
 
Figure 3-10 V-shaped end supports. 
The lower supports were shaped in such a way to prevent movement of the specimens 
in all planes during loading. 
 
Left tibias were mechanically tested under three-point bending using a Bose 
ElectroForce® 3200 until failure. The bending jig was custom-made, where both end 
support was cut in a v-shape to provide stability, as shown in Figure 3-10. The tibias 
were placed horizontally on the lower supports, at a span of 7 mm (Silva et al., 2004) 
with the anterior surface of the tibia was facing upwards. The load was applied on the 
midshaft of the tibia. The force was measured with a 225 N capacity load cell calibrated 
in the full load range according to ISO 7500-1:2004 class 0.5. 
Each bone sample was compressed with a constant displacement rate of 0.155 mm/s 
until failure (Figure 3-11). The average time for the test was approximately 5 to 10s. The 
load and displacement curves were obtained and stored in a computer coupled to the 
testing machine. The peak load was recorded by measuring the maximum force that the 
bone was able to resist. Stiffness characterises how much the bone deforms when 
loaded. It was calculated by measuring the slope of the most linear portion of the elastic 
region of the load-displacement curve. Flexural modulus was determined from the slope 
of the stress-strain curve of a material under bending load. The work-to-fracture defined 
by the area under the load-displacement curve was calculated by using OriginPro 9 64-
bit. Cross-sectional area and shape are assumed constant at the loading point.  
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Figure 3-11 The three-point-bending test arrangements.  
(a) Tibia was placed on the lower supports, with anterior surface facing up. Load was 
applied in the midplane until failure. (b) The force was measured with a 225 N capacity 
load cell calibrated in the full load range according to ISO 7500-1:2004 class 0.5.   
 
3.5.1 Calculations of the Second Moment of Area 
 
Cross-sectional second moment of area (SMA) is the morphological parameter that 
correlates strongly with bending stiffness.  SMA reflects both the amount of mass and 
the spatial distribution of the mass. The SMA in the loading direction (anterior-posterior) 
was calculated using the algorithm in BoneJ, where the two orthogonal axes, anterior-
posterior and medial-lateral, intersect at the centroid. An average value of SMA was 
obtained from the values calculated from 20 slices taken in an area close to the load 
application.  
 
BoneJ protocols 
The SMA was calculated from a digitised bone cross-section obtained from a µCT scan 
(Jepsen et al., 2015; Sharir et al., 2008). ‘Slice geometry’ plugin in BoneJ was used to 
calculate cross-sectional geometric properties of shapes including cross-sectional area, 
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centroid, and second moment of area (SMA), considering the cortex is approximately 
cylindrical and the cross-section is orthogonal to its long axis. 
The pixels that contribute to the calculation of second moment of area are those pixels 
that lie within the ROIs. The minimum and maximum cortical bone pixel values were 
determined by the image threshold.   
Orientation 
This plugin was used to set the direction of the principal axis in a 2D image. Slice 
geometry uses orientation to calculate second moment of area.  The orientations of the 
principal axes were set as in Figure 3-12.  
 
Figure 3-12 Schematic diagram of a cross section of bone.  
The figure shows the loading direction anterior-posterior orthogonal to medial-lateral 
axes, with a pixel at a distance x and y. ‘c’ is the distance measured from the centroid to 
the edge of the cross-section in tension (Adapted from Jepsen et al. 2015).   
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Slice Geometry 
Slice geometry was used for the analysis. This plugin returns the maximum chord 
distance from the centroid of the cross-section to the edge of the cross-section in 
tension for each slice. The algorithm can be used for every slice and slice-specific 
results obtained. The SMA (I) about the maximum Imax and minimum Imin were provided 
automatically in the BoneJ analysis output.  
 
Validation of the method was carried out using a rectangular shape, as illustrated in 
Figure 3-13. 
 
Figure 3-13 Validation test of a known shape. 
(a) The image of an arbitray rectangular shape (b, width=10 mm; h, height=5 mm) was 
modelled to validate the SMA calculation by running the algorithm in ImageJ using Slice 
Geometry plugin. b) The annotated image showing the principal axes with centroid C 
marked.  
 
The maximum Imax and minimum Imin were calculated using the Equation 3-3 and 
Equation 3-4. Both results from BoneJ and theory of elasticity for the case presented in 
Fig 3-13 are given in Table 3-4, showing good agreement. 
Imax=       3-3 
12
hb3
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Imin=       3-4 
 
Table 3-4 A comparison of SMA calculations between the theory and BoneJ algorithm 
for the rectangular shape in Figure 3-13. 
 Theory BoneJ 
Imax (mm
4) 416.67 419.601 
Imin (mm
4) 104.17 104.900 
 
3.5.2 Stress and strain  
Stress and strain curves were obtained from the load-displacement curves, where the 
load was converted to stress and displacement was converted to strain using Equation 
3-5 and Equation 3-6 (Jepsen et al., 2015; Nakagaki et al., 2011).     
        3-5  
               3-6 
 
where  is the stress, F is the load, L is the length of the span, c is the distance from 
the centroid of the cross-section to the edge of the cross-section in tension, I is the SMA 
in the loading direction,   is the strain, and d is the displacement. The flexural strength 
and strain at failure were obtained from the stress-strain curves. 
The parameter ‘c’ was measured using ‘Slice Geometry’ algorithm as the maximum 
distance from the centroid of the cross-section to the edge of the cross-section in 
tension for each slice.  An average value was obtained from the data of 20 slices taken 
in an area close to the load application.  
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3.6 Scanning Electron Microscopy  
The epiphyseal region of the left distal tibia (n=2) of the four genotypes was selected to 
examine the fracture surfaces post three-point bending testing using Scanning Electron 
Microscopy (SEM). The SEM was carried out with compatible digitiser at the 
Environmental Microbiology Laboratory, University of Portsmouth, UK (JSM-6060LV 
JEOL, Tokyo, Japan).  
3.6.1 Sample preparation and methodology for SEM 
The distal part of left tibia per bone per genotype was placed horizontally on the 
specimen support. The tibias were air-dried and gold-palladium-coated before scanning 
(Bozzola and Russel, 1999). Coating was carried out using a sputter coater (Quorum 
Model Q150R ES). The coated tibias were stored in a dust-free desiccator, before 
placed in the SEM chamber for observation.  The SEM was operated at 15kV 
accelerating voltage. SEM images of the fracture surface were captured and compared 
at magnifications from 10 to 500 µm to enable the analysis at both macro and micro 
levels. 
 
3.7 Nanoindentation 
Nanoindentation was performed at the Forensic Laboratory, University of Cranfield, UK, 
using a CSM-Nano Hardness Tester System with Indentation v.3.83 software (CSM 
Instruments SA; 2034 Peseux, Switzerland) (Figure 3-14). A typical Berkovich (three-
sided pyramid) triangular-based pyramid diamond indenter was utilised with optical 
microscope 5x,100x, Nikon (4000x CCD camera). The machine is operated at a load 
range 0.1-500nm. Geometrically, it has a tip with less than 20 nm tip radius, following 
the ISO4577-1:2015 standard. The bone preparation followed the procedures described 
in (Finnilä et al., 2010; Herlin et al., 2013; Zioupos and Rogers, 2006) 
In this study, the transverse cortical bone tissue properties from the proximal and 
midtibia were measured. In the preliminary step, the hardness and elasticity of the bone 
structure of different locations, particularly the cortical regions (medial, lateral, anterior 
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and posterior), were investigated to evaluate the variation and to guide the selection of 
the location of the nanoindentation points.   
 
 
Figure 3-14 Schematic illustration of a nanoindentation. 
A schematic representation of the experimental apparatus used to perform the 
indentation experiments: (A) sample, (B) indenter, (C) load application coil, (D) 
indentation column guide springs, (E) capacitive displacement sensor (Oliver and Pharr, 
1992).  
 
3.7.1 Sample preparation 
The left tibia diaphysis from the mice was cut transversely at the midpoint of each tibia 
shaft using a diamond saw. They were stored in plastic vials and labelled. The fracture 
fragments from three-point bending test consist of both the top and bottom part of the 
tibia. Proximal midtibia sections were used for the nanoindentation test. The upper 
section consists of proximal metaphyseal tibia with trabecular bone in place while the 
bottom section, the midtibia part, consists mainly of cortical bone. The system used and 
the positions of the indenter and the sample were shown in Figure 3-15.  
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Figure 3-15 Nanoindentation test for advanced and sinus protocols. 
(A) The nanoindentation setup showing (A) CSM Instrument Nano-Hardness Tester 
machine. (B) The bone tissue (white arrow) embedded in a resin with clipper in placed, 
(C) The resin (r) was placed under the nano-indenter (i) where a piece of clay was used 
to secure its place on the stage.  
 
The bones were cleaned with distilled water, ultrasonicated and left air-dried in a 
desiccator at room temperature. The tibias were then embedded in low viscosity Kleer-
Set resin (MetPrep, Conventry, UK). The moulds were then allowed to solidify at room 
temperature for 24 hours. The bone cross-section surface was subsequently ground 
using silicon carbide papers with decreasing grain size; midtibia (400, 500, 800, 1200 
grit) and proximal metaphyseal tibia (2500 and 4000 grit) using running water as 
lubricant with semi-automatic grinder. The final step was polishing the bone surface 
using a 0.05 micron -alumina slurry (MetPrep Conventry, UK) (Zioupos and Rogers, 
2006).  

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For trabecular samples, the proximal part of the tibia was cut before embedding to 
remove the condylar part with growth plate. To remove the bone marrow, the bone was 
ultrasonicated in Phosphate-Buffered Saline (PBS). To make sure the individual 
trabeculae was well supported, the medullar space was injected with low viscosity 
superglue into the pores in the trabecular network left unfilled by the Kleer-set resin. 
The bone surface must be flat and clean as well as free of dust and adhesive particles 
that can contaminate the measurement and the indentation tip. The surface of the bone 
cross-section was examined closely for smoothness using the optical microscope. 
Subsequently, the bone surface was air-dried for 24 hours. The indentation targets were 
carefully selected in the centre of the intended bone tissue using an optical microscope 
(Zhang et al., 2015). 
3.7.2 Machine preparation 
3.7.2.1 Indenter-Microscope Distance Calibration 
The machine was calibrated every morning before testing and in between 
measurements. In this study, the distance calibration was done between the indentation 
measurements taken for each of the trabecular bone sample. This would help to 
precisely locate the small trabeculae struts measured approximately less than 20 µm as 
compared to that of human which measured approximately 50 µm (Hamed et al., 2012).  
 
3.7.2.2 Adjust Depth Offset (ADO) 
ADO is an indent made prior to the experiment. The procedure was performed on the 
sample topology for each new measurement. The offset value set by the software will 
ensure a correct position of the depth sensor of the instrument due to vertical variation 
between the indenter and the reference, as well as to optimize measurement duration 
(Figure 3-16; Indentation software manual, DCOM 70050). It is a reference point to 
ensure all indents occur at a similar level. 
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Figure 3-16 A micrograph of a cortical bone sample. 
The figure shows ADO imprinted on the bone surface prior to the measurements 
(numbered indentation points). The cross hair was centered on the imprint point to bring 
the video camera in the center of the bone topology under measurement. 
 
3.7.3 Nanoindentation Systems 
Nanoindentation is capable of performing four operations: (1) apply load (or 
displacement), (2) measure displacement (or load) with very high accuracy, resolution 
and precision; (3) position and perform indentations at any desired location on a 
sample, and (4) interpret load and displacement data to obtain hardness, elastic 
modulus, adhesion force, fracture toughness, and other mechanical properties (Malshe 
et al., 2010).  
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Figure 3-17 The schematic representation of the Berkovich indenter head and 
sample contact (Oliver and Pharr, 2004). hp is the permanent indentation depth; hs is 
the amount of sink-in at contact periphery, where 
S
F
=∈h maxs ; hr is the tangent 
indentation depth, where 
S
F
hh maxmaxr  ; hc is the contact indentation depth, where 
)hh(hh rmaxmaxr  . 
 
 
Figure 3-17 shows the indenter profile before and after removal of load from the object 
being tested. In a typical nanoindentation test, a tip or indenter, typically made of 
diamond, is pressed into the test sample with a known load followed by an intermediate 
holding period if necessary. After some time when the load is removed, the area of the 
projected residual indentation in the sample is measured (Malshe et al., 2010). Most 
experiments were performed using a load-displacement sequence like that shown in 
Figure 3-18. 
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Figure 3-18 A typical nanoindentation curve with corresponding parameters 
presented in this study.  
‘a’ is application of load phase, ‘b’ is removal of load, ‘c’ is tangent to curve ‘b’ at 
Fmax(maximum load), hp is permanent indentation depth, hr is tangent indentation depth, 
hc is contact indentation depth, hmax is maximum indentation depth at Fmax, ‘S’ is 
stiffness, ε is geometric constant  (Adapted from the DCOM 70050 Indentation manual).  
 
The area function of the tip of the indenter was defined based on the calibrated diamond 
indenter by using a series of 110 indentations at different loads and was approximated 
by a polynomial function of the contact depth  (Finnilä et al., 2010; Zioupos and Rogers, 
2006) : 
      3-7 
where Ap is the projected contact area, hc is the contact depth and Cn is the constant 
determined by the curve fitting. The hardness and indentation modulus were measured 
following Oliver and Pharr (1992).  The hardness is determined at the end of the hold 
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phase (Equation 3-8). The contact stiffness is calculated from the unloading phase data 
as the near maximum load derivative of a power law fitted polynomial in between 98% 
and 40% of Fmax. Further, the parameters measured from the curves are Fmax (maximum 
load), hm (maximum displacement), hc (contact depth), Ap (projected contact area), and 
S (contact stiffness) (Figure 3-18). The reduced modulus defined in Equation 3-9 used 
contact stiffness, S, projected contact area, Ap and indenter geometric constant. Er is 
used to calculate the indentation modulus, EIT as in Equation 3-10.  
      3-8 
where Fmax is the maximum load imposed on the surface of the bone and Ap(hc) is the 
projected contact area between the indenter and the specimen. It was determined 
through indenter calibration using series of 110 indentations. 
     3-9 
     
Where β is the indenter geometric constant (β=1.034) and the contact stiffness, S 
(dF/dh) is calculated from the unloading phase.  
     3-10 
where EIT is indentation modulus and Er is reduced modulus while i and s subscripts 
corresponding to the indenter and the sample, respectively. While  is Poisson’s ratio. 
The elastic modulus (Ei) and Poisson’s ratio of the diamond indenting are 1141 GPa 
and 0.07, respectively. 
Prior to each indentation, the bone surface topography was examined so that the 
indenter was accurately placed on the point of interest on the bone, as represented in 
Figure 3-19. Typically, the parameters that can be extracted from the load-displacement 
curves are Hardness (HIT), Indentation Modulus (EIT) and Creep (CIT). Firstly, the 
hardness was computed as in Equation 3-8.  
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Figure 3-19 The micrographs showing indentations of a typical trabecular bone of 
a WT mouse.  
(a) The indentation marks were placed prior to indentation to ensure that impression 
was accurately placed on the bone tissue. The cross hair is in the centre of the 
micrograph. (b) The impressions made on the bone tissue after the indentation 
procedure.  
 
The Indentation Modulus (EIT) was computed after the Reduced Indentation Modulus 
(Er) was determined as in Equation 3-9. The Er represents the elastic deformation that 
occurs in sample or in indenter tip.  
Creep is an increase in depth at constant F as a function of time. It is a time-dependant 
deformation. To measure creep, the maximum load was hold for a given duration 
allowing sample relaxation, as in Equation 3-11. 
      3-11 
where h1 and h2 are the indentation depths at t1 and t2, respectively (Figure 3-20). The 
protocols are defined in Table 3-5 and Table 3-6.  
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Figure 3-20 Expression of creep. Y-axis represents the indentation depth and X-axis 
represents the time, whilst ‘a’ is application of load phase and ‘b’ is removal of load. 
 
Table 3-5 The advanced measurement parameters and settings. 
Advanced Protocol Cortical Trabecular 
Maximum load (mN) 10 10 
Loading rate (mN/min) 20 20 
Unloading rate (mN/min) 20 20 
Pause (s) 30 30 
 
Table 3-6 The sinus measurement parameters as well as sinus settings in the software. 
Sinus Protocol Cortical Trabecular 
Maximum load (mN) 10 10 
Loading rate (mN/min) 10 10 
Unloading rate (mN/min) 10 10 
Sinus Frequency (Hz) 1.0 1.0 
Sinus Amplitude (mN) 1.0 1.0 
98 
 
Advanced Protocol 
For the advanced (standard) protocol, a trapezoidal loading waveform was applied with 
a loading/unloading rate of 20mN/min, plus a 30s hold at the maximum load 10mN 
(Figure 3-21).  
 
Figure 3-21 The description profile for the advanced indentation parameters.  
These parameters need to be specified as the measurement automatically computes a 
linear loading and unloading to reach the maximum load at a preset time.  
Cortical Bone 
For the advanced protocol, 3 phases were employed. The hold phase was at 10 mN 
load and was used to produce creep parameters. The parameters are presented in 
Table 3-5. The load-penetration curve is shown in Figure 3-22. Two parameters were 
determined (Oliver and Pharr, 1992): hardness (HIT) and indentation modulus (EIT).  
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Figure 3-22 The standard indentation profile with associated parameters.  
The loading-unloading cycle completed after approximately 3 minutes.  
 
The stiffness from the unloading phase was defined using a power law curve fitted by 
the Oliver & Pharr method. The upper and lower bounds are defined as 98% and 40% 
of Fmax. For indentation on the cortical bone, the locations of the indents were precisely 
defined under the visualization window and consistently positioned on the medial sector 
of the cortical bone cross-section. The indents were placed between the periosteal and 
endosteal of the bone at a space distance between the indent points. The average 
values of 8-10 indentations in cortical bone samples were taken in advanced and sinus 
loading protocols. The indentation sites were always checked after the indentation and 
the failed impressions were removed. For example poorly supported heads of sphere or 
cross-sections. 
 
Trabecular bone 
A similar protocol to that of cortical bone was applied for trabecular bone. However, 
careful attention was needed as the trabecular bone tissue was distributed and smaller 
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in size compared to cortical bone. All indents were conducted at the center of the bones 
based on the optical microscopy observation to include bone tissue as much as 
possible. The outer edge of the bone was set as a reference. Care should be taken to 
make sure the indentation sites far away from the edge to eliminate the effect of 
embedding. The average values of 3 to 5 indentations in trabecular bone samples were 
taken in advanced and sinus loading protocols.  
 
Sinus Protocol 
In the sinus protocol, a sinusoidal waveform was used with a frequency of 1.0Hz and a 
amplitude of 1.0mN. This protocol is a single indentation measurement with an added 
sine wave during the loading at a constant loading rate. This allows a depth-related 
analysis to be carried out in one cycle indentation. In addition to advanced parameters, 
minimum starting load with the constant strain rate, sinus amplitude and frequency and 
pause at maximum load if needed (0 second means no pause) were set prior to 
indentation.    
The viscoelastic behaviour of the bones was analysed using the sinus protocol (Table 3-
6) (Finnilä et al., 2010). Storage modulus (E') and loss modulus (E'') vary with the depth 
of the indentation and become stable after a penetration depth above 100 nm, and the 
values were calculated from the loading curve using Dynamic Mechanical Analysis 
(CSM V3.75).  
Dynamic Mechanical Analysis (DMA) is used to calculate the dynamic stiffness (S) and 
damping (Diω) that are used later in the calculation of E' (Equation 3-14) and E" 
(Equation 3-15). S and Diω can be defined as in Equation 3-12 and Equation 3-13 with 
reference to Figure 3-23.  
      3-12 
    3-13 
cos
0
0
h
f
S 
 sin
0
0
h
f
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where f0 is the steady state modulated load  amplitude; h0 is the modulated 
displacement amplitude; ø is the angular phase shift between the applied force and 
measured displacement; ω is the frequency of the applied force; Di is the damping 
coefficient. The loss (E’’) and storage (E’) modulus are calculated with,  
     3-14 
     3-15 
E’ is the material capacity to store energy in which the component in phase with applied 
load or displacement whilst E’’ is the material’s capacity to dissipate energy in which the 
component 900 out of phase with applied load or displacement.  
 
 
Figure 3-23 The load-penetration depth curve from a sinus indentation protocol. 
The loading curve consists of sinusoidal cycles in which the stiffness (E*) is calculated 
from each cycle, as indicated by the lines drawn.  The elastic and plastic energy can be 
obtained also (Adapted from Finnila et al. (2010) and Zioupos & Roger (2006)).  
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Table 3-7 A summary of the parameters measured. 
Advanced 
Protocol 
Formula Sinus Protocol Formula 
Indentation 
Hardness (HIT) 
 
Phase Difference 
(tan ∂) 
 
Reduced 
(effective) 
indentation 
modulus (Er) 
 
Storage Modulus 
(Estor) 
 
Elastic Modulus 
 Loss Modulus 
(Eloss) 
 
Creep (CIT)  Elasticity ( ) 
 
3.8 Bone mineral density (BMD) 
Bone mineral density (BMD) was standardised to the volumetric density of calcium 
hydroxyapatite (CaHA) in terms of g·cm-3. The technique used for characterising bone 
mineral provides information about the composition of the bone. BMD has been shown 
to have an impact on the bone mechanical strength measurements. It is hypothesised 
that the reduction in bone strength in mdx mice is due to alterations in bone structure 
and BMD levels. There are several techniques to determine the amount of mineral in 
the bone and relate this to the fracture behaviour.  
3.8.1 Ash content 
In the present study, the classic bone mineral composition techniques: ash content and 
Thermogravimetry Analysis (TGA) (Section 3.8.2), were considered. Ash content has 
been the standard method to determine the bone density of small animals (Keenan et 
al., 1997). An understanding of the composition of bone is essential for the proper 
interpretation of the process of its formation in the living organism. Ash percentage in 
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the tibia is a good indication of bone densitometry. With reference to the ash content 
method reported by Silva et al. (2002), the cortical fracture bone fragments post three-
point bending test were used to calculate the ash content. The measurement was 
divided into two parts: 1) wet weight measurements and 2) dry weight measurements. 
These measurements were calculated based on Archimedes' principle (Equation 3-16 
and Equation 3-17). For wet weight measurement, two bones from each genotype were 
placed in a fresh tube that has been filled with small amount of cotton. This allowed the 
marrow to be collected after centrifuge.  
The bones were centrifuged at 13,200 rpm for 15 minutes using microcentrifuge 5415D 
(Appendorf, USA). The microcentrifuge works at 120 V and 60 Hz at a maximum 
rotational speed of 13,200 rpm and the acceleration time to maximum speed is 13s.  
The bone marrow tissue will be removed in centrifuged bones. The bones were then 
weighed using an analytical balance (Sartorius LA230 S Analytical Balance) and placed 
in porcelain crucibles (heat resistant to 1000ºC). Bone dry weight was determined by 
drying the bone at 90ºC for 24 hours. An environmental chamber Micro LTCL 350 (TAS 
Ltd, UK) was used. After 24 hours, the crucible was taken out before measuring the 
weight.  
Ash weight was determined by heating the bone at 600ºC for 24 hours in a muffle 
furnace. To increase the reliability of the measurement, each bone was measured five 
times. The bone mineral content was determined by ash fraction, to obtain final ash 
content (Keene et al., 2004). The ash content can be expressed on either a dry or wet 
basis:     
Ash % (dry basis) = 100
M
M
dry
ash      3-16   
Ash % (wet basis) = 100
M
M
wet
ash      3-17 
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where Mash refers to the mass (weight) of the ashed sample and Mdry and Mwet refer to 
the original masses (weights) of the dried and wet bone samples. 
There are some limitations in the method. Firstly, the samples used in this technique 
were small in size and fragile to handle. Any errors during handling could contribute to 
inaccurate data. The error increases especially after the bone is heated at a high 
temperature. After heating the bone in the crucible, the crucible, bone, and lid should be 
allowed to cool to room temperature, preferably in a desiccator before weighing them on 
the analytical balance. This is to prevent the air current produced by the high 
temperature and environmental factors such as dust and humidity that can lead to 
inaccurate results. To overcome the limitations of this technique, TGA has been used to 
determine BMD of the tibia bone.  
 
3.8.2 Thermogravimetric Analysis (TGA)  
TGA measures the change in mass as a function of temperature. It consists of a sample 
pan that is supported by a precision balance. The properties and behaviour that can be 
measured by TGA include composition, purity, decomposition reactions, decomposition 
temperature and moisture content (loss of water).  In this study, TGA was used for the 
purpose of determining weight percentage ash. The mass of the bone was measured as 
it was heated, cooled and held at constant temperature.  
The TGA test was performed using a Perkin Elmer TG-7 equipped with a P.E 3700 Data 
Station. The analysis was done using NETZSCH Proteus-Thermal Analysis version 
6.1.0. Heating rate was set at a rate of 5°/min up to 1000°C in an air flow of 20 cm3/min. 
The bone was firstly ground with pestle and mortar agate before being weighed for the 
test.  100 mg ground bones were placed in the alumina crucible. The crucibles were 
pre-weighed accurately using analytical balance and accuracy was taken to be ± 
0.0001g. The weight of the crucible and mass of the bones were recorded in a log book.  
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3.9 Statistical Analyses 
The mean and the standard deviation were reported for all the morphometric, 
mechanical and tissue parameters. Comparisons were made between mdx and each of 
the other three genotypes, Wild-type (WT), P2X7-/- and mdx/P2X7-/-. The non-parametric 
Kruskal-Wallis test was used to test the difference between each pair (i.e. WT vs mdx; 
P2X7-/- vs mdx and mdx/P2X7-/- vs mdx) and significant differences were indicated when 
p-value<0.05. All test assumptions were verified and analyses were carried out using 
SPSS (PASW version 18.0). SPSS (Statistical Package for the Social Science) is one of 
the most popular statistical packages which can perform highly complex data 
manipulation and analysis with simple instructions.  
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Chapter 4 
Investigation of bone morphometric properties and microarchitecture 
due to P2RX7 receptor ablation and murine model of Duchenne 
muscular dystrophy using microCT. 
 
4.1 Introduction 
The objective of the study was to explore the structural alterations due to P2RX7 
receptor ablation in mouse bones. The morphometric properties of cortical and 
trabecular bones of the four genotypes: WT, mdx, P2X7-/- and mdx/P2X7-/-, were 
examined and compared, and the results are reported here.  µCT and image processing 
analysis revealed considerable differences in cortical bone parameters while several 
trends were noteworthy in the trabecular bone.  
4.2 Results 
All data are given as mean ± standard deviation (SD) for each group of samples (n=6 
per genotype). Significance was assessed by non-parametric Kruskal–Wallis tests for 
gross tibial and morphometric measurements. A statistically significant difference is 
indicated by p < 0.05. A comparison of mdx/P2X7-/- is made between WT= a, mdx= b 
and P2X7-/-= c. The comparison of genotypes will be discussed based on WT (control); 
mdx, P2X7-/- (P2RX7 single knockout) and mdx/P2X7-/- (P2RX7 and mdx double 
knockout). 
 
Gross geometric measurements were obtained to determine any changes in skeletal 
geometry (Figure 4-1). The measurements, summarised in Table 4-1, reveal significant 
differences in the average bone length and diameter of some of the genotypes. 
Measured lengths of the tibias showed no significant difference in mdx and P2X7-/- 
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compared to those of WT mice.  P2X7-/- showed a significant knockout effect, with 
significantly greater length compared to mdx mice (p = 0.036). However, mdx/P2X7-/- 
mice were observed to have shorter length compared to those of WT (p = 0.004), mdx 
(p = 0.010) and P2X7-/- (p = 0.004).   
 
A significantly lower average value of midtibia diameter was found in mdx mice than that 
in WT mice (p = 0.048). A similar trend of reduction in midtibia diameter was observed 
in P2X7-/- (p= 0.025) and mdx/P2X7-/- (p= 0.025) mice, which showed mdx/P2X7-/- mice 
to have the lowest average midtibia diameter of the comparison groups. Metaphyseal 
diameter of WT mice seems higher in average value compared to those of mdx, 
although it was not statistically significant. A significant higher metaphyseal diameter 
was observed in P2X7-/- (p= 0.048) mice compared with mdx. However, mdx/P2X7-/- 
mice was observed to have significantly lower metaphyseal diameter compared to those 
of WT (p= 0.032) and P2X7-/- (p= 0.004) mice.  
 
No differences in distal tibia diameters were observed between the genotypes except 
for in the mdx/P2X7-/- mice, which were observed to have lowest distal diameter. 
Although it was not statistically significant, WT and P2X7-/- mice have shown higher 
average distal diameters when compared with the mdx.  
 
 
Figure 4- 1 Morphometric length measurements of tibia. 
Tibial gross length (L) measurement was taken from proximal anatomical point of centre 
of the condyles to the distal anatomical point of medial malleolus. Midtibia diameter 
(MD) measurement was taken at the midtibia, metaphyseal diameter diameter (MPD) 
measurement was taken from proximal anatomical point of centre of the condyles and 
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distal diameter (DD) measurement was taken from the distal anatomical point of medial 
malleolus. 
 Table 4-1 Summary of the bone geometries of the tibias for all genotypes. 
a,b,c 
and bold text indicate p<0.05 (Kruskal-Wallis) 
a
statistically significant difference (<0.05) with WT. 
b
statistically significant difference (<0.05) with mdx. 
c
statistically significant difference (<0.05) with P2RX7
-/-
. 
 
Comparisons of the morphometric properties between the four genotypes in both 
cortical bone at midtibia and trabecular bone at proximal tibial metaphyseal bones are 
presented in Table 4-2. The results for the morphometric properties of the long bones 
demonstrate that many properties of long mdx dystrophic bones were substantially 
affected at four weeks in an early stage of life. At this point, the functional muscle 
impairment is not yet thought to be significant.  
 
4.2.1 Comparison of cortical bone morphometric properties in mdx and WT 
mice. 
One of the major findings in the current study is the reduction found in cortical bone 
parameters in the mdx mice. Lower values of cortical bone parameters in mdx mice 
were observed in the total cross-sectional area inside the periosteal envelope (Tt.Ar, 
10%), cortical bone area (Ct.Ar, 19%), cortical area fraction (Ct.Ar/Tt.Ar, 11%) and 
cortical thickness (Ct.Th, 18%), compared to those of WT mice (Table 4-2). Specifically, 
significantly lower values of cortical bone parameters in mdx mice were found in Ct.Ar 
(p= 0.006) and Cr.Th (p= 0.020). These results are consistent with data reported by 
Nakagaki et al. (2011).  These results are consistent with the findings regarding reduced 
Bone properties (mm) WT mdx P2X7-/- mdx/P2X7-/- 
Length 14.65±0.62 14.10±0.64 15.02 ±0.46b 13.05±0.38a,b,c 
Midtibia diameter 1.10±0.06 0.97±0.12a 1.00±0.06 a 0.82±0.04a,b,c 
Metaphyseal diameter 2.70±0.21 2.65±0.22 2.88±0.13b 2.47±0.15a,c 
Distal diameter 0.93±0.08 0.90±0.11 0.95±0.08 0.73±0.05a,b,c 
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biomechanical strength in mdx bones (Chapter 5); and also consistent with the reduced 
bone strength in DMD patients.  
Table 4-2 Morphometric properties of the cortical bones of the genotypes studied. 
a,b,c 
and bold text indicate p<0.05 (Kruskal–Wallis) 
a
statistically significant difference (<0.05) with WT. 
b
statistically significant difference (<0.05) with mdx. 
c
statistically significant difference (<0.05) with P2RX7
-/-
. 
 
4.2.2 Alterations in cortical bone morphometric properties of mdx/P2X7-/- 
mice. 
Another important structural finding of the study is the alterations found with respect to 
the cortical bone parameters for the mdx/P2X7-/- mice.  
Statistically significant differences were found between Tt.Ar, Ct.Ar and Ct.Ar/Tt.Ar of 
mdx/P2X7-/- and those of the other three genotypes. The mdx/P2X7-/- mice had a 
significantly lower total cross-sectional area inside the periosteal envelope (Tt.Ar) 
compared to those of the other three genotypes (WT (p=0.004); P2X7-/- (p=0.004) and 
mdx (p=0.004)). The mdx/P2X7-/- mice had a 41% lower Tt.Ar than that of the mdx mice. 
By contrast, however, the mdx/P2X7-/- mice had a substantially higher Ct.Ar (by 32%, 
p=0.004) and cortical bone area fraction (by 14%, p=0.010) compared with those of 
mdx, although a slightly lower (by 7%) cortical thickness was noted.  
The morphometric properties of WT and P2X7-/- bones at four weeks were not 
significantly different in any of the parameters measured. The cortical bone property 
values for the P2X7-/- mice remained significantly higher (Ct.Ar, p = 0.036; Ct.Ar/Tt.Ar, p 
= 0.005) than those of the mdx mice, except the total cross-sectional area. The mean 
Properties WT mdx P2RX7-/- mdx/P2RX7-/- 
(Midtibia)     
Tt.Ar (mm2) 1.344±0.263 1.216±0.114 1.089±0.139 0.722±0.123a,b,c 
Ct.Ar (mm2) 0.160±0.017 0.130±0.018a 0.161±0.030b 0.172±0.01b 
Ct.Ar/Tt.Ar (%) 0.405±0.038 0.360±0.015 0.419±0.026b 0.411±0.031b 
Cr.Th (mm) 0.150±0.017 0.123±0.010a 0.137±0.014 0.115±0.009a,c 
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values for the P2X7-/- mice cortical bone parameters are between those of WT and mdx 
mice.  
Figure 4-2 shows bar graphs depicting the quantitative analysis of cortical bone 
parameters.  Note that the majority of the data seem to indicate a clear trend of 
increased cortical area and cortical bone area fraction in mdx/P2X7-/- mice over mdx 
mice (p<0.05), but reduced total cross-sectional area and cortical thickness in the 
midtibia region. 
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Figure 4-2 Comparison of relative changes in morphological parameters of the 
cortical bone at midtibia level of the genotypes.  
(A) Total area (Tt.Ar); (B) cortical bone area (Ct.Ar); (C) cortical area fraction 
(Cr.Ar/Tt.Ar); and (D) cortical thickness (Ct.Th). Bars correspond to mean ± SD. 
Abbreviation: *p<0.05. 
 
 
4.2.3 Trabecular bone volume fraction and trabecular bone thickness of mdx vs. 
WT mice 
Comparisons between the four genotypes revealed that reduced values of trabecular 
bone volume fraction (BV/TV) and trabecular thickness (Tb.Th) were found in mdx 
proximal tibia metaphyseal bones compared with those of WT. Specifically, the mean 
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bone volume fraction in the proximal tibia metaphyseal region in mdx mice was 35% 
lower (p=0.030), whilst the trabecular thickness was 19% lower (p=0.006), compared to 
those of WT mice. No significant difference was observed in trabecular spacing and 
connectivity density between the results of WT and mdx mice, although the mdx had 
lower values in trabecular spacing and higher values in connectivity density. Both 
BV/TV and Tb.Th in mdx mice were the lowest amongst all the genotypes studied. 
These results are consistent with the data reported by Nakagaki et al. (2011).  
Figure 4-3 shows the distributions of data for the trabecular bones, including the 
medians, the 25th and 75th percentiles, and the outliers.  With respect to trabecular 
bones (Fig 4-2A), the BV/TV in the mdx mice were lowest. There were improvements in 
BV/TV and trabecular thickness (Fig 4-2B) in the WT over those of the mdx; however, 
again, no significant changes were noted in either trabecular spacing or connectivity.  
4.2.4 Trabecular bone volume fraction in mdx/P2X7-/- mice. 
A significant increase of BV/TV in mdx/P2X7-/- mice was found compared with that of 
the mdx (p = 0.016), although the other parameters, including trabecular thickness 
(+2%), spacing (-8%) and connectivity density (-22%) were not statistically different 
compared to those of the mdx mice. There may have been some influence from P2RX7 
ablation on these properties, although this was not statistically significant. Connectivity 
density in the mdx/P2X7-/- mice was lower than that of the mdx and closer to that of the 
WT mice. Significant improvements in trabecular bone volume fraction and lower 
quantitative values for trabecular bone spacing suggested a significant treatment effect 
in the mdx/P2X7-/- mice. 
In the P2X7-/- mice, the results showed a significant increase (+53%, p=0.004) in 
trabecular bone volume fraction and a significant reduction (-21%, p=0.043) in 
trabecular spacing compared to the mdx mice, suggesting a significant knockout effect. 
(Findings are summarised in Figure 4-3 and Figure 4-4.)  
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Table 4-3 Morphometric properties of trabecular bones of the genotypes studied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
a,b,c 
and bold text indicate p<0.05 (Kruskal–Wallis) 
a
statistically significant difference (<0.05) with WT. 
b
statistically significant difference (<0.05) with mdx. 
c
statistically significant difference (<0.05) with P2RX7
-/-
. 
 
 
Figure 4-3 shows the distributions of data for the trabecular bones. It seems that the 
data regarding bone volume fraction from the knockout bones are more scattered, 
although the majority of the data seem to indicate a clear trend of higher bone volume 
fraction in the mdx/P2X7-/- mice over that of the mdx mice in the midtibia region. 
 
Properties WT mdx P2RX7-/- mdx/P2RX7-/- 
(Proximal tibial metaphyseal)    
BV/TV (%) 0.193±0.066 0.125±0.027a 0.265±0.125b 0.180±0.036b 
Trab.Th (mm) 0.052±0.004 0.042±0.004a 0.053±0.015 0.043±0.005a 
Trab.Sp (mm) 0.258±0.055 0.242±0.040 0.190±0.028a,b 0.223±0.059 
Conn.D (1/mm3) 113.92±73.05 162.41±90.16 140.79±76.86 125.98±93.19 
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Figure 4-3 Comparison of the morphometric properties of the WT, mdx, P2X7-/-, 
and mdx/P2X7-/- of the trabecular bones at proximal tibial metaphyseal. 
(A) BV/TV, (B) trabecular thickness (Trab.Th), (C) trabecular space (Trab.Sp), and 
(D) connectivity density (Conn.D). Bars correspond to the median (50th percentile) at 
25th and 75th percentiles with some outliers (º) and far outliers (*). 
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Figure 4-4 shows the representative 3D µCT scans of trabecular bones for all the 
genotypes studied. The metaphyseal regions in the mdx mice revealed a more 
porous trabecular bone structure compared to those of the WT, P2X7-/- and 
mdx/P2X7-/- mice. In contrast, a more robust trabecular structure, with an increased 
network of rods and plates, was found in knockout bones and WT. The porosity was 
less evident in these bones compared to those of mdx mice.  
 
 
Figure 4-4 3D μCT images.  
The figure shows representative trabecular samples from WT, mdx, P2X7-/- and 
mdx/P2X7-/-. 
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4.3 Discussion 
The morphometric studies show that genetic ablation of the P2RX7 receptor 
knockout in mdx mice bone results in significant changes in the bone both at the 
macro and microstructural level. The results seem to suggest that most 
microstructural properties in mdx dystrophic bone are already significantly affected at 
four weeks, which is an early stage when, despite histological changes, the 
functional muscle impairment in this DMD mouse model is not yet thought to be 
significant (Nakagaki et al. 2011). The alternations in cortical and trabecular bone 
parameters in the structure found could account for the biomechanical results 
reported in the subsequent results.  
In mdx mice, muscle degeneration associated with inflammatory cell infiltrations is 
thought to start at about three weeks, and at four weeks it closely resembles the 
human pathology (Grounds et al., 2008).  Spinal cord injury or sciatic neurectomy 
leading to rapid, profound and permanent loss of muscle mass produces significant 
bone loss within 10–14 days (Gross et al., 2010). The degeneration in mdx muscles 
at four weeks does not cause a comparable functional impairment. It seems unlikely 
that muscle strength and associated mechanical loads are as significantly affected 
one week into the pathology, and so the bone abnormality is considered less likely to 
be caused by the decreased osteogenic stimulation. Moreover, Anderson et al. 
(1993) showed that, in contrast to other disuse osteopenia studies, bone parameters 
remained significantly affected despite muscle mass and strength recovery in 18-
week-old mdx. 
The cortical bone parameter analysis of mdx/P2RX7-/- mice revealed a 32% increase 
in cortical bone area, 14% increase in cortical bone fraction, 41% reduction in total 
cross-sectional area and 7% reduction in cortical bone thickness over those mdx 
(Figure 4-2). The results revealed that the mdx/P2RX7-/- mice had smaller bones 
than the other three types. However, the cortical bone fraction was relatively higher 
in the mdx/P2RX7-/- mice bones. Hence, this might have been responsible for the 
similar strength achieved in this to the other three types. The preliminary studies 
involving thermogravimetric analysis were carried out on two samples per genotype. 
The inorganic phase content of the samples was determined from the results of the 
analysis. The TGA test provides information on the loss in mass as temperature 
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changes. The information includes water content, organic matrix content and 
residual mass (hydroxyapetite-HA) (Figure 4- 5). 
 
 
 
Figure 4- 5 A TG-DTG curve shows plot from a mouse bone. 
The TG-DTG plots recorded from bone samples display three thermal processes 
which are identified as follows: loss of water up to 200°C, organic content from 200 
to 600°C and carbonate content above 600°C (Florez et al., 2014).  
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The preliminary studies revealed that there was significantly higher organic content 
than those of mdx mice (Table 4-4). The changes suggest that the higher organic 
content in mdx/P2RX7-/- mice might contribute to the bone ductility. It was also 
presented in the mechanical test results (Chapter 5).  
 
Table 4-4 The bone mineral composition obtained from TG-DTG curves of the 
studied bone samples. 
Bone properties WT mdx P2X7-/- mdx/P2X7-/- 
Water (%) 7.97±0.29 7.69±0.199 8.19±0.29 7.53±0.21 
Organic (%) 24.99±0.54b 21.06±0.24 23.51±0.85 25.79±1.52b 
Mineral (%) 8.31±3.50 9.53±0.43 11.45±0.07 10.82±1.17 
Carbonate (%) 57.51±3.27 60.19±0.23 55.56±0.60 54.96±2.86 
a,b,c 
and bold text indicate p<0.05 (ANOVA) 
a
statistically significant difference (<0.05) with WT. 
b
statistically significant difference (<0.05) with mdx. 
c
statistically significant difference (<0.05) with P2RX7
-/-
. 
 
 
The findings regarding the cortical and trabecular bone parameters seem consistent 
with those reported in mdx mice bone by Nakagaki and colleagues (2011). They 
reported a reduced trabecular area fraction of 41% and thickness of 40% in the distal 
epiphysis of mdx femur, along with a significantly lower cortical cross-sectional area 
of 24%, diaphyseal cortical area of 44%, and cortical bone thickness of 43% in the 
diaphyseal of the mdx femur (Nakagaki et al., 2011). In the current study, trabecular 
bone of the mdx tibia showed a reduction of 35% in the trabecular bone volume 
fraction and 19% in trabecular thickness. At the cortical bone level, only a 10% 
reduction in total cross-sectional area was noted in mdx compared with WT mice, 
which was not statistically significant.  
The trends of reduction in cortical and trabecular bone parameters are consistent 
with the subsequent biomechanical test results (Chapter 5), and the micro-structural 
arrangement may be a possible mechanism for the reduced bone strength seen in 
mdx mice. The findings regarding the cortical bone parameters are also consistent 
with Rufo’s (Rufo et al. 2010) analysis of mdx mouse bone, in which they showed a 
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similar reduction of 11.3% in cortical thickness and 13% in cortical area, but modest 
reduction in cortical thickness of 6%, as compared to the WT mouse model. For 
trabecular bone parameters, they showed a reduction of bone volume fraction of 
38%, bone thickness of 22%, and trabecular number of 15%. The bone thickness in 
WT and mdx were not found to be different, which is in line with the current findings. 
Although the trend is similar between the two studies, the quantitative difference 
between the current study and Rufo’s analysis may be due to the high variance 
found in the statistical analysis of the mouse models, or differences in the age and 
strain type between the mouse models (Rufo et al., 2011). With respect to the age 
difference, Rufo’s mdx mouse was much older (six months) than the current mdx 
mouse (four weeks). Hence, the reduction of the cortical bone parameter in the mdx 
mice may be worsened with age. This is consistent with the fact that bone phenotype 
(reduction in all cortical and trabecular bone parameters) in DMD patients has been 
reported to deteriorate with age (McDonald et al., 2002; Bianchi and Morandi, 2008; 
Morgenroth et al., 2012). 
It is not known whether the bone abnormality is due to the lack of dystrophin in 
specific bone cells. This is because expression of the DMD gene in osteoblasts and 
osteoclasts has not been studied. Given that bone abnormalities in mdx mice have 
been linked to chronic inflammation (Abou-Khalil et al., 2013), and, in general, 
inflammation can cause bone loss (Redlich and Smolen, 2012), this is the most likely 
mechanism behind dystrophic bone abnormalities. Importantly, if this is the case, the 
current data indicate that sterile inflammation may exert very rapid (within one week) 
and profound effects on the bone physiology. 
The P2RX7 receptor was identified as a powerful activator of the “danger mode” of 
the native immune response through release of pro-inflammatory cytokines (Di 
Virgilio, 2007). Based on the observation that ablation of this receptor alleviates 
muscle symptoms (Sinadinos et al., 2015), it was hypothesised that ablation of the 
P2RX7 receptor could improve the morphometric and mechanical properties of 
dystrophic bones. The present results show  that its ablation in mdx mice produced 
an overall decrease in the muscle inflammatory signature of dystrophic muscles 
(Sinadinos et al., 2015), and this reduced inflammatory signature in mdx/P2X7-/- 
muscles may therefore have translated into reduced bone loss in these mice.     
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The influence of P2RX7 inhibition, which is known to have therapeutic effects on 
skeletal muscles, seems significant on the morphological properties of bones. 
Importantly, the significantly higher cortical bone area and fraction, as well as bone 
volume fraction, in both cortical and trabecular mdx/P2X7-/- bones, respectively, 
would seem to suggest that the overall effect of the ablation is bone formation for the 
models studied. The longer-term effects of P2RX7 receptor ablation have also been 
tested, and a significant improvement in bones of six-month-old mdx/P2RX7-/- mice 
found (Sinadinos et al., 2015). As bone abnormalities in mdx mice have been linked 
to chronic inflammation (Abou-Khalil et al., 2013), the reduced inflammatory 
signature in mdx/P2X7−/− muscles may also translate into reduced bone loss in these 
mice. However, at this stage it is difficult to ascertain whether the mechanism is 
secondary to the improvements in muscle morphology observed in the later phases 
of mdx pathology. 
One of the unique features of the current study is the use of an mdx/P2X7-/- mouse 
model for the structural analysis of bone. This is the first time that this mouse model 
has been used to explore the micro-structural effect in P2RX7 receptor ablation of 
mdx mice. The mdx/P2X7-/- mice did show a significant improvement in cortical and 
trabecular bone structural parameters. These findings highlight the need to further 
explore the possible alterations in bone mechanical properties at both macro and 
micro levels, these results are presented in Chapters 5 and 6.  
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Chapter 5 
Evaluation of bone biomechanical properties across the genotypes 
using three-point bending test  
5.1 Introduction 
Bones play unique roles in the body, maintaining its shape, protecting internal 
organs and withstanding force. However, bones can only sustain loads up to a 
certain limit, beyond which they fail. Understanding the fracture behaviour of bone is 
necessary for the prevention and diagnosis of trauma. This can be achieved by 
studying the mechanical properties of bone (Li et al., 2013). Given that DMD patients 
have a demonstrated increased risk of fracture and reduced bone strength, the aim 
of this study is to analyse the biomechanical properties of bones in mdx/P2X7-/- 
mouse model compared to WT, mdx and P2X7-/- mice. It was aim to explore the 
potential genotype-related deficiencies in mechanical properties of bones and it was 
hypothesised that improved bone strength in mdx/P2X7-/- mice may be obtained with 
improved functional integrity following P2RX7 receptor inhibition.  
In DMD patients, fracture often occurs in long bones, which consists mainly of 
cortical bone. In the current study, the left tibias from each comparison genotype 
were subjected to a three-point bending test after they were scanned using µCT. 
Generally, biomechanical test revealed that the mdx/P2X7-/- bones have relatively 
higher average flexural strength, work-to-fracture and significantly higher strain to 
failure compared with those of mdx, suggesting greater resistance to fracture. 
 
5.2 Results 
5.2.1 Mechanical properties of mdx vs WT mice. 
Following the morphometric analysis, mechanical tests were applied in order to 
explore possible differences in the biomechanical properties of the mice bones under 
study. Figure 5-1 shows the individual stress-strain curves for the four genotypes,  
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Figure 5-1 Stress-strain curves for the four genotypes. 
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from which the load is converted into stress and deformation is converted into strain. 
The stiffness, maximum load, and work-to-fracture were determined from the load-
displacement curves, whilst the flexural strength and strain at failure were calculated 
using Eq. 3-3 and Eq. 3-4, as described in Chapter 3. Post-yield stress-strain curves 
show a greater strain at failure in mdx than in WT mice; however, two mdx tibias 
(n=2) had the lowest strain to failure and fractured at less than 0.1 (Figure 5-1). In 
contrast, the stress or flexural strength of mdx mice was observed to be lower 
compared to that of WT mice, although this difference was not statistically significant 
(Table 5-1). Table 5-1 shows the mean and the standard deviation of the mechanical 
properties for the four genotypes, indicating the statistically significant differences. 
Abbreviations: p<0.05 with symbol: A comparison of mdx/P2X7-/- is made between 
WT= a, mdx= b and P2X7-/-= c. The comparison of genotypes will be discussed 
based on WT (control); mdx, P2X7-/- (P2RX7 single knockout) and mdx/P2X7-/- 
(P2RX7 and mdx double knockout). Tibias from P2X7-/- revealed that the post-yield 
stress-strain curve measures were close to those of mdx/P2X7-/-, indicating greater 
strain at failure for the knockout models.   
Table 5-1. The mechanical properties of the genotype bones. 
a,b,c 
and bold text indicate p<0.05 (Kruskal-wallis) 
a
statistically significant difference (<0.05) with WT. 
b
statistically significant difference (<0.05) with mdx. 
c
statistically significant difference (<0.05) with P2RX7
-/-
. 
 
 
Bone properties WT mdx P2X7-/- mdx/P2X7-/- 
Maximum load (N) 4.99±0.89 3.10±0.90a  4.32±1.63 2.43±0.45a,c 
Stiffness (N/mm) 12.16±2.12 7.19±2.58a 8.64±2.73a 3.38±1.51a,b,c 
Work-to-fracture (N·mm) 4.01±1.00 3.31±1.36 5.79±2.02 4.59±2.06 
SMA (mm4) 0.11±0.03 0.09±0.03 0.08±0.03 0.04±0.01a,b,c 
Flexural strength (MPa) 60.49±9.74 49.65±19.09  73.36±48.27 62.97±17.39 
Strain at failure 0.15±0.02c 0.14±0.04 0.37±0.15b 0.39±0.12a,b 
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Results revealed that mdx mice have a reduced maximum load (38%, p=0.016), 
stiffness (41%, p=0.037), work-to-fracture (17%, p>0.05), flexural strength (18%, 
p>0.05) and second moment of area (SMA) (18%, p>0.05) compared to WT mice. 
Strain at failure was the only aspect that showed a similar value to that of WT mice 
(WT=0.15±0.02 vs mdx=0.14±0.04). Tibias from P2X7-/- (p=0.037) showed 
significantly increased strain at failure compared to those of mdx mice. Moreover, 
P2X7-/- mice did not differ significantly when compared with mdx for work-to-fracture 
(P2X7-/-=5.79±2.02 vs mdx=3.31±1.36) and flexural strength (P2X7-/-=73.36±48.27 
vs mdx=49.65±19.09), although P2X7-/- mice clearly showed the values were 
increased. No significant difference was noted between P2X7-/- and WT mice 
indicative of a knockout effect, except for stiffness. P2X7-/- mice revealed significantly 
reduced stiffness (29%, p=0.025) when compared with WT.  
Figure 5-2 and Figure 5-3 show the measured mean, the standard deviation and the 
spread of the mechanical properties, including the medians, the 25th and 75th 
percentiles and the outliers, in boxplots for the four genotypes. It seems that the 
mechanical properties of P2X7-/- bones have a greater average distribution than the 
other comparison groups. This is followed by WT and mdx/P2X7-/- bones. Again, 
knockout mice showed a significant effect and measures were not found to be 
significantly different from those of WT bones.  
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Figure 5-2 A comparison of the mechanical properties of bones obtained from 
the three-point bending tests. 
(A) Maximum load; (B) flexural modulus; and (C) work-to-fracture. The boxplots for 
the four genotypes include the medians, the 25th and 75th percentiles and the 
outliers.  
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Figure 5-3 A comparison of the mechanical properties of bones obtained from 
the three-point bending tests. 
(A) SMA; (B) flexural strength and (C) strain at failure. The boxplots for the four 
genotypes include the medians, the 25th and 75th percentiles and the outliers. 
  
5.2.2 Alterations in mechanical properties of mdx/P2X7-/- mice. 
Post-yield stress-strain curves (Figure 5-1) clearly show that the mdx/P2X7-/- mice 
had a greater strain to failure than most of the other types, including mdx. Greater 
strain to failure is inversely related to the brittleness of the bone. Hence, the 
mdx/P2X7-/- mice showed ductile behaviour compared with the other genotypes. 
Significantly lower stiffness was found in mdx/P2X7-/- compared to mdx (by 53%, 
p=0.010), WT (72%, p=0.004) and P2X7-/- (61%, p=0.004) mice (Table 5-1). 
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Although the average maximum load achieved in mdx/P2X7-/- was relatively lower 
than that of mdx (mdx/P2X7-/-=2.43±0.45 vs mdx=3.10±0.90) and WT mice 
(mdx/P2X7-/-=2.43±0.45 vs WT=4.99±0.89), the average flexural strength in 
mdx/P2X7-/- mice was relatively higher than that of mdx (62.97±17.39 vs 
49.65±19.09), due mainly to the significantly lower SMA in the former (p=0.010) 
(Figure 5-4). A significant deficit in SMA was observed in mdx/P2X7-/- mice 
compared to those of WT (p=0.010), mdx (p=0.010) and P2X7-/- (p=0.016). 
Significantly higher strain at failure was obtained in the mdx/P2X7-/- mice compared 
with those of both WT (by 60%, p=0.008) and mdx mice (by 79%, p=0.008), 
indicating greater ductility and resistance to fracture.  
 
Figure 5-4 Three-point bending results in mdx/P2X7-/- mice measures of (A) 
Work-to-Fracture, (B) Flexural Strength; (C) Strain at Failure. 
The mdx/P2X7-/- mice displayed significantly greater strain at failure, indicative of 
ductile bone; however, they did not display significantly greater work-to-fracture and 
flexural strength.  
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It seems that the measured low maximum load and stiffness in the mdx/P2X7-/- mice 
did not translate into low material properties (Figure 5-2). In fact, relatively higher 
average flexural strength and work-to-fracture were found in the mdx/P2X7-/- mice 
compared with those of mdx, possibly due to the high cortical bone area and fraction 
(Table 4-2 and Table 4-3), as well as the low SMA, found in the knockout bones 
(Table 5-1). 
5.2.3 Analysis of fracture paths and modes post testing.  
Qualitative analysis using scanning electron microscopy (SEM) of the distal tibia post 
three-point bending test (n=2 per genotype) are shown in Figure 5-5 and Figure 5-6 
for typical fracture surfaces in WT, mdx, P2X7-/-,and mdx/P2X7-/- mice.  
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Figure 5-5 Scanning electron micrograph of the fracture surfaces of distal 
tibias post-three-point bending testing in WT, mdx, P2X7-/- and mdx/P2X7-/- 
mice.  
(A) Compression and tension were experienced in anterior (A) and posterior (P), 
respectively. (B) Higher-powered images of the posterior cortex of the bones 
showing fibrous fracture surfaces in WT and double mutant bones, as opposed to 
brittle fracture surfaces in mdx bone.   
 
The more brittle type of fracture found in mdx mice stands in contrast to the more 
ductile fracture found in the mdx/P2X7-/- bones, as well as in the WT bones. The 
paths of the fracture are indicated in Figure 5-5(A), where instantaneous brittle 
fracture along the weak planes (posterior surface experienced tension) appears in 
the mdx sample, as opposed to the fibrous fracture surfaces found in the WT and 
knockout bones, with the latter indicating a gradual separation of the bones as a 
result of competition between cracking and fibre bridging. Figure 5-5(B) shows the 
cross-sections of the failed samples, where the posterior surface was in tension and 
the anterior surface was in compression.  
High magnification images at selected resolutions are shown in Figure 5-6 to reveal 
the micro-fracture mechanisms in the posterior area, where maximum tension led to 
the initiation of cracks. It seems that rougher fracture surfaces characterise the 
samples of WT, P2X7-/- and mdx/P2X7-/-, as opposed to relatively smoother fracture 
surfaces in the mdx bones. Pulling out of collagen fibrils can be observed in all 
genotypes, but particularly in P2X7-/- and mdx/P2X7-/-, which also show twisted 
collagen fibrils. The twisted collagen fibrils are attributed to the presence of interface 
areas or empty spaces that may interrupt the propagation of cracks. Whilst pull-out 
collagen fibrils were a reaction towards large traction force produced during crack 
growth. The observation seems to be consistent with the results presented in Table 
5-1, Figure 5-1 and Figure 5-4 where higher values of strain at failure and work-to-
fracture are obtained from the mdx/P2X7-/- bones compared with those from the mdx 
bones. 
 130 
 
 
Figure 5-6 Representative SEM images show microarchitecture features of 
fractured surfaces.  
Magnified images of the cortical regions reveal a smooth surface and looser 
microarchitecture features in mdx mice when compared with WT mice. Apparent 
fibrous texture was clearly observed in WT and knockout mice, where pull-out and 
twist bone tissues were indicated.    
 
 5.3 Discussion 
Bone health remains a substantial concern in DMD. Approximately 20% of ambulant 
males and 27% of those using orthoses have been found to lose mobility 
permanently as a result of fracture (McDonald et al., 2002). The lower-limb long 
bones were found to be the most commonly affected bones in significantly young 
DMD patients in terms of increased rate of fracture (Morgenroth et al., 2012). 
Therefore, the tibia was used in the current study for morphometric and 
biomechanical analysis. This is the first time that P2RX7 receptor knockout mice 
have been used for modelling the DMD bone phenotype.  
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A major finding of the current study is the significant deficit in mechanical properties 
of bone seen in the mdx mice. The mechanical test has been performed on a four-
week-old P2RX7 receptor knockout mouse model. Anderson et al. (1993) studied the 
WT and mdx mouse model at different ages (4 weeks, 12 weeks and 18 weeks). The 
deficiencies in mechanical properties noted in mdx mice were profound (38% 
reduction in maximum load and 41% in stiffness) compared with those of WT.  This 
could explain the occurrence of low-energy fractures reported in DMD patients 
(Vestergaard et al.; 2001, Chan et al., 2011; Pouwels et al., 2013).  
Most significantly, the mechanical properties of the mdx/P2X7-/- bones also changed, 
and the knockout bones are found to be more ductile compared with those of mdx. A 
28% increase in work-to-failure, 21% increase in flexural strength and 64% increase 
in strain at failure are found in the mdx/P2X7-/- mice compared with those of mdx 
(Figure 5-4).  Moreover, mdx/P2X7-/- bones are found to have higher values for the 
above properties when compared with that of WT and have approximately close 
values to P2X7-/- bones. These findings are encouraging in supporting our original 
hypothesis of the role of P2RX7 receptor. These changes might be attributed to the 
substantially higher cortical bone area and cortical area fraction of the mdx/P2X7-/- 
bones. These results suggest that the mdx/P2X7-/- bones are stronger and more 
resistant and therefore less susceptible to fracture.  Although the strength of the 
double mutant bones did not improve significantly compared with that of the mdx, the 
improvement in strain to failure in these bones is quite remarkable. The mdx/P2X7-/- 
mice showed a lower maximum load values of 22% and stiffness values of 53% 
(p=0.010) compared to age-matched WT mice, while the P2X7-/- mice showed 
improvement in all mechanical parameters compared to mdx, but no improvement in 
SMA values. However, none of these measures are statistically significant (Table 5-
1). 
Mechanically, the average flexural strength in mdx/P2X7-/- mouse bones improved 
due to the reduced moment of inertia of smaller bones compared to that of mdx, 
despite an apparent reduction in the measured maximum load (Table 5-1). More 
importantly, the improved work-to-fracture and the significantly increased strain to 
failure indicate a marked improvement in ductility for the mdx/P2X7-/- mouse bones 
over that mdx. On the other hand, the slightly different bone phenotypes in P2X7-/- 
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and mdx/P2X7-/- may indicate some interplay between this receptor and the 
dystrophin absence. Further studies are needed to explore the expression of 
dystrophin in bone cells and its possible impact on the functions of P2RX7 receptors 
in this tissue. 
This study has several limitations. Specifically, the complex bone geometry (i.e non-
uniform cross-section of the bone) may be a factor that limits the accuracy of the 
results. However, several assumptions underlie the use of beam theory. They are (a) 
the beam should be made from a homogeneous, linear-elastic, material, (b) the 
beam should have a uniform cross-section, and (c) it should be long in proportion to 
its depth (Young and Budynas, 2002). These assumptions are well known and have 
been identified as potential errors in the three-point bending test as it is clear that 
they are not met for the mouse bone (van Lenthe et al., 2008). Indeed, it is also 
noted greater variance in this test than in the other biomechanical tests, which may 
limit our ability to resolve subtle changes in mechanical parameters. Nevertheless, 
this test has been used in similar mouse models to show deficits in tibia integrity 
(Nakagaki et al., 2011; Novotny et al., 2011). Furthermore, in this work the 
specimens were fixed in phosphate buffered formal saline (PBFS) solution for long 
term storage with limited tissue shrinkage for CT scanning and mechanical testing.  
Although fixing bone samples in formalin is one of the common fixation methods for 
microscopic studies, there have been reports on the variation of the strength 
measured in embalmed samples, possibly due to an increase in collagen cross-
linking.  Nevertheless, as the same fixation method was used for all the samples 
examined here, the relative values of mechanical properties obtained should be 
useful for comparison purposes. 
An important finding of the current study is the improvements in cortical bone 
mechanical properties due to the ablation of the P2RX7 receptor in dystrophic mice. 
This finding mirrors the improvements seen in dystrophic muscle and non-muscle 
symptoms (Sinadinos et al., 2015).  
Quantitative assessments of the strength and toughness of small animal bones may 
be carried out using a number of approaches (Jepsen et al., 2015; Ritchie et al., 
2008). In terms of toughness, both work-to-fracture and fracture toughness may be 
used. Work-to-fracture has the advantage of measuring both strength and toughness 
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using the same un-notched specimen at the same time, although the measured 
properties are usually size-dependent. Fracture toughness measurements require a 
pre-crack or sharp notch, which is considered best suited for controlled fracture tests 
(Ritchie et al., 2008) for characterising the inherent resistance of a material to 
fracture.  In this work, we adopted the former due to the similar sizes of the samples 
across phenotypes; for convenience; and to ensure a lack of ambiguity of the 
measured mechanical properties in terms of strength, stiffness and work-to-fracture.  
Our approach follows the guidelines of Jepsen et al. (2015) with respect to assessing 
the mechanical properties of mouse bones. 
A variety of toughening mechanisms (Li et al., 2013), such as bridging, might be at 
work, giving rise to the ductile behaviour observed particularly in mdx/P2X7-/- bones. 
A twisting and pulling-out of collagen fibrils in response to the external force were 
observed. This may interrupt the propagation of cracks, resulting in higher resistance 
to fracture and greater strain to failure. These findings are quite encouraging and 
potentiate our hypothesis regarding P2RX7 receptor knockout of the DMD bone 
phenotype. 
These results suggest that the bone abnormalities present in DMD mouse model 
might be reversible by the ablation of the P2RX7 receptor. It has also been found 
that significant amelioration of the symptoms of DMD can be achieved from the 
blockade of the P2RX7 receptor in the DMD mouse model (Sinadinos et al., 2015).  
The primary organic component of the bone matrix is type 1 collagen. An alteration 
in the type 1 collagen may affect the mechanical behaviour of the bone structure 
(Vashishth, 2007). The reduction in mechanical properties of the mdx mice bone 
might be attributed primarily to poorer organization of collagen fibers and reduced 
collagen content. A similar bone condition in the oim model of osteogenesis 
imperfecta and bone fragility (SAMP6) has mutated collagen leading to reduction in 
bone strength. Lower collagen content might be a feature of the lower stiffness and 
flexural strength in mdx mice bone at microstructural level (Silva et al., 2006).  
The results obtained from the mechanical test study are quite encouraging, in terms 
of the improvement in certain mechanical properties in mdx/P2X7-/- mice.  These, 
together with improved bone volume, would suggest improved bone integrity when 
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the P2RX7 receptor is switched off. Further exploration is needed with respect to the 
mechanism by which the P2RX7 receptor causes the improvements. A further 
experiment to explore the tissue properties of the genotypes under study will be 
discussed in the next chapter.  
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Chapter 6 
Analysis of bone tissue properties across the genotypes using 
nanoindentation 
6.1 Introduction 
Nanoindentation is a tool to characterise bone material tissue properties in the sub-
micron range. In addition to measuring the basic hardness values, depth-sensing 
indentation has been routinely used to extract the elastic properties of bone, with 
known indenter geometry and material properties.  
The results from the previous chapters suggest that there are likely to be alterations 
in bone material properties in mdx/P2X7-/- mice. In the current experiments, it was 
hypothesised that alterations in material tissue properties may explain the changes 
in the morphological and mechanical properties observed in the mdx mouse model 
and P2RX7 ablation. Thus, the specific aim of the experiment reported in this 
chapter was to determine the tissue properties of bones in P2RX7 knockout in mdx 
mice, mdx/P2X7-/-, compared to those of WT, mdx and single knockout mice (P2X7-/-
). The objective is to explore potential receptor-related deficiencies in material 
properties of bone at the bone matrix level. It is also aim to establish whether 
compared with possibly altered and deteriorated properties of mdx mice, the 
properties of mdx/P2X7-/- are somewhat reversed as far as the elastic and 
viscoelastic behaviour is concerned.  
6.2 Results 
Following the morphometric and three-point bending analysis, nanoindentation was 
conducted and the results are presented as the mean ± standard deviation (SD) for 
each group of samples (n=6 per genotype). Significant difference was assessed by a 
non-parametric Kruskal–Wallis test for advanced (standard) and sinus (dynamic) 
indentations. A statistically significant difference was indicated by p<0.05. A 
comparison of the properties is made between mdx/P2X7-/- and WT=a, mdx=b, 
P2X7-/-=c. The comparison of genotypes will be discussed based on WT (control), 
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mdx, P2X7-/- (P2RX7 single knockout) and mdx/P2X7-/- (P2RX7 and mdx double 
knockout) mice.  
6.2.1 Cortical bone tissue properties in WT and mdx mice from the advanced 
loading protocol.  
Table 6-1 shows the mean and the SD of nanoindentation parameters from the 
advanced protocols. For cortical bones, statistically significant differences in the 
hardness (p=0.028), indentation modulus (p=0.007), elasticity (p=0.000) and creep 
(p=0.000) were observed between the mdx and WT mice. Significantly lower 
hardness (by 4.3%) and elasticity (the elastic part of the indentation work, by 11.1%), 
but higher creep (by 15.6%) and modulus (by 6%) were found in the mdx mice 
compared to in the WT mice.  
6.2.2 Trabecular bone tissue properties in WT and mdx mice from the 
advanced loading protocol.  
For trabecular bones, there seemed to be no significant differences between the 
properties of WT and mdx mice. Approximately similar values in elasticity and creep 
were obtained across the genotypes, although differences were found between 
hardness and modulus between the knockout and WT bones. The average values 
for the latter two properties were higher in knockout mice compared to those of mdx, 
although not statistically significant. Compared with the mdx mice, WT mice have 
lower advanced nanoindentation property values, except for elasticity, which is 
slightly higher in WT than that in mdx mice (24.58±2.86 vs. 24.40±3.56, %).  
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Table 6-1 Nanoindentation results produced by using the ‘advanced’ loading 
protocol for the tissue properties of the mouse bones.  
a,b,c 
and bold text indicate p<0.05 (Kruskal–Wallis). 
a
 Statistically significant difference (<0.05) with WT. 
b
 Statistically significant difference (<0.05) with mdx. 
c
 Statistically significant difference (<0.05) with P2RX7
-/-
. 
 
6.2.2 Cortical bone tissue properties in mdx/P2X7-/- mice from the advanced 
loading protocol. 
For cortical bones, statistically significant differences in the hardness, indentation 
modulus, elasticity and creep were observed between the mdx/P2X7-/- and the mdx 
mice. Lower modulus (p=0.003, by 4.8%) and creep (p=0.000, by 13%), but higher 
hardness (p=0.040, by 3.5%) and elasticity (p=0.000, by 11.3%), were found in the 
mdx/P2X7-/- compared to those in the mdx mice; hence, the double-mutant mice 
showed properties closer to those of WT than those of mdx. For example, the 
Material 
properties 
WT mdx P2X7-/- mdx/P2X7-/- 
    
Cortical Advanced    
Hardness 
(MPa) 
643.65±66.62 616.27±57.42a 628.36±57.36 637.89±49.58b 
Ind. Modulus 
(GPa) 
17.28±1.91 18.31±1.52a 16.87±1.22b 17.44±1.28b,c 
Elasticity (%) 22.88±2.25 20.34±2.12a 22.76±2.75b 22.63±2.59b 
Creep (%) 5.89±1.05 6.81±1.15a 6.02±1.23b 5.92±0.91b 
     
Trabecular Advanced    
Hardness 
(MPa) 
437.14±104.63 475.65±97.37 523.46±98.60a 505.79±102.47a 
Ind. Modulus 
(GPa) 
10.97±1.87 11.77±2.18 12.56±1.98a 12.48±2.07a 
Elasticity (%) 24.58±2.86 24.40±3.56 24.93±4.80 24.40±3.60 
Creep (%) 6.53±1.08 6.77±1.90 6.18±2.17 6.55±1.58 
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elasticity in mdx/P2X7-/- mice was significantly higher than that of mdx mice, but 
close to that of WT and P2X7-/-. 
 
Figure 6-1 Comparison of hardness (A) and elasticity (B).  
Bar charts show hardness (A) and elasticity (B) across the genotypes. Star (*) shows 
statistically significant difference. 
For P2X7-/- cortical bones, statistically significant differences were observed in all 
advanced properties except for hardness (p>0.05). The advanced loading properties 
were found to have no difference with those of WT whilst there were differences 
between P2X7-/- and mdx mice. P2X7-/- mice were observed to have a similar trend to 
the mdx/P2X7-/- in contrast with the mdx. Significantly lower indentation modulus 
(p=0.000) and creep (p=0.005) were found in the P2X7-/- mice compared to those of 
the mdx mice, whilst significantly higher elasticity (p=0.000) was observed in the 
former.  
 
6.2.3 Trabecular bone tissue properties in mdx/P2X7-/- mice from advanced 
loading protocol.  
For trabecular bones, there seemed to be no significant differences between the 
properties of mdx/P2X7-/- and mdx mice. Quantitatively, the mdx/P2X7-/- trabecular 
bones show higher average hardness and indentation modulus compared to those of 
the mdx bones whilst elasticity (% of elastic to total work) seemed to be of similar 
value.  Lower creep was found in the mdx/P2X7-/- mice (6.55±1.58 vs 6.77±1.90, %) 
than that of mdx. The mdx/P2X7-/- bones show significantly higher hardness (p= 
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0.006, 505.79±102.47 vs. 437.14±104.63) and indentation modulus (p= 0.014, 
12.48±2.07 vs. 10.97±1.87) than those of the WT mice. No significant differences 
were observed for elasticity (nIT)  and creep (CIT) between those of mdx/P2X7
-/-, WT 
or mdx mice. 
A Pearson’s correlation analysis was conducted to investigate the relationship 
between creep and elasticity, as shown in Figure 6-2 and Figure 6-5. They show that 
creep decreases with the increase in elasticity for all WT, mdx and mdx/P2X7-/- 
bones. The negative correlations between creep and elasticity are shown in Figure 
6-2 for cortical bones, and Figure 6-3 for trabecular bones. Figure 6-2 (Cortical bone) 
shows WT (R2= 0.590) and mdx/P2X7-/- (R2= 0.530) bones produced lower R2 
value than that of mdx (R2= 0.652). The variability of the data around the two 
regression lines was approximately identical for (a) and (b). The results seem to 
suggest that P2RX7-/- ablation reverses, to a large extent, the effects of the 
dystrophic abnormality; thus, the tissue response of mdx/P2X7-/- bones is close to 
that of WT bones. 
 
 
Figure 6-2 The correlation between creep and elasticity. 
The linear regression graphs show the cortical bones of (a) WT and mdx and (b) 
mdx and mdx/P2X7-/- from the advanced nanoindentation.  
 
For cortical bone, indentation hardness, modulus and creep are broadly correlated 
with the elasticity, although in some cases weakly (WT). The elasticity is positively 
correlated with the hardness, but negatively correlated with the indentation modulus 
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and creep.  Highly significant negative correlations are found between elasticity and 
creep. 
Further correlation analyses were used to analyse relationships as shown in Table 6-
2. A similar trend exists for the mdx and the mdx/P2X7-/- mice (p<0.01). Figure 6-3 
(Trabecular bone) shows that there are strong negative correlations between the 
creep and the elasticity in mdx (R=-0.720, p=0.000) and mdx/P2X7-/- (R=-0.843, 
p=0.000), as opposed to WT (R=0.173, p=0.388) trabecular bones. The relationships 
between creep and elasticity of the mdx (R=-0.720, p=0.000) and mdx/P2X7-/- bones 
are almost identical.  
Table 6-2 Correlations between some of the advanced nanoindentation parameters.   
** Correlation is highly significant at the level 0.01 level (2-tailed) 
* Correlation is significant at the level 0.05 level (2-tailed)  
 
Advanced 
  Hardness 
(MPa) 
Indentation 
Modulus (GPa) 
Creep  
(%) 
Cortical      
Elasticity (%) WT R 0.317* -0.436** -0.768** 
  p 0.028 0.002 0.000 
 mdx R 0.646** -0.309* -0.808** 
  p 0.000 0.033 0.000 
 P2X7-/- R 0.671** -0.526** -0.852** 
  p 0.000 0.000 0.000 
 mdx/P2X7
-/- R 0.641** -0.668** -0.728** 
  p 0.000   0.000 0.000 
Trabecular      
Elasticity (%) WT R 0.064 -0.390* 0.173 
  p 0.750 0.045 0.388 
 mdx R 0.242 -0.384* -0.720** 
  p 0.224 0.048 0.000 
 P2X7-/- R 0.810** -0.360 -0.896 
  p 0.000 0.065 0.000 
 mdx/P2X7
-/- R 0.563** -0.255 -0.843** 
  p 0.002 0.200 0.000 
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Figure 6-3 Linear regressions between creep and elasticity of trabecular bone 
of (a) WT and mdx and (b) mdx and mdx/P2X7-/-.  
 
6.2.4 Cortical bone tissue properties in mdx and WT mice from the sinus 
loading protocol.   
Table 6-3 shows the mean and the SD of nanoindentation parameters from the sinus 
protocols. For sinus indentation, there were no significant differences between the 
properties of WT and mdx mice except for elasticity. The elasticity in the cortical 
bones of the mdx mice was found to be significantly lower than that of the WT mice 
(p=0.007). Figure 6-4 also shows that the elasticity in mdx mice is significantly lower 
than that of the P2X7-/- mice (p=0.040).  
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Table 6-3 Nanoindentation results produced by using the sinus loading protocol for 
the tissue properties of the mouse bones.  
a,b,c 
and bold text indicate p<0.05 (Kruskal–Wallis). 
a
 Statistically significant difference (<0.05) with WT. 
b
 Statistically significant difference (<0.05) with mdx. 
c
 Statistically significant difference (<0.05) with P2RX7
-/-
.
 
 
 
Figure 6-4 Comparison of elasticity for cortical bones from sinus indentation. 
The percentage elasticity in mdx mice is lower compared to that of the WT mice 
(p<0.05), as well as compared to the P2X7-/- mice (p<0.05). Star (*) shows 
statistically significant difference. 
Material properties WT mdx P2X7-/- mdx/P2X7-/- 
     
Cortical sinus     
Phase Difference (∂) 3.50±0.61 3.72±1.01 4.14±1.04 4.13±0.91a 
Storage Modulus (GPa) 20.63±2.29 20.13±2.05 19.33±2.19 21.31±1.86c 
Loss Modulus (GPa ) 1.28±0.27 1.32±0.32 1.43±0.44 1.56±0.33a,b 
Elasticity (%) 21.36±2.04 19.36±1.78a 20.85±2.08b 20.56±2.29 
     
Trabecular sinus     
Phase Difference (∂) 4.75±1.58 4.95±2.42 4.08±1.67 4.23±1.18 
Storage Modulus (GPa) 13.61±2.47 16.92±2.74a 17.43±2.08a 15.45±2.42a,c 
Loss Modulus (GPa ) 1.07±0.46 1.50±0.74 1.24±0.45 1.17±0.41 
Elasticity (%) 23.10±3.01 22.53±3.22 24.25±5.09 21.62±3.27 
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6.2.5 Cortical bone tissue properties in mdx/P2X7-/- mice from the sinus 
loading protocol.  
Statistically significant differences were found in loss modulus between the 
mdx/P2X7-/- and the mdx (p=0.025) and the WT (p=0.014) mice in the cortical bone 
(Figure 6-5). Otherwise, the average values of elasticity in the mdx/P2X7-/- bones 
appear to be closer to those of the WT and P2X7-/- mice. Although there were no 
significant differences across the genotypes. 
 
 
Figure 6-5 Comparison of loss modulus for cortical bones from sinus 
indentation. Star (*) shows statistically significant difference. 
 
Significant differences were seen in loss modulus between the four comparison 
genotypes (WT=1.28 ± 0.27, mdx=1.32 ± 0.32, P2RX7-/-=1.43 ± 0.44, mdx/P2RX7-/-
=1.56 ± 0.33). For P2X7-/- cortical bones, a statistically significant increase in 
elasticity (p= 0.040, by 8%) was observed compared to that of mdx. The average 
value of sinus indentation properties for most sinus loading protocols were higher for 
both knockout mice bones compared to that of mdx.   
 144 
 
6.2.6 Trabecular bone material properties in mdx and WT mice from the sinus 
loading protocol. 
A higher storage modulus is found in mdx trabecular bones compared to WT bones 
(p=0.001) (Figure 6-6), whilst no significant difference is observed in other sinus 
properties. Similar to cortical bones, the elasticity in trabecular bones is positively 
correlated with the hardness, but negatively correlated with the indentation modulus 
and creep (except in WT) (Table 6-3).  
 
 
Figure 6-6 Comparison of storage modulus for all genotypes. 
The comparison between WT and mdx revealed a significant difference, where the 
mdx mice showed a higher storage modulus. Star (*) shows statistically significant 
difference. 
 
6.2.7 Trabecular bone material properties in mdx/P2X7-/- mice from the sinus 
loading protocol  
No significant difference was observed in mdx/P2X7-/- trabecular bones as compared 
to that of mdx from sinus indentation. Although a higher storage modulus (p=0.029) 
was found when compared with that of the WT mice, a lower value (p=0.016) was 
noted when compared to the P2X7-/- mice. The storage and loss modulus values in 
mdx/P2X7-/- trabecular bones appear to be closer to those of the WT mice.  
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Significant positive correlations are found between elasticity and hardness in the 
knockout mice (P2X7-/-, R=0.810, p=0.000; mdx/P2X7-/-, R=0.563, p=0.002), whilst 
significant negative correlations are found between elasticity and creep in the mdx 
and mdx/P2X7-/- models. 
The results seem to suggest that P2RX7-/- ablation reverses, to a large extent, the 
effects of the dystrophic abnormality, thus the tissue responses of mdx/P2X7-/- are 
close to those of WT bones. 
 
6.3 Discussion 
A major finding of the current study is the significantly deficient tissue properties of 
mdx mice as compared to other genotypes, as well as an improvement in 
morphometric and mechanical properties of mdx/P2X7-/- mice, indicating the effect of 
ablation. This is the first time that nanoindentation tests have been performed on 
mdx and P2RX7 ablation mice.  
Nanoindentation has made it possible to characterise the quality of bone matrix. The 
matrix properties, as a result of the composition and organisation of mineralised 
collagen fibres, together with anatomy, define the mechanical behaviour of the whole 
bone. In this study, the indents were consistently positioned in the medial surface of 
the midtibia to obtain the cortical. Due to the heterogeneity of the bone 
microstructure, the method reduces the measurement variation within the sample 
(Hengsberger et al., 2002; Zysset et al., 1999). Precise and selective positioning of 
the indentor in the heterogeneous bone microstructure (i.e. on thick or thin lamellae; 
on interstitial or osteonal matrix) might help in some cases to reduce data variation 
(Finnila et al., 2010). 
The nanoindentation was carried out in dry conditions, which is a common practice 
adopted for easy comparison with the published work, and to reduce the influence of 
factors such as noise and hydration state of the bones. Although the modulus 
measured in the wet condition is known to be about 10–20% lower than that in dry, 
this is not considered an issue for comparison purposes. 
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The deficiencies in the mdx cortical bone matrix are evident (4.3% lower hardness, 
11.1% lower elasticity and 15.6% higher creep than those of the WT mice), and 
these could explain the occurrence of low energy fractures reported in DMD patients. 
Nanoindentation data showed, for the first time, the tibias of mdx mice to be more 
brittle and less able to store energy compared to the WT bones (Table 6-3). There is 
evidence that the bone tissue is also significantly affected in DMD at an early stage 
of the disease before the muscle fibers are fully developed. These results are 
consistent with the report by Nakagaki et al. (2010) who demonstrated biochemical 
and mechanical properties alteration at 21 days of age. Overall the properties of the 
mdx/P2X7-/- cortical bone matrix are significantly better than those of the mdx bones 
(3.5% hardness, 11.3% elasticity, 11% phase difference, 6% indentation modulus 
and 18% loss modulus). The mdx/P2X7-/- trabecular bone matrix seems to follow a 
similar trend, although no statistically significant difference is observed.  
The mdx/P2X7-/- mice, in which P2RX7 is switched off, revealed a significant 
increase in cortical bone mechanical properties (strain at failure, flexural strength 
and work-to-fracture) as compared to mdx mice. Furthermore, the tissue properties 
revealed significant increases in hardness, elasticity, phase difference, storage and 
loss modulus (cortical bone), and hardness and indentation modulus (trabecular 
bone).  
An extensive analysis of osteogenic markers reported by Rufo et al. (2010) suggests 
the overall downregulation of many transcripts in DMD has reduced the ability of 
osteoblasts to mineralise. In the thesis, the influence of bone mineralisation, where 
an increase in the mineral content of the matrix increases both the indentation 
modulus and hardness, is observed in both knockout mice bones (mdx/P2X7-/-: 
10.82±1.17, % and P2X7-/-: 11.45±0.07, %) as compared to those of the mdx mice 
(9.53±0.43,%). Additionally, an increase in the mineral content reduced the plasticity 
of the bone, the viscoelasticity (i.e., increased storage modulus/decreased loss 
modulus) and the overall creep strain magnitude. The increase in mineralization 
resulted in a stiffer material with improved matrix strength. The increased storage 
modulus (cortical bone) increased the viscoelasticity, while high collagen 
concentrations were related to a decreased loss modulus.  
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The loss modulus is significantly higher in the cortical bone of the mdx/P2X7-/- mice, 
and slightly higher, though not significantly so, in P2X7-/- mice when compared with 
those of mdx mice, suggesting a relatively higher collagen–mineral ratio in P2RX7 
knockout bones, most likely as a consequence of increased mineralisation. The 
trabecular bone architecture seems to be unaffected, except the significantly 
reduced storage modulus compared to those of the WT and P2X7-/- mice. 
The current data demonstrate that the relationship between bone matrix material 
properties and mineralisation across the genotypes principally follow the same 
general pattern. Our results suggest that P2RX7 ablation has improved the tissue 
properties of the mdx mice bones. The macroscopic changes in bone morphometric 
and biomechanical properties had a significant adverse effect on the mechanical 
outcome. At the micromechanical level, the data show severity in bone changes for 
the mdx mice, and a positive effect on the P2RX7 knockout mice.  
As a composite material, the fracture toughness and strength of bone are related. A 
decrease in mineral content, or an increase in porosity and disorganisation (isotropy 
in micro-architecture and layout of fibrils) is associated with the decrease in 
hardness and the modulus of elasticity. 
Bone remodelling involves replacing old bone tissues with new ones. A high 
remodelling rate results in undermineralisation, which makes the bone less stiff, 
while low remodelling results in a higher mineralization level, causing bones to be 
more brittle (Seeman, 2008).  
Taken together, for the first time, this study demonstrates tissue properties of DMD 
bone and P2RX7 knockout models as evaluated by nanoindentation at the bone 
matrix level. The ablation of P2RX7 has resulted in a mechanically stronger bone 
matrix that is able to store more energy than mdx mice.  
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Chapter 7 
Conclusions 
The effects of P2RX7 ablation on bone morphometric, mechanical and tissue 
properties have been studied using imaging, biomechanical and nanoindentation 
techniques.  Four genotypes have been examined, including WT, mdx, P2X7-/- and 
mdx/P2X7-/- mice. The objective of the experiments was to examine if the ablation of 
P2RX7 in dystrophic mice will result in improving bone phenotypes. Male mdx mice 
are considered the most appropriate pre-clinical model to test treatment efficacy for 
DMD, as this dystrophin-mutant mimics the pathology seen in human DMD. 
The study has provided some important information for future genetic therapeutic 
interventions that are likely to impact on bone phenotypes. In this chapter, the major 
findings are summarised, together with limitations and possible future work. 
7.1. Major findings of the study 
Morphometric properties 
 In cortical bones, mdx mice have lower values of total cross-sectional area inside 
the periosteal envelope (Tt.Ar), cortical bone area (Ct.Ar), cortical area fraction 
(Ct.Ar/Tt.Ar) and cortical thickness (Ct.Th) compared to those of WT mice, 
although the difference was only statistically significant in Ct.Ar and Ct.Th. The 
findings are in a good agreement with published literature (Anderson et al., 1993; 
Nakagaki et al., 2011).  
 In cortical bones, the morphometric properties of WT and P2X7-/- bones at four 
weeks are not significantly different.  
 In cortical bones, significantly more bone per area/per volume is found in 
mdx/P2X7-/- mice than in all other types, as indicated by the significantly higher 
cortical bone area (Ct.Ar) and cortical bone area ratio (Ct.Ar/Tt.Ar). However, the 
ablation of P2RX7 led to smaller bones, with significantly lower cross-sectional 
area (Tt.Ar) and SMA in mdx/P2X7-/- mice than the other types.   
 In trabecular bones, the mdx mice are found to have significantly lower bone 
volume fraction (BV/TV) and trabecular thickness (Tb.Th) compared to those of 
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WT. These results are similar to those reported in the literature (Nakagaki et al., 
2011).  
 In trabecular bones, no significant difference between P2X7-/- and WT is noted 
except for the trabecular space, which is found lower in P2X7-/- bones.  
 In trabecular bones, significantly higher BV/TV is found in mdx/P2X7-/- mice. The 
ablation of P2XR7 does not seem to affect the trabecular bone architecture, as 
indicated by the similar values of Tb.Th, trabecular spacing (Tb.Sp) and 
connectivity (Conn.D).   
 
Mechanical properties 
 Mechanical analysis has revealed a low maximum load, stiffness, work-to-
fracture, flexural strength and second moment of area (SMA) in mdx mice 
compared to those of WT mice. These findings suggest that the mdx bones are 
weaker and prone to fracture, consistent with increased incidence of fracture in 
DMD patients. 
 No significant difference between P2X7-/- and WT mice is noted in mechanical 
properties, except for stiffness, which is significantly lower in P2X7-/- compared to 
that in WT. 
 The significant improvement in strain at failure in mdx/P2X7-/- over mdx  mice (by 
64%) seemed to suggest greater ductility in mdx/P2X7-/- mice; whilst higher 
average values of work-to-failure and flexural strength are found than those of 
mdx (by 28% and 21%, respectively), although not statistically significant.  
 
Tissue properties 
 In cortical bones, significantly lower hardness and elasticity, but higher creep and 
modulus are found in the mdx mice compared to those of the WT mice in both 
nanoindentation loading protocols. 
 In cortical bones, the advanced and sinus loading properties in P2X7-/- mice are 
found to have no difference from those of WT. 
 The hardness and elasticity in cortical bones of mdx/P2X7-/- mice are significantly 
higher whilst indentation modulus and creep significantly lower than those of mdx 
bones. Thus overall the ablation seems to have improved the bone tissue 
properties.  
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 In trabecular bones, no differences are found between the properties of WT and 
mdx mice. However, a higher storage modulus is found in mdx compared to that 
in WT bones. The trabecular bone tissue properties seem to be not affected by 
the disease at tissue level. 
 A similar trend is observed in mdx/P2X7-/- and P2X7-/- bones. where no 
differences are found between the trabecular tissue properties of mdx/P2X7-/- and 
mdx mice. Specifically, the average values for hardness and modulus are 
relatively higher in the knockouts mice compared to those of mdx, although not 
statistically significant. The two properties are also found to be higher in 
mdx/P2X7-/- than in WT trabecular bones. In sinus indentations, the storage and 
loss modulus in mdx/P2X7-/- trabecular bones appear to be closer to those of the 
WT mice. 
 
Overall 
The main finding of the current study and one with therapeutic significance is that the 
bone anomalies observed in mdx mice in terms of cortical bone material and 
biomechanical properties seem to be rescued by the inactivation of P2RX7, the 
receptor that is expressed in both osteoblast and osteoclasts. It is noted that the 
receptor appears to have different roles in bone physiology and in disease states, 
although the overall effect appears to be positive.   
 
7.2 Limitations 
In the current study, µCT was mainly used to obtain 3D images of the bone 
microstructure facilitating in bone morphometric analysis. Although µCT is 
considered the gold standard for assessing bone mass (bone mineral density), due 
to the absence of phantom material of known bone density, a calibration could not be 
conducted in the laboratory to allow bone mineral density to be measured from the 
µCT images.  
 Another finding is the absence of significant difference in bone mineral density 
(TGA test). The test was conducted on only two bones per genotype (n=2). 
Based on the sample size, the measurements were analyzed by conducting 
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ANOVA tests to compare means of more than two groups. More tests and a 
power test should be performed to verify the preliminary results obtained here. 
The preliminary TGA test was conducted to explore the bone tissue composition 
in these animal models. The bone compositions in mdx/P2X7-/- and P2X7-/- mice 
seem to be higher in organic, mineral, and water content values than mdx. These 
findings indicate a need to further explore other possible factors (cellular function 
and alteration in extracellular matrix) that might be involved in the robust increase 
of bone strength and structural parameters seen in mdx/P2X7-/- mice.  
 In this work the specimens were fixed in phosphate buffered formal saline (PBFS) 
solution for long term storage with limited tissue shrinkage for CT scanning and 
mechanical testing.  Although fixing bone samples in formalin is one of the 
common fixation methods for microscopic studies, there have been reports on the 
variation of the strength measured in embalmed samples, possibly due to 
increase in collagen cross-linking. Nevertheless, as the same fixation method 
was used for all the samples examined here, the relative values of mechanical 
properties obtained should be useful for comparison purposes. 
7.3 Future studies 
The aim of this project was to explore the consequence of inactivation of P2RX7 
receptor on bone properties in an animal model of DMD. This represents a logical 
path in reaching the ultimate goal of examining the impact of P2RX7 ablation on the 
bone properties during the acute disease phase in human, before muscle wasting is 
fully developed. 
 The role of P2RX7 receptor on bone cells (osteoblasts and osteoclasts) has been 
studied but the results are unclear. To investigate whether ablation affects bone 
formation or bone resorption would require extensive experimental work in future 
studies, for example analysis of biochemical markers of bone formation and 
resorption e.g. tartrate-resistant acid phosphatase (TRAP) staining for 
osteoclasts.  
 Further substantial experimentation to investigate the effects of ablation on 
mineralization, collagen crosslinking or cortical porosity. Future experimental 
work may include, for example, testing mineralisation of osteoblasts in culture,  
 152 
 
 Tibia was a suitable bone for the current study. It was used in order to extend 
our analysis in the 4 week assessment period of previous studies. Testing either 
femur or radius would have been a better choice for future studies because they 
are more uniform in shape.  
 In the current study, 4 week old mouse model was used. In future, animal studies 
may be done to explore the possible effects of P2RX7 on bone mass formation 
and later on ossification of the bone, using the embryonic and postnatal murine 
models. These experiments will give a better understanding on the exact time in 
which the deleterious effects of P2RX7 start impacting bone properties. This will 
also help in the development of therapeutic strategies and the exact time at which 
they should be implemented.       
 The study serves a potential treatment strategy at the very early phase of disease 
before the muscle wasting has fully developed. The mechanisms that led to the 
changes in the bones due to the loss of P2RX7 may be complex and require 
further studies.    
 
Based on the findings of the study, the altered structural parameters, increased 
mechanical properties as well as tissue properties in mdx/P2X7-/- mice points toward 
the fact that targeting P2RX7 can attenuate DMD symptoms affecting bone structure 
in addition to the therapeutic effects in the muscle. Improved knowledge on how 
P2RX7 is involved in bone metabolism is important to assist directions for prevention 
and treatment in order to improve bone health in DMD patients. 
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